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A strategy for the preparation of 3-vinyl-2-alkylidene-3-cyclohexen-1-ones has been developed 
using an intramolecular rhodium(I)-catalyzed carbocyclization reaction of allene-ynones.  
Application of this strategy towards the preparation of analogs of the anticancer agent irofulven 
was realized, leading to highly functionalized spiro[2.5]octatrienes. 
A novel approach to ε-lactams from allene-containing propargyl amides has been 
achieved, also using the rhodium(I)-catalyzed carbocyclization reaction.  Further elaboration of 
this strategy has afforded triene-containing azepines and a pyrroloazepinone. 
A diverging diversity-oriented synthesis (DOS) strategy using tryptophan as a key 
starting material was investigated.  Constructon of allenic tetrahydro-β-carboline scaffolds via a 
Pictet-Spengler reaction and subsequent silver(I)-catalyzed cycloisomerization afforded 
tetrahydroindolizinoindoles.  Conversion of the tetrahydro-β-carboline to an allenic propiolamide 
followed by a microwave-assisted allenic [2 + 2] cycloaddition reaction provided 
tetrahydrocyclobutaindoloquinolizinones.  An allene-yne substituted derivative of tryptophan 
gave indolylmethylazabicyclooctadiene when subjected to a microwave-assisted allenic [2 + 2] 
cycloaddition reaction. This same tryptophan-derived precursor afforded an  
indolylmethyldihydrocyclopentapyridinone when subjected to a rhodium(I)-catalyzed 
cyclocarbonylation reaction.   
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1.0  RHODIUM(I)-CATALYZED CARBOCYCLIZATION REACTIONS OF 
ALLENE-YNONES:  PREPARATION OF 3-VINYL-2-ALKYLIDENE-3-
CYCLOHEXEN-1-ONES 
1.1 INTRODUCTION 
1.1.1 Transition Metal-Catalyzed Carbocyclization Reactions of Enynes 
Transition metal-catalyzed carbocyclization reactions of enynes have been used extensively to 
prepare 1,4-dienes.  A number of transition metals catalyze the carbocyclization process with 
palladium being the most popular metal.1  For example, enyne 1-1 was reacted with 5 mol% 
palladium(II)triphenylphosphine acetate [Pd(PPh3)2(OAc)2] to afford 1,4-diene 1-2 in 71% yield 
as only the E isomer (Scheme 1.1, eq. 1).2a-c  Two other examples are shown below, highlighting 
metal complexes of ruthenium and rhodium, which are gaining in popularity.  Enyne 1-3 was 
reacted with 10 mol% tris(acetonitrile)cyclopentadienyl ruthenium(II) hexafluorophosphate 
[CpRu(CH3CN)3PF6] to obtain 1,4-diene 1-4 in 82% yield (Scheme 1.1, eq. 2).2d  Zhang used 
rhodium(I)(BICPO) chloride dimer activated with silver hexafluoroantimonate 
([Rh(BICPO)Cl]2-AgSF6) to produce 1,4-diene 1-6 in 84% yield (Scheme 1.1, eq. 3).3  
  
 2 
1.5 mol% 
[Rh(BICPO)Cl]2,
 3 mol% AgSbF6,
 
DCE, rt, 16 h, 
90%
eq. 1
eq. 2
eq. 3
CpRu(CH3CN)3PF6
HE
E
E
E
10 mol%
0.2 M, DMF, 
rt, 1 h, 82%
1-1
1-41-3
1-2
1-61-5
5 mol%
C6D6, 60 °C, 
1 h, 71%
(CH2)8CH(OMe)2
(MeO)2HC(H2C)7
E
E
E
E
Pd(PPh3)2(OAc)2
E = CO2CH3
E = CO2CH3
E
E
E
E
 
Scheme 1.1 Transition Metal-Catalyzed Carbocyclization Reactions of Enynes Affording 1,4-Dienes 
1.1.2 Transition Metal-Catalyzed Carbocyclization Reactions of Allene-ynes 
Until recently, transition metal catalyzed carbocyclization reactions of allene-ynes have been 
rare.  The first transition metal-mediated allene-yne carbocyclization reaction was reported by 
Malacria; allene-yne 1-7 was reacted with stoichiometric cyclopentadienyl dicarbonyl cobalt(I) 
[CpCo(CO)2] affording a 2 : 3 mixture of cross-conjugated trienes 1-8 and 1-9 (Scheme 1.2, eq. 
1).4  Sato reported the carbocyclization of allene-ynes 1-10 using 1.25 equivalents of propenyl 
titanium diisopropoxide to afford high yields of triene 1-11 when an alkoxide leaving group was 
present (Scheme 1.2, eq. 2).5  Finally, Livinghouse reported triene 1-13 as a by-product in a 
cobalt-catalyzed cyclocarbonylation reaction of allene-yne 1-12 (Scheme 1.2, eq. 3).6 
  
 3 
•
t-Bu
O
O
CpCo(CO)2
xylenes, heat,
irradiation, 3 h, 
60%
t-Bu
O
O
t-Bu
O
O CoCp
+
•
C5H11 Ti(Oi-Pr)2
50% isolated
quant. by 1H NMR
C5H11
E
E
•
125 mol%
10 mol% Co2(CO)8
21%
E
E
eq. 1
eq. 2
eq. 3
1-7 1-8
1-131-12
1-111-10
1-91-8 : 1-9, 2 : 3
OAc
 
Scheme 1.2 Previous Transition Metal-Catalyzed Allenic Carbocyclization Reactions 
In the first two examples, the substrate structure was used to control the double bond 
selectivity.  For example, in Malacria’s system, the bulky t-butyl group of 1-7 directed the 
reaction to the distal double bond, while in Sato’s case, the metal was forced to react with the 
distal bond due to the decreased tether length of 1-10, favoring formation of a five-membered 
ring over a four-membered ring. 
In 2002, Brummond and coworkers showed that cross-conjugated trienes could be 
produced in high yields using rhodium or iridium containing catalysts, and for the first time, the 
catalyst, not the substrate, was responsible for a selective reaction with the distal double bond of 
the allene.7,8  Similar carbocyclization reactions using Wilkinson’s catalyst were subsequently 
reported by Shibata.9  Examples demonstrating the scope and limitation of the initial study are 
shown in scheme 1.3. 
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E
E
•
1-14
R1
CH2R2
TsN
•
1-16
R1
CH2R2
O
•
CH3
C6H13
•
R1
CH2R2
*Conditions: 2 mol% [Rh(CO)2Cl]2, N2, toluene or DCE
E
E
1-15
R1
R2
TsN
1-17
R1
R2
O
1-19
C6H13
1-21
R1
R2
E : Z
6 : 1
74%
R1 = TMS, R2 = H, 45%
R1 = H, R2 = C5H11, 80%
3 : 1
1-18
1-20
R1 = TMS, R2 = C5H11, 85%
R1 = H, R2 = C5H11, 64%
R1 = TMS, R2 = C5H11, 69%
R1 = H, R2 = C5H11, 80%
5 - 4 : 1
3 - 2 : 1
eq. 1
eq. 2
eq. 3
eq. 4
OHHO
Rh(I)
Conditions*
Rh(I)
Conditions*
Rh(I)
Conditions*
Rh(I)
Conditions*
 
Scheme 1.3 Scope of the Rh(I)-Catalyzed Allenic Carbocyclization Reaction 
Preliminary studies by Brummond on the Rh(I)-catalyzed carbocyclization reaction 
demonstrated a high tolerance for substrate functional groups.  For example, all carbon 
containing tethers with a diester group at the homopropargylic position 1-14 cyclized to give 
trienes 1-15 in 45 – 80% yields (Scheme 1.3, eq. 1).  Similarly, propargyl sulfonamides 1-16 and 
ethers 1-18 cyclized under the same conditions to afford trienes 1-17 and 1-19 in 64 – 85% 
yields (Scheme 1.3, eqs. 2 and 3).  Finally, allene-ynes containing a hydroxymethyl group at the 
bis-homopropargylic position 1-20 reacted to provide trienes 1-21 in 69 – 80% yields (Scheme 
1.3, eq. 4).  
Another interesting observation by Brummond was that [Ir(COD)Cl]2 activated with 
AgBF4 produced much higher E:Z ratios than [Rh(CO)2Cl]2 (Scheme 1.4).  This was presumably 
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due to the fact that skeletal reorganization processes occur more slowly for transition metals 
lower on the periodic table.   
•
1-22
TMS
C7H15H2C
2 mol% [Rh(CO)2Cl]2
toluene, N2, 90 °C, 
1 h, 72%
or
10 mol% [Ir(COD)2Cl]2, 
20% AgBF4, DCE, 60 °C, 
5 min, 57%
TMS
C7H15
E:Z
5:1
>20:1
1-23  
Scheme 1.4 Selectivity Advantage of Ir(I)-Catalysis vs. Rh(I)-Catalysis 
A mechanism for the rhodium(I)-catalyzed process is shown in Scheme 1.5 and is based 
upon the accepted carbocyclization mechanism of enynes.  Chelation of the metal complex to the 
allene-yne provided complex 1-24, then oxidative coupling afforded metallocycle 1-25.             
β-Hydride elimination occurred to give rhodium hydride (deuteride) species 1-26 followed by 
reductive elimination to afford triene 1-27 or 1-28.  The proposed mechanism was supported by 
deuterium labeling experiments, where the carbocyclization of 1-29 afforded 1-27.7  A crossover 
experiment was performed using a 1 : 1 molar ratio of 1-29 and 1-30, affording only 1-27 and   
1-28, respectively, with no signs of deuterium scrambling. 
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•
1-29 X = D
1-30 X = H
CH3
X3C
E
E
CX3
2 mol% [Rh(CO)2Cl]2
toluene, N2, 90 °C
CH3
X X
CX3
E
E
E = CO2Me
1-27 X = D
1-28 X = H
•
CH3
X3C
E
E
CX3
[Rh]
Oxidative
Coupling
CH3E
E [Rh]
X3C CX3
β-Hydride 
Elimination
CH3E
E [Rh]
CX3
X
X X
Reductive 
Elimination
X
1-27 X = D
1-28 X = H
1-24 1-25
1-26
 
Scheme 1.5 Mechanism for the Rh(I)-Catalyzed Allenic Carbocyclization Reaction 
1.1.3 Transition Metal-Catalyzed Carbocyclization Reactions of Ynones and Allene-
ynones 
More recently, efforts to expand the scope of the allenic carbocyclization reaction were focused 
on substrates in which the resultant double bonds can be differentiated and chemoselectively 
manipulated.  For example, 3-vinyl-2-alkylidene-3-cyclohexen-1-one 1-32 is a triene-containing 
ring system where each double bond is sterically and electronically different.  It is anticipated 
that a suitably functionalized trienone such as 1-32 can be used in an expeditious synthesis of 
cassiol (1-31) (Scheme 1.6).   
  
 7 
R1
1-32
R2
OO
OH
OH
HO
Cassiol (1-31)
O
•
R3
R2 CH2R3
R1
1-33
 
Scheme 1.6 Potnetial Use of an Allene-ynone in the Synthesis of Caassiol (1-31) 
Interestingly, allene-ynones have not previously been employed in carbocyclization 
reactions; however, enynone carbocyclization reactions have been reported.  For example, Trost 
reacted ynone 1-34 with tris(dibenzylideneacetone)dipalladium(0) chloroform adduct 
[(dba)3Pd2•CHCl3] in the presence of tri-o-tolylphosphine to give cyclopentanone 1-35 in 63% 
yield (Scheme 1.7, eq. 1).10  Extension of the reaction conditions to the preparation of alkylidene 
cyclohexenones was not as straightforward.  For example, reaction of ynone 1-36 required 
“ligandless” conditions (4 mol% [(dba)3Pd2•CHCl3] in the presence of formic acid in DCE) in 
order to access diene-one 1-37 (Scheme 1.7, eq. 2).11 
O
TMS
(dba)3Pd  CHCl3
P
3
HOAc, PhH, 80 °C, 63%
O TMS
1-34 1-35
O TMS
OTBDMS
OTBDMS
OTBDMS
O
TBDMSO
TMS
OTBDMS
OTBDMS
Conditions: 4 mol% (dba)3Pd2•CHCl3, BBEDA, HOAc, PhH, no rxn
                    4 mol% (dba)3Pd2•CHCl3, HCO2H, DCE, rt, 83%
Conditions
1-36 1-37
eq. 1
eq. 2
 
Scheme 1.7 Early Carbocyclization Reactions of Enynones 
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1.2 RESULTS AND DISCUSSION 
1.2.1 Testing the Feasibility of a Rh(I)-Catalyzed Carbocyclization Reaction of Allene-
ynones 
We propose to test the feasibility of the carbocyclization reaction of allene-ynones using a triene 
like 1-32 as the initial target compound.  This compound was chosen for three reasons: its 
structure resembled the natural product cassiol (1-31), the starting material could be rapidly 
synthesized, and E/Z isomers of the appending alkene are not possible, thus simplifying product 
analysis.  The scope and limitations of this carbocyclization reaction will then be further tested 
by appending different groups to the alkyne terminus.  Finally, the products will be reacted in 
with various dienophiles to gauge the chemoselectivity of the alkenes. 
1.2.1.1 Preparation of Allene-ynones 
Synthesis of amide 1-39 was accomplished by refluxing α-angelica lactone 1-38 and 40% 
aqueous dimethylamine in toluene with simultaneous removal of water, affording the                 
γ-ketoamide 1-39 in 84 - 97% yields.12  This reaction protocol was used to prepare 12 g of 1-39 
(Scheme 1.8). 
O
O
N
1-39
toluene, reflux
Dean Stark
O O
1-38
HNMe2
 
Scheme 1.8 Synthesis of γ-Ketoamide 1-39 from α-Angelica Lactone 
Conversion of ketone 1-39 to allene 1-44 (Scheme 1.10) by way of the corresponding 
propargyl acetate 1-41 was challenging.  Addition of ethynyl magnesium bromide or lithium 
acetylide to 1-39, followed by acylation of the crude alcohol afforded acetate 1-41 in low yield 
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(Table 1.1, entries 1 and 2).  Competing enolate formation of the ketone was deemed responsible 
for the low yields of 1-41. 
Table 1.1 Formation of Acetate 1-41 
O
OH
N
O
O
N
[M]
1-401-39
acetylation
O
OAc
N
1-41
- 78 °C, THF reagent
 
Entry Type [M] (eq) Acetyl Reagent (eq) Yield of 1-41 
1 2 pot MgBr (3) Ac2O (7) 26% 
2 2 pot Li (5) Ac2O (7) 24% 
3 2 pot CeCl2 (3) Ac2O (7) 46 - 49% 
41 2 pot CeCl2 (1.5) Ac2O (7) 54% 
51,2 2 pot CeCl2 (2) Ac2O (7) 49% 
6 1 pot CeCl2 (3) Ac2O (7) 80% 
7 1 pot CeCl2 (3) AcCl (5) 92 - 97% 
Average yields shown.  1 Reaction incomplete.  2 Side product also isolated in small amount 
Organocerium reagents were next explored.13  In all cases use of organocerium reagents 
improved yields of acetate 1-41 by 20 – 30% (Table 1.1, entries 3 – 5); however, a three fold 
excess of the organocerium reagent was required for full conversion to alcohol product 1-40 
(Table 1.1, compare entries 3 and 4).  Attempts to add more ethynyl magnesium bromide (the 
organocerium reagent precursor) to the reaction after it had started gave a side product (Table 
1.1, entry 5).  This product was characterized as diyne 1-43 as evidenced by the loss of the 
resonances at 3.03 and 2.93 ppm in the 1H NMR spectrum corresponding to the dimethylamide 
and the presence of a much less polar compound by TLC analysis (Scheme 1.9).  It was reasoned 
that cerium activated the amide carbonyl to nucleophilic addition. 
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O
OH
O
O
N MgBr
1-431-39
CeCl3 OH
O
N
CeCl2
H2O
1-42
THF, -78 °C
 
Scheme 1.9 Proposed Mechanism for Formation of Diyne 1-43 
Because of the water solubility of alcohol 1-40, a one-pot procedure for acetylide 
addition/acetylation was investigated.  Addition of acetic anhydride following alkyne formation 
afforded an 80% yield of acetate 1-41 (Table 1.1, entry 6).  Addition of acetyl chloride, a more 
oxophilic acetylating reagent, provided optimal yields of 1-41, averaging 95% (Table 1.1, entry 
7). 
With propargyl acetate 1-41 in hand, its conversion to allene-amide 1-44 was explored 
(Table 1.2).  Stoichiometric CuBr·DMS was reacted with 1-41, leading to the formation of 
allenes 1-44 and 1-45 in a 1 : 3 ratio.  Use of copper bromide and lithium bromide resulted in a   
1 : 2 ratio of 1-44 : 1-45 in 55% yield (Table 1.2, entry 2).  Reducing the equivalents of methyl 
magnesium bromide reversed the selectivity in favor of the addition product, giving a 2 : 1 ratio 
of 1-44 : 1-45 (Table 1.2, entry 3).  Because the products were inseparable by column 
chromatography and normal phase HPLC, investigations to lessen the amount of formal 
reduction product 1-45 began. 
As proposed by Claesson, copper added across the acetate bond of 1-41 to form adduct  
1-46 followed by reversible rearrangement to allenic copper adduct 1-47.  Copper intermediate 
isomers 1-46 and 1-47 were stable enough to survive until reaction workup (Scheme 1.10).14  
Two paths were possible; in path A, reductive elimination occured to afford the desired addition 
product 1-44; in path B, upon workup, protonolysis occured to give the formal reduction product 
1-45. 
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•
H
H
O
NMe2
•
H
Cu(III)
Me
•
H
Me
O
NMe2
•
H
Cu(III)
Me
OAc
O
Me2
N
Cu(III)
H
Me
1-46
1-44
1-47
1-41
Path B: 
protonolysis  H2O
+
H
1-45
1-47
1. MeMgBr  
       [Cu]
2. H3O+
+
Path A :
red-elim
•
H
Cu(III)
Me
Path C: CH3 
addition
I
CH3
1-47
•
H
Me
O
NMe2
1-44
 
Scheme 1.10 Formation of Allenes 1-44 and 1-45.  Reductive Elimination vs. Protonolysis vs. CH3 Addition 
Marshall has reported a means to circumvent the reduction product by adding MeI to the 
reaction mixture before the acidic workup.15  Under these conditions, the methyl group can be 
added to copper intermediate 1-47 via path C, to obtain the desired product 1-44 (Scheme 1.10).  
Indeed, using Marshall’s protocol in the reaction of 1-41 with methyl cuprate afforded only 1-44 
(Table 1.2, entry 4).  A 1 : 1 mixture of aqueous 3% NH4OH : sat’d NH4Cl was also found to be 
the best quenching agent (Table 1.2, entry 4).  Although successful, this reaction used copper 
bromide salt that required drying prior to use, making the conditions less convenient.  These 
conditions were also less consistent, causing incomplete reactions. 
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Table 1.2 Conversion of Propargyl Acetate 1-41 to Allene 1-44 
O
•
N
O
OAc
N
O
•
N
1-41 1-44 1-45
1. [Cu], MeMgBr
THF, -78 °C
+
2. quench A, B, or C
 
Entry [Cu] (eq) MeMgBr (eq) 
Quench 
Conditions Yield 
Product 
Ratio1                 
(1-44 :1-45) 
1 CuBr • DMS (2) 4 A 55%2 1 : 3 
2 CuBr / LiBr (2) 4 A 55%2 1 : 2 
3 CuBr / LiBr (2) 2 A Not determined 2 : 1 
43 CuBr / LiBr (2) 2 B Not determined 100 : 0 
5 CuBr • DMS (2) 2 B 62% 1 : 3 
6 CuCN / PBu3 (1.2) 2 A Not determined 10 : 1 
7 CuCN / PBu3 (1.2) 2 C 49% 10 : 1 
84 CuBr / LiBr (2) 2 B 85 - 100% 100 : 0 
Quench Conditions A: sat’d NH4Cl; B: 4 to 6 eq. MeI then 1 : 1 3% aq. NH4OH : NH4Cl;  
C: 4 to 6 eq. MeI then sat’d NH4Cl 
1 Determined by integration of allene resonances in the 1H NMR spectrum 
2 Average Yield 
3 Reaction performed using improperly purified CuBr 
4 Reaction performed using properly purified CuBr 
 
Formation of the cuprate using the more convenient CuBr·DMS complex followed by 
addition of MeI to the reaction mixture still resulted in a 1 : 3 ratio of 1-44 : 1-45 (Table 1.2, 
entry 5).  Next, a procedure employing CuCN and PBu3 was attempted.  Mixed results were 
reported in the literature where addition of phosphine ligand has served to suppress the formation 
of the reduction product, and in other cases it increased the yield of the reduction product.  This 
effect appeared to be complex and dependent upon conditions and substrates.16  Using these 
conditions afforded the products 1-44 : 1-45 in a 10 : 1 ratio (Table 1.2, entry 6).  Addition of 
MeI under the CuCN/PBu3 conditions in the manner described in Table 1.2, entry 4 did not 
improve this ratio (Table 1.2, entry 7).  During these experiments, an error in the published 
purification procedure for CuBr was corrected.17  After which, scale-up of the original CuBr 
conditions afforded reproducibly high yields of only the desired allene 1-44 (Table 1.2, entry 8). 
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With sufficient quanties of allene 1-44 secured, the alkyne moiety was installed by 
addition of lithium trimethylsilyl acetylide to 1-44 in the presence of BF3·Et2O using Trost’s 
procedure,13 to afford allene-yne 1-48a in 50 - 71% yield.  The structure of 1-48a is evidenced 
by the resonance at 0.21 ppm (s, 9H) in the 1H NMR spectrum, corresponding to the TMS 
moiety, and the absorbance at 2151 cm-1 in the IR spectrum, corresponding to the alkyne 
(Scheme 1.11).  
O
•
N
O
•
TMS
1-48a1-44
TMS
BF3·Et2O, AcOH
n-BuLi
50 - 71%
 
Scheme 1.11 Synthesis of Allene-Ynone 1-48a from Allene-Amide 1-44 
1.2.1.2 Feasibility and Optimization of the Carbocyclization Reaction of Allene-ynones 
To test the feasibility of the allenic carbocyclization reaction of allene-ynones, we reacted 1-48a 
with 10 mol% rhodium biscarbonyl chloride dimer at room temperature in DCE.  Complete 
consumption of the starting material occurred in less than five min based upon TLC analysis, 
affording trace amounts of the desired product 1-49a (< 10%), and another product that 
decomposed before it could be characterized (Table 1.3, entry 1).  Decreasing the reaction 
temperature to 0 °C gave 55% yield of triene 1-49a, but an undesired product could still be seen 
by TLC analysis (Table 1.3, entry 2). 
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Table 1.3 Optimization of the Carbocyclization Reaction Conditions to form Trienone 1-49a 
O
•
TMS
1-48a
O TMS
[Rh(CO)2Cl]2
1-49a  
Entry mol% [Rh(CO)2Cl]2 Temp. (°C) Solvent Yield 
1 10 rt DCE < 10% 
2 10 0 DCE 55% 
3 3 0 DCE 92% 
4 3 0 Toluene 95% 
5 1 0 Toluene 62% 
All reactions were complete in 5 min or less. 
Lowering the catalyst loading to 3 mol% had a much larger effect, and the product was 
obtained in 92% yield (Table 1.3, entry 3).  Changing the solvent from DCE to toluene resulted 
in a marginal increase in the yield (Table 1.3, compare entries 3 and 4).  Finally, reacting 1-48a 
with 1 mol% catalyst in toluene gave 62% yield of 1-49a (Table 1.3, entry 5).  Characterization 
of triene 1-49a was supported by the 1H NMR spectrum; resonances at 6.27 (dd, 1H), 6.01 (s, 
1H), 5.45 (dd, 1H), and 5.15 ppm (dd, 1H), corresponding to Ha, Hb, Hc, and Hd (Table 1.4). 
Table 1.4 1H NMR Characterization of Trienone 1-49a 
O TMS
CH3
1-49a
Ha
HcHd
(He)
(Hf)
Hb
(Hg)
 
Proton Chemical Shift (ppm) Multiplicity Integration J-value (Hz) 
Ha 6.27 dd 1 17.7, 11.3 
Hb 6.01 s 1 - 
Hc 5.45 dd 1 11.3, 2.1 
Hd 5.15 dd 1 17.7, 2.1 
He 1.95 s 3 - 
Hf 2.61 – 2.51 m 4 - 
Hg 0.13 s 9 - 
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1.2.2 Exploration of the Scope and Limitations of Carbocyclization Reactions of Allenic-
ynones by Varying Substitution at the Alkyne Terminus 
Allene-ynones possessing alkyl 1-48b,18 alkyl ether 1-48c-e, alkenyl 1-48f, alkoxy 1-48g, and 
aryl groups 1-48i-k, were prepared in a manner entirely analogous to that discussed for 1-48a 
(Table 1.5).  Allene-ynone 1-48h was prepared in 90% yield by removing the TMS-moiety from 
1-48a using dilute (0.05 M) aqueous sodium tetraborate.19  
Table 1.5 Allene-ynones with Varied Substitution at the Alkyne Terminus 
•
N
O O
•
R
1-44
R
BF3·Et2O, AcOH
n-BuLi
1-48  
Cmpd. R Yield (%)  Cmpd. R Yield (%) 
1-48a TMS 63  1-48g OCH2CH3 83 
1-48b Me 89  1-48h* H 90 
1-48c (CH2)3OTBS 41  1-48i Ph 92 
1-48d CH2CH2OTBS 98  1-48j p-C6H4OMe 88 
1-48e CH2CH2OTHP 98  1-48k p-C6H4CF3 89 
1-48f 1-cyclohexenyl 94     
 *Prepared from 1-48a 
When allene-ynone 1-48b (R = Me) was subjected to the optimized Rh(I)-catalyzed 
carbocyclization conditions, the reaction proceeded much more slowly than the reaction of 1-48a 
(R = TMS), requiring a higher temperature (room temperature vs. 0 °C) and a longer reaction 
time (1.5 h vs. 5 min) (Table 1.6, entry 1).  Similarly, the alkyne substituted with a TBS-
protected propanol (1-48c (R = (CH2)3OTBS), Table 1.6 entry 2), afforded trienone 1-49c in 
80% yield after 1.5 h at rt.  However, the reaction of allene-ynone 1-48d (R = (CH2)2OTBS) 
proceeded in 20 min at rt to give trienone 1-49d proceeded in 20 min (Table 1.6, compare entries 
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2 and 3).  Similarly, reaction of 1-48e (R = (CH2)2OTHP, Table 1.6, entry 4) afforded 1-49e in 
15 min at rt.  
Table 1.6 Formation of Substituted Trienones 
O
R
•
O R
[Rh(CO)2Cl]2
O
1-48 1-501-49
toluene
or
 
Entry Starting Material R T (°C) Time Product 
Average 
Yield 
1 1-48b Me rt 1.5 h 1-49b 73% 
2 1-48c (CH2)3OTBS rt 1.5 h 1-49c 80% 
3 1-48d (CH2)2OTBS rt 20 min 1-49d 88% 
4 1-48e (CH2)2OTHP  rt 15 min 1-49e 88% 
5* 1-48f 1-cyclohexenyl 45 - 50 3 h 1-50 26% 
6 1-48g OEt 45 3 h 1-49g Decomp. 
7 1-48h H rt - 1-49h Decomp. 
8† 1-48i phenyl 50 5 min 1-49i 76% 
9† 1-48j p-C6H4OMe 50 5 min 1-49j 76% 
10† 1-48k p- C6H4CF3 50 5 min 1-49k 76% 
All reactions carried out at 0.3 M in toluene with 3 mol% catalyst except where noted. 
* 5 mol% catalyst 
† 8 mol% catalyst    
 
Rate differences for allenic carbocyclization reactions of 1-48d and 1-48e, as compared 
to 1-48b and 1-48c, can be explained by chelation of the protected alcohol to the rhodium 
(Scheme 1.12).20  It is proposed that the appending oxygen coordinated to the rhodium complex 
1-51 facilitated the oxidative coupling to give 1-52 by stabilizing the rhodium metallocycle.  
Formation of a six-membered chelate did not occur (Table 1.6, compare entries 1 and 2). 
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O
O•
TBS
LnRh
1-51
O
RhLn
O TBS
1-53
H
O
RhLn
O TBS
1-52
O
OTBS
1-49d  
Scheme 1.12 Effects of Ether Chelation in the Carbocyclization Reactions 
Computational work on the mechanistically similar rhodium(I)-catalyzed 
cyclocarbonylation8 and the ruthenium-catalyzed carbocyclization reactions21 have found 
oxidative coupling to be the rate determining step for these similar reactions.  There is also 
precedent for rate enhancements due to heteroatom chelation in cobalt mediated Pauson-Khand 
reactions reported by Krafft.22,23   
Interestingly, reaction of 1-48f (R = 1-cyclohexenyl, Table 1.6, entry 5) produced 
aromatic compound 1-50 as the only isolated product in 26% yield.  The structure of 1-50 was 
supported by 1H NMR analysis.  For example, new resonances appeared at 6.85 ppm (d, 1H) and 
6.56 ppm (d, 1H), corresponding to Ha and Hb, and at 4.86 ppm (dd, 1H), corresponding to Hc.  
Formation of this product can be explained through a carbocyclization/electrocyclization/ 
aromatization cascade mechanism in which tetraene 1-54 was first formed via the allenic 
carbocyclization reaction.  Next, an electrocyclization reaction provided cyclic tetraene 1-55.  
Finally, aromatization occurred, via an oxidative process, to afford styrene-derivative 1-50 
(Scheme 1.13). 
O
[Rh(CO)2Cl]2
toluene
OO
•
1-48f 1-501-54
O
1-55
26%
Hc
Ha
Hb
 
Scheme 1.13 A Carbocyclization/Electrocyclization/Aromatization Cascade Reaction 
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Performing the carbocyclization reaction on 1-48g (R = OEt), produced a product that 
rapidly decomposed afterward (Table 1.6, entry 6).  Terminal allene-ynone 1-48h also 
decomposed with no sign of product (Table 1.6, entry 7).   
Reaction of 1-48i was carried out using 8 mol% [Rh(CO)2Cl]2 at 50 °C in 5 min to afford 
1-49i in 76% yield (Table 1.6, entry 8).  A higher catalyst loading and elevated temperature were 
necessary to overcome the developing A1,3 strain between the ketone and bulky phenyl group in 
the trienone.  Allene-ynones with aryl groups possessing para electron-donating 1-48j or 
electron-withdrawing groups 1-48k gave similar results (Table 1.6, entries 9 and 10). 
1.2.3 Carbocyclization Reactions of Allenes and Propargyl Ethers 
It was hypothesized that the rate of cyclization would be slowed for propargyl ethers relative to 
the ynones.  In order to test this possibility, ynones 1-48i and 1-48j were reduced under Luche 
conditions and then the alcohols protected to give 1-57i-j (Scheme 1.14). 
O
C6H4R
•
OH
C6H4R
•
O
C6H4R
•
CeCl3, NaBH4
THF, -70 °C
NaH, MeI, THF
2 steps, 84 - 87%
1-48i, R = H
1-48j, R = OMe
1-56i, R = H
1-56j, R = OMe
1-57i, R = H
1-57j, R = OMe  
Scheme 1.14 Synthesis of Allenic Propargyl Ethers 
Reaction of propargyl ethers 1-57i and 1-57j to 8 mol% rhodium(I) catalyst at 50 ºC 
afforded 1-58i and 1-58j in 5 – 10 min (Table 1.7).  The yield increased significantly for 1-58i, 
but the reaction rate was nearly identical for both for both ethers when compared to the allene-
ynones (Table 1.6 enties 8 and 9 compare to Table 1.7 enties 1 and 2).  
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Table 1.7 Allenic Carbocyclization Reactions of Propargyl Ethers 
O
R•
1-57
O
R
1-58
[Rh(CO)2Cl]2
toluene, 50 °C
8 mol%
 
Entry Starting Material R 
Time 
(min) Product Yield 
1 1-57i H 5 1-58i 95% 
2 1-57j OMe < 10  1-58j 80% 
1.2.4 Examining the Synthetic Utility of 3-Vinyl-2-Alkylidene-3-Cyclohexen-1-ones: 
Participation in Diels-Alder Reactions 
Inspired by the work of Frank You in the Brummond group, it was hypothesized that triene 1-49l 
would undergo an intermolecular Diels-Alder reaction with a dienophile.24  In turn, this Diel-
Alder adduct 1-59 would then react with the appended alkynoate in an intramolecular Diels-
Alder reaction to give 1-60 (Scheme 1.15).  
dienophile
catalyst
O O
O O
R'
R
O
O
1-49l 1-60
O
R'
R
O
O
1-59  
Scheme 1.15 Potential Tandem Intra- and Intermolecular Diels-Alder Reactions of Trienones 
The most appealing approach to the synthesis of 1-49l involved the removal of the TBS 
group from 1-48d and coupling of the resultant alcohol with 2-butynoic acid.  However, reaction 
of 1-48d with TBAF did not produce the desired alcohol 1-61 (Scheme 1.16).  Analysis of the 
crude 1H NMR spectrum suggested formation hemiketal 1-62 as evidenced by changes in the 
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proton-proton splitting pattern.  For example, the resonances at 6.20 ppm (dd, 1H) corresponding 
to Ha and 4.16 (m, 1H) and 3.83 (dd, 1H) corresponding to Hb (Scheme 1.16).   
O
1-49d
OTBS O
1-61
OH
TBAF
O
1-62
HO
Ha
Hb
Hb
Hb Hb
 
Scheme 1.16 Formation of Hemiketal 1-62 from Silyl Ether 1-49d Under TBAF Conditions 
The next approach to 1-49l involved coupling 2-butynoic acid to the allene-ynone prior to 
the allenic carbocyclization reaction (Scheme 1.17).  Removal of the silyl group under KHSO4 
conditions provided alcohol 1-63 which was used without purification in a DCC coupling 
reaction to give 1-48l in 82% yield over two steps (Scheme 1.17).25 
O TBSO
•
1-48d
O HO
•
1-63
O
O
•
1-48l
DCC, DMAP
2 steps, 82%
O
HO
O
KHSO4
30% aqueous 
MeOH
 
Scheme 1.17 Formation of Butynoic Ester 1-48l 
Reaction of allene-ynone 1-48l under the optimized Rh(I)-catalyzed carbocyclization 
conditions afforded 1-49l in 70% yield; however, this reaction required heating to 100 °C for 1 h 
(Scheme 1.18 conditions a).  Diluting the reaction concentration from 0.3 M to 0.01 M 
(conditions b) afforded the product in 95% yield after 1.5 h at 55 °C.   Interestingly, the reaction 
was slow in comparision with 1-48d and 1-48e (Table 1.6) 
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O
O
•
1-48l
O
O
[Rh(CO)2Cl]2
a. 0.3 M toluene, 
100 °C,1 h, 70%
b. 0.01 M toluene,
55 °C, 1.5 h, 95%
3 mol%
1-49l
O
O
 
Scheme 1.18 Rh(I)-Catalyzed Allenic Carbocyclization Reaction of 1-48l to Afford 1-49l 
With the precursor 1-49l in hand, efforts were made to effect Diels-Alder reactions of    
1-49l using a variety of dienophiles such as dimethyl acetylenedicarboxylate (DMAD), maleic 
anhydride, nitrosobenzene, and 4-phenyl-1,2,4-triazoline-3,5-dione (PTAD).  These reactions 
gave only complex mixtures over long reaction times or decomposed.  Reaction of 1-49l with 
sulfur dioxide gave decomposition and transition metal catalyzed formal Diels-Alder reactions 
using Wender’s catalyst and 3-hexyne resulted in no reaction.26  Thus, tandem Diels-Alder 
reactions of 1-49l are not feasible.  We attribute this to the propensity of the trienone 1-49l to 
aromatize under forcing conditions. 
1.3 CONCLUSIONS 
In conclusion, 3-vinyl-2-alkylidene-3-cyclohexen-1-ones can be prepared from allene-ynones 
using a rhodium(I)-catalyzed carbocyclization reaction.27  This reaction was tolerant of 
substitution at the alkyne terminus with observable rate effects caused by the groups appended at 
this position.  Reactions of propargyl ethers showed similar results, indicating that the ketone 
played only a small role in the outcome of the reaction.  These conditions are more general than 
the ligandless conditions reported by Trost to effect formation of six-membered rings, and 
provide rapid access trienones that possess electronically differentiated double bonds.  However, 
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this method is not without its shortcomings since the stability of the 3-vinyl-2-alkylidene-3-
cyclohexen-1-ones limits its utility, specifically in Tandem Diels-Alder reactions. 
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2.0  PROGRESS TOWARDS THE SYNTHESIS OF BICYCLIC IROFULVEN 
(HMAF) ANALOGS VIA RHODIUM(I)-CATALYZED ALLENIC 
CARBOCYCLIZATION REACTIONS  
2.1 INTRODUCTION 
Motivated by the success of the Rh(I)-catalyzed carbocyclization reaction of allene-ynones, we 
surmised that functionally dense trienes could be afforded using a Rh(I)-catalyzed 
carbocyclization reaction.  The resultant spiro[2.5]octatrienes would serve as excellent targets 
due to their similarity to the illudins.  A single step following the carbocyclization reaction 
would provide potentially biologically active compounds that exploit the placement of the double 
bonds found in the triene product via the known mode of action within cells. 
2.1.1 Third Generation Illudin-type Compounds 
In 1996, McMorris discovered a third generation analog of illudins M and S (2-1) with excellent 
therapeutic value against cancer (IC50 in HL-60 cells = 73 ± 8) - hydroxymethylacylfulvene 
(HMAF), also known as irofulven 2-3 (Fig 2.1).28,29  This compound also promoted complete 
tumor regression in MV 522 lung carcinoma xenographs, a property that earlier illudin analogs 
did not possess. 
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Figure 2.1 The Illudins (2-1), Acyclfulvene 2-2, and Irofulven 2-3 
Several investigations into the mode of action for the illudins and their analogs have been 
performed.30  Recently, Sturla investigated the mechanism of DNA alkylation by synthesizing 
acylfulvene-DNA.31  In Sturla’s report, acylfulvene 2-2 (Fig 2.1) was reacted with 
deoxyadenosine or deoxyguanosine in the presence of AOR/NADPH, affording acylfulvene 
metabolites of both nucleosides respectively (AF-dAdo 2-5 and AF-dGuo).  The mechanism of 
DNA depurination involving acylfulvene 2-2 affording AF-Ade 2-6 or AF-Gua 2-7 is shown in 
Scheme 2.1. 
O
HO
bioreductive 
activation
OH
HO
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N
N
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H2N
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Scheme 2.1 Recently Proposed Biological Mode of Action of Acylfulvene 2-2 
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2.1.2 Kinder’s Bicyclic Illudin Analogs 
In 1996 Kinder synthesized and tested the activity of several bicyclic illudin analogs.32  
Biological activity of the analogs varied, but the general trend showed that as the inserted R 
group became bulkier, activity decreased.  Table 2.1 shows IC50 values for various analogs as 
compared to dehydroilludin M 2-9 (Table 2.1, entry 8), another second generation illudin analog.  
The data showed a good correlation between the known mechanism and the functional groups 
present.  When small groups were present as in 2-8a and 2-8b (R = Cl, Me, respectively), the 
α,β-unsaturated ketone was still very accessible to reduction, and the compounds showed high 
activity.  As R became larger such as in 2-8e and 2-8f (R = Ph, thienyl), the activity diminished 
as the point of reductive activation became more sterically crowded.  Although in the case of 2-
8c (R = iPr) the activity is actually improved, other bulky groups, such as aromatic rings, 
decrease the activity.  Interestingly, substituting another double bond, such as in 2-8d (R = 
vinyl), onto the end of the analog resulted in an increased activity. 
Table 2.1 Biological Activity of Kinder's Bicyclic Analogs 2-8  as Compared to Dehydroilludin M 2-9 
RHO
O
2-8
O
HO
O
2-9
Dehydroilludin M  
Entry Compound R IC50 (nM) 
1 2-8a Cl 200 
2 2-8b Me 150 
3 2-8c i-Pr 110 
4 2-8d Vinyl 2 
5 2-8e Ph 1,500 
6 2-8f thienyl > 10,000 
7 2-8g OH  3,000 
8 2-9 N/A 200 
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Kinder’s experiments have shown that it is possible to construct bicyclic illudin analogs 
that have biological function.  This observation provided support for the biological mode of 
action at the time, and also created precedent for possible future bicyclic analogs of the illudins. 
2.1.3 Brummond Irofulven Synthesis. 
In 1998, Brummond and Lu reported a synthesis of irofulven 2-3, using a molybdenum-mediated 
allenic Pauson-Khand-type cyclocarbonylation reaction as the key step (Scheme 2.2).33  The 
synthesis began with addition of alkyne 2-11a to known cyclopropyl diketone 2-10 to afford 
ketone 2-12 as a mixture of diastereomers.  Addition of ethynyl magnesium bromide to ketone  
2-12a followed by selective acylation of the resultant alcohol gave propargyl acetate 2-13.  The 
propargyl acetate 2-13 was reduced using Stryker’s reagent to afford allene-yne 2-14.  A 
molybdenum-mediated cyclocarbonylation reaction produced the tricyclic core of irofulven 2-3, 
ketone 2-15, in 69% yield.  Addition of methyl lithium to ketone 2-15 resulted in formation of an 
unstable alcohol that eliminated upon acidic workup, to give the fulvene skeleton.  The TBS 
protecting group was then removed using tetrabutylammonium fluoride (TBAF) conditions to 
give fulvene 2-16.  The secondary alcohol was oxidized using Martin’s reagent to give 
acylfulvene 2-2 and the hydroxymethyl group installed via an electrophilic aromatic substitution 
reaction to afford irofulven (2-3) in 11 linear steps. 
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Scheme 2.2 Brummond Synthesis of Irofulven 2-3 
2.1.4 Synthetic Route Towards Bicyclic Trienyl Acylfulvene Analogs 
Inspired by the previously reported biological activity of the bicyclic analogs of the illudins and 
a potentially facile route approach to these using a Rh(I)-catalyzed allenic carbocyclization 
reaction, we initiated a program to prepare bicyclic illudin analogs.  Challenges presented by this 
endeavor include the reactivity of functionally dense substrates. 
 We envisioned that trienone 2-17 could be synthesized via oxidation of the product of a 
Rh(I)-catalyzed carbocyclization reaction of allene-yne 2-18.  This allene-yne 2-18 could be 
formed in three steps from diketone 2-10 (Scheme 2.2 and 2.3).  The synthesis of five 
spiro[2.5]octatrienes has been accomplished using the Rh(I)-catalyzed allenic carbocyclization 
reaction and the results described below. 
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Scheme 2.3 Retrosynthetic Analysis for Bicyclic Acylfulvene Analog 2-17 
2.2 RESULTS AND DISCUSSION 
2.2.1 Testing the Feasibility of the Rh(I)-Catalyzed Carbocyclization Reaction for the 
Synthesis of Bicyclic Illudin Analogs 
We began synthesis of analogs 2-17 by first reacting the propargyl anion of alkyne 2-11a      
(1.25 eq. of the propargyl anion) with diketone 2-10.  Alkyne 2-12 was obtained in 75% yield as 
a 2.4 : 1 ratio of anti to syn hydroxyl isomers, as determined previously in the Brummond 
synthesis of irofulven 2-10, that were separated by column chromatography on silica gel.  The 
anti diastereomer 2-12a was then subjected to ethynyl magnesium bromide in the presence of 
cerium trichloride to afford the respective alcohol in 83% yield.  The alcohol was then reacted 
with acetic anhydride and 4-(dimethylamino)pyridine in triethylamine to provide propargyl 
acetate 2-13a in 90% yield. Propargyl acetate 2-13a was subjected to a number of different 
methyl cuprate addition conditions.  Optimal conditions were copper cyanide and methyl lithium 
in THF at -40 °C.  These conditions were reported by Krause to work well with substrates 
containing heteroatoms that could potentially coordinate to the copper and cause side reactions 
or loss of reactivity.34  Allene-yne 2-18a was obtained in 68% yield after SN2’ addition of the 
methyl cuprate.  The structure of 2-18a was evidenced in the 1H NMR spectrum by the 
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resonance at 4.97 – 4.93 ppm (m, 1H) corresponding to the allene proton and in the IR spectrum 
by absorbances at 1961 cm-1 and 2177 cm-1 corresponding to the allene and alkyne respectively.  
With allene-yne 2-18a in hand, the Rh(I)-catalyzed allenic carbocyclization reaction was next 
attempted using 3 mol% [Rh(CO)2Cl]2 in toluene at 0.05M; however, this reaction was not 
successful (Scheme 2.4).  Two compounds were isolated from this reaction, one contained trace 
product, and the other contained some starting material as determined by 1H NMR.  Both 1H 
NMR spectra for these products contained large resonances at 1.15 (m, 45H) and 0.83 ppm (m, 
48H) that indicated that side reactions may have occured. 
OTBS
HO
•
2-18a
TMS
O O TMS
OTBS
O
OTBS
HO
TMS
MgBr
CeCl3, 83%
1.
2. Ac2O, 
DMAP, 
NEt3, 90%
OAc
OTBS
HO
TMS
CuCN, MeLi
THF, - 40 °C
68%
t-BuLi, -78 °C, 75%
2.4 : 1, anti : syn
only anti 
diasteromer used 2-13a2-12a2-10
2-11a
[Rh(CO2)Cl]2
TBSO
HO
TMS
0.05M toluene
3 mol%
2-19a  
Scheme 2.4 Synthesis of Allene-yne 2-18a and Initial Attempt at the Allenic Carbocyclization Reaction 
We hypothesized that developing A1,3 strain in the transition state between the 
trimethylsilyl and TBS-ether groups was hindering formation of rhodacycle 2-20a, and leading 
to side reactions (Fig. 2.2).  Efforts were next undertaken to remove these silicon groups. 
HO
O Si
Si
[Rh]
2-20a
Ln
 
Figure 2.2 Developing A1,3 Strain in Rhodacycle 2-20a 
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2.2.2 Selective Removal of the Silyl Protecting Groups of Allene-yne 2-18a and the First 
Successful Allenic Carbocyclization Reactions Affording Spiro[2.5]octatrienes 
A strategy to selectively remove each or both silyl protecting groups was developed.  First, 2-18a 
was subjected to KHSO4 in methanol, removing the TBS group to afford allene-yne diol 2-18b in 
80% yield (Scheme 2.5, eq. 1).  The TMS group of 2-18a was selectively cleaved from the 
alkyne terminus using K2CO3 in methanol to give 2-18c in 41% yield.  This deprotection reaction 
could also be performed on crude 2-18a immediately following formation of the allene in 54% 
yield over two steps (Scheme 2.5, eq. 2).  Finally, both silyl groups were removed 
simultaneously under TBAF conditions, affording 2-18d in 93% yield (Scheme 2.5, eq 3).  
Unfortunately, the yield of the reaction of 2-18a under TBAF conditions was not reproducible, as 
subsequent attempts gave only trace amounts of product.  Removal of the TMS group from       
2-18b using K2CO3 in methanol afforded 2-18d reproducibly in 62% yield (Scheme 2.5). 
eq. 1
eq. 2
eq. 3
OTBS
HO
•
2-18a
TMS
KHSO4
MeOH, 40 h, 80%
TBAF, THF
K2CO3, MeOH
41%
OH
HO
•
2-18b
TMS
OTBS
HO
•
2-18c
OH
HO
•
2-18d
(54% over 2 steps 
from 2-13a)
93%
(yield not reproduced)
K2CO3, 
MeOH
62%
 
Scheme 2.5 Selective Removal of One or Both Silyl Protecting Groups of Allene-yne 2-18a 
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Allene-ynes 2-18b-d were next subjected to the Rh(I)-catalyzed allenic carbocyclization 
reaction.  Reaction of allenic TMS-protected alkyne 2-18b afforded triene 2-19b in 73% yield 
after 5 min, using 3 mol% of [Rh(CO)2Cl]2 (Scheme 2.6, eq. 1).  Allene-yne 2-18c also reacted 
under mild conditions, providing a 64% yield of triene 2-19c in 1.5 h, using 6 mol% catalyst 
(Scheme 2.6, eq. 2).  Finally, reaction of desilylated allene-yne 2-18d required 6 mol% 
[Rh(CO)2Cl]2 and a temperature of 50 °C to give triene 2-19d in 55% yield after 1 h (Scheme 
2.6, eq. 3).  Triene 2-19d could also be obtained from triene 2-19c in quantitative yield using 
TBAF in THF.  The trienes were characterized similarly to the trienones discussed in chapter 1.  
For example, triene 2-19d was identified by the presence of resonances at 6.29 (dd, 1H), 5.41 
(dd, 1H), 5.21 (s, 1H), 5.17 (s, 1H) and 5.14 ppm (dd, 1H) in the 1H NMR spectrum, 
corresponding to Ha, Hb, Hd, and Hc respectively (Table 2.2). 
TBAF, 
THF
100%
OH
HO
[Rh(CO)2Cl]2
3 mol%
toluene, 0.05 M
rt, 5 min, 73% TMS
[Rh(CO)2Cl]2
6 mol%
toluene, 0.05 M
50 °C, 1 h, 55%
OTBS
HO
OH
HO
[Rh(CO)2Cl]2
6 mol%
toluene, 0.05 M
rt, 1.5 h, 64%
OH
HO
•
2-18b
TMS
OTBS
HO
•
2-18c
OH
HO
•
2-18d
2-19b
2-19c
2-19d
eq. 1
eq. 2
eq. 3
 
Scheme 2.6 Initial Allenic Carbocyclization Reactions to form Spiro[2.5]octatrienes 2-19 
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Table 2.2 1H NMR Characterization of 2-19d 
CH3
HO
HO
H3C
2-19d
Ha
Hb
Hc
(Hd)
(He)
(Hf)
(Hg)
(Hh) Hj(Hi)
 
Proton Chemical Shift (ppm) Multiplicity Integration J-Value (Hz) 
Ha 6.29 dd 1 17.7, 11.1 
Hb 5.41 dd 1 11.1, 2.1 
Hc 5.14 dd 1 17.7, 2.1 
Hd 5.21, 5.17 s, s 1, 1 - 
He 1.54 s 3 - 
Hf 
1.19 – 1.11 
0.91 – 0.84 
0.80 – 0.71 
m 
m 
m 
1 
1 
2 
- 
- 
- 
Hg 1.10 s 3 - 
Hh 2.39 s 1 - 
Hi 1.96 d 1 7.2 
Hj 3.96 d 1 4.8 
 
2.2.3 Synthesis of a p-Methoxybenzene Substituted Allene-yne 
Following the initial allenic carbocyclization studies towards bicyclic illudin analogs, we became 
interested in the scope of this carbocyclization reaction with regards to substitution at the alkyne 
terminus.  A route to both alkyl and aryl substituents was derived from alkynyl ketone 2-12. 
The minor diastereomer, alkynyl ketone 2-12b, was chosen as the starting material for 
this synthetic endeavor because a large amount was left over from the synthesis of alkynyl 
ketone 2-12a.  It was envisioned that a methyl group could be appended via an alkylation 
reaction of terminal alkynyl ketone 2-12c, which would afford alkynyl ketone 2-12d.  An aryl 
group would be added to the terminus of alkynyl ketone 2-12c via a Sonogashira coupling 
reaction to obtain alkynyl ketone 2-12e (Scheme 2.7).  Alkynyl ketone 2-12c could be 
synthesized from alkynyl ketone 2-12b via removal of the TMS group from the alkyne terminus.  
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Alkynyl ketones 2-12d and 2-12e would then be carried through the previous synthetic steps to 
their respective allenic carbocyclization products. 
O
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HO
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HO
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O
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HO
2-12d, R = Me
2-12e, R = p-C6H4OMe
R
 
Scheme 2.7 Route to Terminal Alkyne Substituted Acylfulvene Analog Precursors 
 Alkynyl ketone 2-12b was reacted with K2CO3 in methanol to give alkynyl ketone 2-12c 
in 80% yield.  Alkylation of the alkyne terminus was attempted using a variety of bases (NaH,  
n-BuLi, LDA, KHMDS) and methyl iodide; however, alkynyl ketone 2-12d was never observed, 
likely due to the number of acidic protons within the molecule that could cause side reactions 
(Scheme 2.8).  Synthesis of alkynyl ketone 2-12d was also attempted from diketone 2-10 via 
addition of alkyne 2-11b under the same conditions used to obtain 2-12a and 2-12b.  This 
reaction also did not provide ketone 2-12d because alkyne 2-11b underwent a retro-Brook 
rearrangement to afford alkynol 2-11c.  
2-12b 2-12c
O
OTBS
HO
2-12d
O O H3C
OTBS
t-BuLi, -78 °C
O
OTBS
HO
TMS K2CO3
 MeOH
80%
O
OTBS
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BuLi, LDA, 
KHMDS
2-10
2-11b
H3C
OH
2-11c TBS
 
Scheme 2.8 Attempted Syntheses of Methyl Alkyne 2-12d 
 Coupling of p-iodoanisole to alkyne 2-12c was accomplished via a Sonogashira reaction 
using 1 mol% Pd(PPh3)2Cl2 in the presence of copper iodide and diisopropylamine in THF to 
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afford alkyne 2-12e in 77% yield.  An 8% yield of the Glaser alkyne dimerization product 2-21 
was also obtained from this reaction (Scheme 2.9).  Structural characterization of the dimer 2-21 
was confirmed by ESI-HRMS (exact mass found = 613.3338) and by the absence of a resonance 
near 2.77 ppm (s, 1H), corresponding to the terminal alkyne proton, in the 1H NMR spectrum.  
O
OTBS
HO
2-12e
OMe
1 mol% Pd(PPh3)2Cl2,
CuI, HN(i-Pr)2, THF
I O
O
OTBS
HO
O
OTBS
OH
8%
2-12c
O
OTBS
HO
+
2-21
77%  
Scheme 2.9 Sonogashira Coupling Reaction of Alkyne 2-12c with p-Iodoanisole to Afford Alkyne 2-12e 
 Alkynyl ketone 2-12e was next subjected to the same synthetic sequence as alkynyl 
ketone 2-12a.  Reaction of 2-12e with ethynyl magnesium bromide in the presence of cerium 
trichloride afforded the desired propargyl alcohol in 71% yield.  Although, the alcohol contained 
minor impurities after column chromatography on silica gel, it was used without further 
purification.  This propargyl alcohol was then reacted with acetic anhydride in triethylamine to 
give propargyl acetate 2-13b in 84% yield.  Finally, propargyl acetate 2-13b was subjected to the 
optimized cuprate conditions to afford allene-yne 2-18e in 47% yield as a 1.5 : 1 mixture of 
diastereomers as determined by the relative integrations of the resonances at 4.87 and 4.82 ppm 
in the 1H NMR spectrum, corresponding to the propargylic protons (Scheme 2.10). 
O
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HO
2-18e
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OMeR =
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Scheme 2.10 Synthesis of Terminal Aryl Allene-yne 2-18e 
The TBS group of 2-18e was removed using TBAF to give allene-yne 2-18f in 84% 
yield.  The allenic carbocyclization reaction was next performed on the protected and 
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unprotected allene-ynes 2-18e and 2-18f.  Reaction of allene-yne 2-18e with 6 mol% 
[Rh(CO)2Cl]2 afforded triene 2-19e in 54% yield (Scheme 2.11, eq. 1).  The desilylated allene-
yne 2-18f also reacted under the same conditions to afford triene 2-19f in a similar 53% yield 
(Scheme 2.11, eq. 2).  Triene 2-19f could also be obtained in 63% yield from 2-19e using TBAF 
in THF. 
TBAF, 
THF
84%
[Rh(CO)2Cl]2
6 mol%
toluene, 0.05 M
rt, 20 min, 53%
TBSO
HO
OH
HO
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rt, 30 min, 54%OTBS
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OMe
OMe
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Scheme 2.11 Allenic Carbocyclization Reactions of 2-18e-f to Form Spiro[2.5]octatrienes 2-19e and 2-19f 
The results obtained for the carbocyclization reactions of allene-yne 2-18e and allene-yne 
2-18a supported the hypothesis of developing A1,3 strain in the rhodacycle transition state.  This 
effect was observed in intermediate 2-20a, where the TMS group caused a poor A1,3  interaction 
with the OTBS group, whereas in 2-20e the aromatic ring could position itself in an orthogonal 
conformation to avoid this interaction (Scheme 2.12).    
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Scheme 2.12 Conformational Considerations for Reactions of 2-18a vs. 2-18e 
The results for all allenic carbocyclization reactions affording spiro[2.5]octatrienes 
discussed in this chapter are summarized in table 2.3.  The stereochemistry is denoted by the 
configuration of the diol. 
Table 2.3 Summary of Allenic Carbocyclization Reactions Affording Spiro[2.5]octatrienes 
OR1
HO
•
2-18
R2
6 mol% 
[Rh(CO)2Cl]2
0.05 M in toluene, rt HO
OR1 R2
2-19  
Entry R1 R2 Product Diol Time (min) Yield (%) 
1 TBS TMS 2-19a Anti N/A Complex mixture 
2a  H TMS 2-19b Anti < 5 73 
3  TBS H 2-19c Anti 90 64 
4b  H H 2-19d Anti 60 55 
5  TBS p-C6H4OMe 2-19e Syn 30 54 
6  H p-C6H4OMe 2-19f Syn 20 53 
a. 3 mol% [Rh(CO)2Cl]2  b. 50 °C 
2.2.4 Progress Towards Bicyclic Acylfulvene Analog Synthesis Endgame 
With the spiro[2.5]octatrienes 2-19 in hand, illudin analog synthesis was investigated.  Oxidation 
of triene 2-19b with DMP gave 2-22b in 77% yield.  The structural characterization of 2-22b 
was supported by a resonance in the aldehyde region and resonances indicative of the triene in 
1H NMR spectrum.  Reaction of 2-19f with DMP afforded 2-22f in 50% yield (Scheme 2.13).  
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This product was confirmed by the resonances in the 1H NMR spectrum at 9.39 ppm (s, 1H), 
corresponding to the aldehyde and at 6.83 (dd, 1H), 5.14 (d, 1H), 4.97 ppm (d, 1H) 
corresponding to the triene was isolated from.  Characteristic absorbances at 1673 cm-1 and 1602 
cm-1 corresponding to the carbonyl groups are also observed in the IR spectrum.   
2-19 2-22
OH
HO
Dess-Martin
R R = TMS, 77%, 2-22bR = p-C6H4OMe, 50%  2-22f
O
O
R
CH2Cl2, 2 h
2-17
O
HO
R
not observed  
Scheme 2.13 Oxidative Cleavage of Spiro[2.5]octatrienes 2-19b and 2-19f 
Several other oxidation conditions were attempted affording three typical results: 
cleavage, no reaction, or small amounts of uncharacterized products that did not resemble the 
desired analog as observed by 1H NMR analysis.  Cleavage products were obtained when using 
pyridinium dichromate (PDC), manganese dioxide (MnO2), or Dess-Martin periodinane (DMP).  
No reaction occurred when using Swern conditions, sulfur trioxide pyridine complex (SO3⋅pyr), 
or catalytic tetrapropylammonium perruthenate with stoichiometric N-methylmorpholine-N-
oxide (TPAP/NMO).  Uncharacterized products were found in small amounts when using                    
2-iodoxybenzoic acid (IBX) or Kinder’s oxidation conditions (50 mol% Ru(PPh3)2Cl2 and 
NMO).  Although there is no mention, it seemed likely that Kinder used such uncommon 
oxidation conditions because he encountered similar problems with this step in his synthesis.  
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2.3 CONCLUSIONS 
A route to spiro[2.5]octatrienes has been developed using the Rh(I)-catalyzed allenic 
carbocyclization reaction, affording five trienes in 53 – 73% yields under mild conditions.  The 
carbocyclization reaction was tolerant of TBS-protected or deprotected alcohols, aryl and silyl 
substituted alkynes, and anti or syn diols and performed well in these structurally compact, yet 
highly functionalized systems.  
Developing A1,3 strain between the TBS ether and the TMS group at the alkyne terminus 
of 2-18a prevented the desired carbocyclization reaction, resulting in complex mixtures.  
Removal of the TBS group or substituting a less bulky group at the alkyne terminus alleviated 
this limitation.   
Synthesis of the final analogs through oxidation of the secondary alcohol was 
problematic, affording only ketoaldehyde 2-22, an oxidative cleavage product.  This final 
oxidation step was necessary to the biological function of these molecules, as tests performed by 
John Skoko in the laboratories of Dr. John Lazo have shown that spiro[2.5]octatriene 2-19d has 
no activity against A549 lung carcinoma cells at concentrations up to 50 µM. 
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3.0  SYNTHESIS OF ε-LACTAMS USING RHODIUM(I)-CATALYZED ALLENIC 
CARBOCYCLIZATION REACTIONS 
3.1 INTRODUCTION 
3.1.1 Transition Metal-Catalyzed Cycloisomerizations Affording Seven-Membered Rings  
Transition metal-catalyzed cycloisomerization reactions to form seven-membered rings are rare. 
Trost has reported a ruthenium catalyzed enyne cycloisomerization reaction that produces both 
five- and seven-membered rings, and the ratio was dependent upon the substrate structure 
(Scheme 3.1, eq. 1).35  Similarly, Mukai has synthesized cross-conjugated cycloheptenes 3-6 in 
57-66% yield by reacting allene-yne 3-5 with 2.5 mol% [Rh(CO)2Cl]2 in refluxing toluene 
(Scheme 3.1, eq. 2).36  Azepines and oxepines 3-8 have also been synthesized from ene-allenes 
in the Brummond group under Rh(I)-catalyzed carbocyclization conditions (Scheme 3.1, eq. 
3).37,38 
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Scheme 3.1 Formation of Seven-Membered Rings via Transition Metal-Catalysis 
While formation of seven-membered rings using rhodium(I)-catalyzed 
cyclocarbonylation conditions has been demonstrated, all attempts to obtain seven-membered 
rings from allene-ynes using rhodium(I)-catalyzed carbocyclization conditions have met with 
failure.39  Inspired by the successful conversion of allene-containing propiolamides to δ-lactams 
via a Rh(I)-catalyzed carbocyclization reaction, we turned our attention to the feasibility of 
forming ε-lactams.40  The importance of ε-lactams can be put into perspective by a simple search 
showing 16,000 ε-lactams in over 8,000 references in the literature.41  For example, caprolactam 
3-9 showed binding activity to src protein, which is thought to be involved in the complications 
of osteoporosis (Fig 3.1).42  Rolb has reported use of ε-lactams, such as 3-10, as Leu-Phe 
replacements in vasopeptidase inhibitors (Fig 3.1).43  Finally, cephalotaxine (3-11) has 
anticancer activity (Fig 3.1).44 
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Figure 3.1 Biologically Active ε-Lactam Derivatives  
We envisioned that ε-lactams like 3-12 could be accessed via the Rh(I)-catalyzed allenic 
carbocyclization reaction of 3-13.  The allene-yne precursor 3-13 could be readily synthesized 
via DCC coupling reaction between a secondary amine 3-15, and allenic acid 3-14 followed by 
alkylation of the resultant amide (Scheme 3.2).  The successful synthesis of ε-lactams and 
extensions of this methodology to form azepines and fused 7-5 lactams are discussed herein. 
•
O
N
R1
R2
3-12 3-13
•
O
OH
3-14
N
O
R1
R2
H2N R1+
3-15
R1, R2 = Alkyl, aryl, H  
Scheme 3.2 Synthetic Route to ε-Lactams 
3.2 RESULTS AND DISCUSSION 
3.2.1 Testing the Feasibility of a Rh(I)-Catalyzed Carbocyclization Reaction to form ε-
Lactams   
We thus set out to synthesize a suitable precursor to test the feasibility of the rhodium(I)-
catalyzed carbocycliation reaction to form 3-12.  We first determined that disubstitution at the α-
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position of the ester would be necessary to prevent isomerization of the allene to the conjugated 
diene under basic conditions.  Formation of α-methyl allenic ester 3-18 was effected via 
Johnson-Claisen rearrangement of triethyl orthopropionate (3-16) and 3-butyn-2-ol (3-17) in 
91% yield.45  Chris Wach, in the Brummond group, has shown that ester 3-18 can be α-
methylated using LDA and iodomethane in 60-79% yield.46  The resultant α,α-dimethyl ester 
was then saponified using 2M KOH in methanol to afford the desired allenic acid 3-19 in 81-
99% yield (Scheme 3.3).   
•
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OEtO OEt
OEt OH
+
3-183-173-16
cat. 
propionic
acid
91% •
O
OH
3-19
1. LDA, MeI, 
60 - 79%
2. KOH, 2 M in 
MeOH, 48 h, 
81 - 99%
 
Scheme 3.3 Synthesis of Allenic Acid 3-19 
Next, the isobutyl chloroformate mixed anhydride of acid 3-19 was prepared and reacted 
with benzyl amine (3-20a), affording a 78% yield of amide 3-21.40  Attempts to effect this 
coupling with DCC gave a 28% yield of product along with an uncharacterized product that 
contained multiple resonances in the alkyl region of the 1H NMR spectrum.  Attempts to alkylate 
amide 3-21 using sodium hydride and propargyl bromide (3-22) resulted in no reaction or 
multiple product spots by TLC analysis over prolonged reaction times (Scheme 3.4). 
•
O
OH
3-19
1. i-Bu chloroformate
2. benzyl amine 3-20a, 
N-methylmorpholine, 
78%
•
O
N
H
3-21
Bn
Br
3-22
NaH
•
O
N
Bn
3-23a  
Scheme 3.4 Formation of Amide 3-21 and Attempts at Alkylation to Afford 3-23a 
To circumvent the difficulties associated with amide alkylation of 3-21, we considered 
coupling acid 3-19 with a 2° propargyl amine to obtain 3-23a directly.  Reaction of benzyl amine 
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(3-20a) with propargyl bromide (3-22) afforded benzyl propargyl amine (3-24a) in 25% yield as 
shown in Scheme 3.5.47 
H2N
NaI, THF, reflux
Br
H
N
25%
3-20a 3-24a
3-22
 
Scheme 3.5 Formation of Secondary Propargyl Amine 3-24a 
Reaction of 3-19 with isobutyl chloroformate, N-methylmorpholine, and amine 3-24a did 
not afford the desired amide 3-23a, but instead gave only isobutylcarbamate 3-25 in 92% yield 
(Scheme 3.6).  The presence of a resonance at 0.88 ppm (d, 6H) corresponding to the methyl 
groups in the isobutyl unit of the carbamate supported the characterization of 3-25 by 1H NMR 
spectroscopy.  Carbamate 3-25 resulted from attack of the amine at the undesired carbonyl center 
of the mixed anhydride, due to the bulky gem dimethyl group next to the carbonyl. 
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Scheme 3.6 Attempted Coupling to Form Allenyl Propargyl Amide 3-23a 
Alternatively, reaction of acid 3-19 with oxalyl chloride and catalytic DMF for 3 h 
resulted in formation of an acid chloride that was concentrated and redissolved in THF.  The 
resultant solution was added via cannula to a solution of amine 3-24a to provide allenic 
propargyl amide 3-23a in 90% yield (Scheme 3.7).  With the allene-containing propargyl amide 
3-23a in hand, reaction to the standard conditions for δ-lactam formation (10 mol% 
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[Rh(CO)2Cl]2 in toluene at 0.05M immersion in an oil bath preheated to 50 °C) provided ε-
lactam 3-26a in 62% yield (average) after 1.5 h (Scheme 3.7).40 
HN
•
O
OH
3-19
1. (COCl)2, cat. 
DMF, THF
2.
•
O
N
Bn
3-24a
3-23aDMAP, THF, 90%
[Rh(CO)2Cl]2
10 mol%
0.05 M toluene,
50 °C: 1.5 h, 
62%
N
O
3-26a  
Scheme 3.7 Synthesis of e-Lactam 3-26a 
Lactam 3-26a was characterized by 1H NMR as shown in Table 3.1.  The 1H NMR 
spectrum has also been reproduced below (Fig. 3.5, see chapter 3 experimental section for full 
characterization data).  Evidence for the trienyl structure of 3-26a was supported by the 
resonances at 6.36 (dd, 1H), 5.69 (s, 1H), 5.36 (d, 1H), 5.12 (d, 1H), 5.09 (s, 1H), 4.45 ppm (s, 
1H), corresponding to Hg, Hj, Hi, Hh, and Hf respectively. 
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Table 3.1 1H NMR Characterization of ε-Lactam 3-26a 
N
O
H3C
H3C
3-26a
Hd
Hd
HbHb
Hc Hc
Ha
He
HeHj
Hi
Hh Hf
Hf
(Hk)
Hg
 
Proton Chemical Shift (ppm) Multiplicity Integration J-Value (Hz) 
Ha, Hb, Hc 7.35-7.24 m 5 - 
Hd, He 4.68, 3.93 s, s 2, 2 - 
Hf 5.09, 4.95 s, s 1, 1 - 
Hg 6.36 dd 1 17.0, 10.6 
Hh 5.12 d 1 10.6 
Hi 5.36 d 1 17.0 
Hj 5.69 s 1 - 
Hk 1.52 s 6 - 
 
 
Figure 3.2 1H NMR Spectrum of 3-26a 
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3.2.2 Exploration of the Scope of the Allenic Carbocyclization Reaction for the Formation 
of ε-Lactams via Substitution at the Propargyl Amide 
Investigations into the scope and limitations of the Rh(I)-catalyzed allenic carbocyclization 
reaction for the formation of ε-lactams were undertaken through modifications at the amide 
nitrogen atom and the alkyne terminus.  Using previously described conditions to generate the 
acid chloride in situ, eight amides (Table 3.2, entries 1-4 and 6-9) and one ester (Table 3.2, entry 
5) were synthesized from allenic acid 3-19 and a variety of substituted secondary amines 3-24 or 
propargyl alcohol (Table 3.2).  Yields from these coupling reactions ranged from 69% to 96%, 
with the volatile propargyl ester 3-23e affording the lowest yield. 
Table 3.2 Formation of Allenic Propargyl Amides 3-23 
•
O
OH
1. (COCl)2, DMF, THF
2. amines 3-24 or 
alcohol, TEA, 
DMAP
•
O
Z
3-19 3-23
R1
R2
 
Entry Z R1 R2 Product Yield (%) 
1 N Bn propargyl 3-23a 90 
2 N H propargyl 3-23b 81 
3 N H allyl 3-23c 86 
4 N Bn allyl 3-23d 81 
5 O - propargyl 3-23e 69 
6 N (CH2)2OTBS propargyl 3-23f 96 
7 N furfuryl propargyl 3-23g 79 
8 N Bn  3-23h 83 
9 N Bn MeO  3-23i 88 
 
Reaction of amide 3-23f to the optimized carbocyclization conditions afforded lactam    
3-26f in 61% yield (average).  Furfuryl amide 3-23g reacted to afford 3-26g in 63% yield in 1.5 h 
(Table 3.3, entry 3).  Both methyl substituted alkyne 3-23h and p-methoxyphenyl substituted 
alkyne 3-23i reacted under the optimized conditions to afford 3-26h and 3-26i in 49% and 65% 
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yields, respectively (Table 3.3, entries 4 and 5).  The spectral data of crude products from the 
carbocyclization reactions contained impurities, typically in the 1.9 to 1.0 ppm region of the 1H 
NMR spectrum (resonances were not integrated).  A brown precipitate was also observed upon 
dilution of each reaction mixture with 30% ethyl acetate/hexanes during workup; however, no 
by-products could be isolated. 
Table 3.3 Formation of Substituted ε-Lactams via Rh(I)-Catalyzed Allenic Carbocyclization Reactions 
•
O
NR1 [Rh(CO)2Cl]2
10 mol%
0.05 M in toluene
1.5h, 50 °C
NR1
O
R2
R23-23 3-26  
Entry Starting Material R
1 R2 Time (h) Product Yield (%) 
1 3-23a Bn H 1.5 3-26a 62a 
2 3-23f (CH2)2OTBS H 2 3-26f 61a 
3 3-23g furfuryl H 1.5 3-26g 63 
4 3-23h Bn Me 1.5 3-26h 49 
5 3-23i Bn p-C6H4OMe 1.5 3-26i 65 
a Average of 4 yields 
Secondary allenic propargyl amide 3-23b, allyl amides 3-23c-d, and propargyl ester        
3-23e, were unreactive under the optimized Rh(I) conditions and this can be attributed to their 
unfavorable rotamer populations (Scheme 3.8).  These compounds favor the O(N)-Z 
conformation and, the alkyne is too distant to take part in the carbocyclization reaction.  
Attempts to overcome the unfavorable rotamer populations (~18 kcal/mol) in the secondary 
amides by heating to 90 – 100 °C only resulted in formation of insoluble solids that could not be 
characterized. 
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Scheme 3.8 Conformational Considerations of Secondary and Tertiary Propargyl Amides 
3.2.3 Formation of Trienyl Azepines via Reductions of ε-Lactams  
Extension of the ε-lactam forming reaction to the synthesis of additional alkaloids, was 
accomplished by reduction of the amide moiety.  Trienyl azepines 3-27a and 3-27f were 
synthesized in 60% and 74% yields, respectively, by reacting 3-26a and 3-26f with four 
equivalents of lithium aluminum hydride (LAH) in ether at 0 °C (Scheme 3.9). 
NBn
O
3-26a
N
O
OTBS
3-26f
LiAlH4
Et2O, 0 °C
LiAlH4
Et2O, 0 °C
NBn
3-27a
N
OTBS
3-27f
60%
74%
H H
H H
 
Scheme 3.9 Reduction of ε-Lactams 3-26 to form Trienyl Azepines 3-27 
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3.2.4 Synthesis of a 7-5 Fused ε-Lactam via a Rh(I)-Catalyzed Allenic Carbocyclization 
Reaction 
With the successful reduction of the lactams to azepines in hand, efforts were made to synthesize 
a 7-5-fused ε-lactam scaffold.  Synthesis of such a scaffold would open the door to a synthesis of 
the structurally similar natural product cephalotaxine (3-11) (Fig 3.1). 
For example, it was envisioned that 7-5 fused azepine 3-28 could be accessed from 
allenic propargyl amide 3-23j via a Rh(I)-catalyzed carbocyclization followed by a reduction of 
the lactam.  An ideal synthetic route to allenic propargyl amide 3-23j would start with the five-
membered ring already intact.  Coupling of allenic acid 3-19 and propargyl amine 3-29 would 
rapidly provide the desired compound 3-23j (Scheme 3.10). 
N
3-28
•
O
N
3-23j
•
O
OH +
N
H
3-19 3-29
N
OMe
HO
H
O
O
(-)-cephalotaxine (3-11)  
Scheme 3.10 Synthetic Route to 7-5 Fused Azepines 
Commercially available Boc-L-proline 3-30 was first reduced using borane 
dimethylsulfide complex to afford Boc-L-prolinol 3-31 in quantitative yield.  Boc-L-prolinol 3-31 
is then oxidized under Swern conditions to give aldehyde 3-32 in 81% yield.  This aldehyde 3-32 
was then subjected to a Colvin rearrangement using Shioiri’s conditions, producing the Boc-
protected proline derivative 3-33 in 68% yield (Scheme 3.11).48 
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Scheme 3.11 Synthesis of Boc-Protected Propargyl Amine 3-33 
Removal of the protecting group from Boc-amine 3-33 under standard trifluoroacetic acid 
conditions to give 3-29 (Scheme 3.10) appeared to proceed by TLC analysis; however, isolation 
of the volatile product proved difficult.  The trifluoroacetate salt of propargyl amine 3-33 could 
be isolated as observed by loss of the resonance near 1.6 ppm (s, 9H) corresponding to the Boc 
group in the crude 1H NMR spectrum, but attempts to couple it to acid 3-19 proved unsuccessful. 
In an effort to decrease the volatility of amine 3-29, a TIPS group was appended to the 
end of the alkyne of 3-33 under n-BuLi conditions, providing Boc-amine 3-34 in 91% yield.  The 
Boc group was then removed under TFA conditions immediately following purification of 3-34 
providing propargyl amine 3-35, which was easily isolated by column chromatography in 52% 
yield (72% brsm, Scheme 3.12).  
N
Boc
3-33
n-BuLi, TIPSCl
THF, -78 °C,
1 h, 91%
N
Boc
TIPS
50% TFA, 
CH2Cl2
20 min, 52%
N
H TIPS
3-34 3-35  
Scheme 3.12 Formation of TIPS Propargyl Amine 3-35 
The TIPS-protected propargyl amine 3-35 was next coupled to allenic acid 3-19 via the 
acid chloride to afford allenic propargyl amide 3-23k in 83% yield (Scheme 3.13).  Allenic 
carbocyclization reaction of 3-23k did not afford 3-26k due to the steric bulk of the TIPS group 
at the alkyne terminus.  Removal of the TIPS group under TBAF conditions gave allenic 
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propargyl amide 3-23j as a 1 : 1 mixture of diastereomers in 90% yield.  The structural 
characterization of 3-23j was evidenced by the terminal alkyne singlet at 2.94 ppm by 1H NMR 
analysis.  Absorbances at 1962 cm-1, 2110 cm-1, and 1630 cm-1 in the IR spectrum, 
corresponding to the allene, alkyne, and amide respectively, also support the structure.  Allenic 
carbocyclization of amide 3-23j was successful under the optimized conditions for the formation 
of ε-lactams, providing 7-5 fused bicyclic ε-lactam 3-26j in 62% yield.  Support for the structure 
of 3-26j was provided by the appearance of similar trienyl splitting patterns as described for      
3-26a in the 1H NMR spectrum (Scheme 3.13). 
N
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•
O
OH
1.(COCl)2, DMF, THF
2. amine 3-35 
(R= TIPS), TEA, 
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O
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N
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O
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3-23j
R = H
3-26k, R = TIPS, no reaction
3-26j, R = H, 62%TBAF, THF
90%
 
Scheme 3.13 Final Synthesis of the 7-5 Fused Bicyclic ε-Lactam 3-26j 
3.3 CONCLUSIONS 
In conclusion, a Rh(I)-catalyzed allenic carbocyclization reaction, affording ε-lactams has been 
developed.  Furthermore, the transition metal-catalyzed process proceeded readily in the 
presence of an amide, alkyl, and aryl functional groups under relatively mild conditions.            
ε-Lactams can be reduced to form trienyl azepines, a functionality that may be used in the 
synthesis of natural product-like compounds.  
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4.0  A DIVERGING DOS STRATEGY: APPLICATION OF ALLENIC RHODIUM(I)-
CATALYZED CYCLOCARBONYLATION, MICROWAVE-ASSISTED [2 + 2] 
CYCLOADDITION, AND SILVER(I)-CATALYZED CYCLOISOMERIZATION 
REACTIONS TO THE SYNTHESIS OF FUSED TETRA- AND PENTACYCLIC 
INDOLE SCAFFOLDS 
4.1 INTRODUCTION 
4.1.1 Diversity-Oriented Synthesis and Common Chemical Methods to Achieve Diversity 
Chemical synthesis of complex organic molecules has branched into three directions over the 
years: target-oriented synthesis (TOS), medicinal (and combinatorial) chemistry, and diversity-
oriented synthesis (DOS).49  In DOS, forward synthetic analyses, are used to design routes to 
diverse targets and plans to achieve molecular complexity normally involve appendage diversity, 
stereochemical diversity, and skeletal diversity.  Skeletal diversity provides sets of distinct 
compound scaffolds, and is often considered the most powerful technique of the three because 
each different scaffold is likely to occupy a separate region of chemical space. 
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4.1.2 Strategies to Achieve Skeletal Diversity 
Skeletal diversity can be achieved by a substrate-based approach that employs a common set of 
reagents to elaborate several substrates, or a reagent-based approach that is less common.50  In 
the reagent-based approach a common intermediate (sometimes referred to as the pluripotent 
substrate) is subjected to varied conditions to afford different scaffolds.51  The common 
intermediate approach to skeletal diversity has also been expanded to a “functional group 
pairing” methodology, recently referred to as the “build/couple/pair” strategy by Schreiber.52  
Such examples have included work by Porco starting with β-nitrostyrenes,53 and most recently 
by Hanson, who incorporated masked functionality that is selectively activated through 
functional group interconversions.54  
The Brummond group was the first to demonstrate a DOS strategy in which multiple 
scaffolds were formed from a common intermediate through catalyst and condition control.  For 
example, deprotection of α-allenic amino-ester 4-1 followed by reaction with silver(I)-nitrate 
under Dieter’s conditions afforded 3,4-dehydroproline 4-2.55,56  Coupling of 4-1 to propargyl (or 
allyl) bromide (4-3) provided allene-yne or allene-ene 4-5 (Scheme 4.1).  Subjecting allene-yne   
4-5 to microwave irradiation afforded bicyclo[4.2.0]octa-1,6-diene 4-4.57  Reaction of 4-5 with 
Mo(0) under carbon monoxide atmosphere afforded α-alkylidene cyclopentenone 4-7.58  
Reacting 4-5 with Rh(I) in the presence of CO provided 4-alkylidene cyclopentenone 4-8 via a 
cyclocarbonylation reaction,58c,58f,59 whereas similar catalytic conditions in the absence of CO 
gave cross-conjugated triene 4-9 via a carbocyclization process.20,27,38,40,60  Finally, reacting the 
allene-ene version of 4-5 with Rh(I) afforded azepine 4-6.37,38  
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Scheme 4.1 Brummond Group Strategy for Diversification of α-Allenic Amino-esters 
Several scaffolds shown in Scheme 4.1 have been further elaborated by subjecting each 
to complexity generating reactions.61  These studies have produced libraries of 2-pyrrole 
carboxamides,58b,62 5-iminoozazolodin-2-ones, hydantoins, and acylureas,63 3,4-
dehydroprolines,64 and cyclic ethers.38  All compound structures and biological assay data have 
been uploaded to the Pubchem database.65  
4.1.3 New Scaffold Diversity: Tryptophan-Derived Amino-Esters  
We propose to continue investigating the potential of the diverging DOS strategy of allene-ynes 
by attachment of an allene and alkyne directly to a heterocycle.  It is hypothesized that this 
heterocycle template will serve as a starting point for rapid access to a number of compounds 
possessing interesting biological activity.  Moreover, it is envisioned that minimal effort will be 
required to prepare a number of heterocycle-containing allene-ynes, thus lowering the barrier to 
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the preparation of more compound libraries with greater chemical diversity.  Our general strategy 
is depicted in Scheme 4.2.   
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Scheme 4.2 Diverging DOS Strategy for the Synthesis of Tryptophan-Derived Scaffolds 
Starting with an allene-substituted tryptophan 4-11, it is reasoned that a Pictet-Spengler 
reaction could be employed at an early stage, providing access to a tetrahydro-β-carboline.  
Conversion of the tetrahydro-β-carboline amine group to a propiolamide followed by: 1. A 
Rh(I)-catalyzed cyclocarbonylation reaction should give 4-10; 2. A microwave-assisted [2 + 2] 
cycloaddition reaction will afford 4-13; and 3. Reaction with molybdenum hexacarbonyl in turn 
provides 4-14.  Alternatively, appending an allyl group to the nitrogen atom of the tetrahydro-β-
carboline is postulated to give azepine 4-15 when reacted under Rh(I)-catalyzed carbocyclization 
conditions.  Finally, reaction of the tetrahydro-β-carboline with Ag(I) should afford 4-12. 
The value of synthesizing a novel and diverse set of tetrahydro-β-carboline scaffolds is 
exemplified by the number of biologically important indole-alkaloids possessing this substrate.  
Examples include: geissoschizine (4-16), a known biosynthetic intermediate for a number of 
indole alkaloid natural products including strychnine;66 yohimbine (4-17); and 4-18, a compound 
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that has been reported in the National Cancer Institute’s database as having topoisomerase II 
activity comparable to doxorubicin.67 
N
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MeOOC OH
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H
N
H
MeOOC OH
H
H
(+)-Yohimbine (4-17)
O2N NH
N
N
H O
O OH
O
4-18  
Figure 4.1 Biologically Important Tetrahydro-β-Carbolines 
4.2 RESULTS AND DISCUSSION 
4.2.1    Diverging DOS Strategy of Allenic Tetrahydro-β-Carbolines: Early Stage Pictet-
Spengler Reaction 
4.2.1.1 Synthesis of Allenic Tetrahydro-β-Carbolines 
The first goal of the new diverging DOS strategy was to synthesize allenic amino-ester 
intermediate 4-23 for use in the Pictet-Spengler reaction.  The amine moiety of commercially 
available L-tryptophan (4-19) was first protected as the benzamide, and the product then coupled 
to propargyl alcohol using DCC and DMAP to afford propargyl ester 4-21a in 84% yield over 2 
steps after purification via column chromatography.  This esterification reaction proceeded 
through isoxazolone intermediate 4-20, which was attacked by propargyl alcohol to afford 
propargyl ester 4-21a (Scheme 4.3).68  Ester 4-21a was next subjected to carbon tetrachloride, 
triethylamine, and triphenylphosphine in acetonitrile to affect a dehydrative Claisen 
rearrangement that also racemized the product.  Addition of methanol to the reaction mixture 
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provided racemic α-allenic amino-ester rac-4-22a in 52% yield.69  The synthesis of rac-4-22a 
(Scheme 4.3) provided an intermediate of type 4-11 as shown in Scheme 4.2.  Finally, the N-
benzoyl group was removed using Meerwein’s reagent (Et3OBF4) to give α-allenic tryptophan 
methyl ester 4-23 in 59% yield following flash chromatography.40  
N
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O
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2.HO
DCC, DMAP NH
NHBz
O
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N
H
O
O
4-20
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HO
N
H
NHBz
•
OO1. NEt3, CCl4, PPh3
N
H
NH2
•
OO1. Et3OBF4, DCM, 
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2. 1:1 THF : 5% 
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2. MeOH, NEt3
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84% from 4-19
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Scheme 4.3 Synthesis of the α-Allenic Amine Precursor to the Pictet-Spengler Reaction 
No examples of a Pictet-Spengler reaction performed in the presence of an allene could 
be identified in the literature; this fact is likely because strong acids and elevated temperatures 
are typically required for the Pictet-Spengler reaction and could lead to allene hydrolysis.70  We 
reasoned that hydrolysis of the allene of 4-23 during the Pictet-Spengler reaction could be 
avoided by performing the reaction at ambient temperature, and in the presence of an organic 
acid and molecular sieves.69,71,72  We subjected allenic amine 4-23 to aqueous formaldehyde and 
trifluoroacetic acid in the presence of 4 Å molecular sieves in methanol at room temperature to 
afford allenic tetrahydro-β-carboline 4-24a in 71% yield.  Reaction of 4-23 with p-
fluorobenzaldehyde under similar conditions in CH2Cl2 afforded 4-24b in 70% yield as a 2 : 1 
trans : cis isomeric mixture (Table 4.1, entry 2).  Reacting 4-23 with n-butanal under the same 
conditions gave tetrahydro-β-carboline 4-24c in 68% yield, also as a 2 : 1 trans : cis isomeric 
mixture (Table 4.1, entry 3).   
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The trans- and cis-isomers of 4-24b were not separated, but characterized as a mixture.  
Loss of the primary amine resonance at 1.92 ppm and the appearance of secondary amine 
resonances at 2.80 and 2.65 ppm, and the C-1 methine proton resonances at 5.43 and 5.24 ppm 
were observed in the 1H NMR spectrum of the 2 : 1 trans : cis mixture.  The diastereomers of    
4-24c were separated by column chromatography, and then characterized independently.  The 
trans : cis product ratios for 4-24b and 4-24c were determined using the relative integrations of 
the resonances corresponding to the C-1 methine protons in the pure and crude 1H NMR spectra 
for each, respectively.   
Table 4.1 Synthesis of Allenic Tetrahydro-β-Carboline Derivatives via a Pictet-Spengler Reaction 
N
H
NH2
•
OO
4Å mol sieves, TFA (1 equiv),
CH2Cl2 or CH3OH, rt
4-23
O
H R
N
H
NH
•
OO
R
trans-4-24
N
H
NH
•
OO
R
+
cis-4-24
1 1
33
 
Entry R Solvent Time Product Yield (%) dr 
1 H CH3OH 5 h 4-24a 71 N/A 
2 p-C6H4F CH2Cl2 2.5 h 4-24b 70 2 : 1 
3 n-Pr CH2Cl2 50 min 4-24c 68 2 : 1 
 
We determined that the trans-isomers were the major products of the Pictet-Spengler 
reactions for reasons provided in section 4.2.1.2.  The product ratio can be explained through 
chair-like transition states trans-4-25 (allene equatorial) and cis-4-25 (allene axial).72a,b,73,74  
Thus, the allene moiety at C-3 more favorably occupied the pseudoequatorial position due to its 
larger A-value (1.53 kcal/mol vs. 1.2 – 1.3 kcal/mol for a methyl ester), resulting in the trans-
tetrahydro-β-carbolines as the major products (Fig 4.2).75 
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Figure 4.2 Hypothesized Transition States for the Pictet-Spengler Reactions to Form 4-24 
4.2.1.2  Synthesis and Characterization of New Scaffolds Using the Early Stage Pictet-
Spengler Strategy 
Allenic tetrahydro-β-carbolines 4-24 were next subjected to the Ag(I)-catalyzed allenic 
cycloisomerization reaction.55,76  Reaction of tetrahydro-β-carboline derivative 4-24a with        
20 mol% silver nitrate in acetone in a vial wrapped in aluminum foil and kept in a dark hood for 
18 h afforded 4-26a in 56% yield.  Treatment of a 2 : 1 trans : cis mixture of tetrahydro-β-
carboline 4-24b to the same conditions gave 4-26b in 72% yield as a 2 : 1 trans : cis isomeric 
mixture (Scheme 4.4).  
N
H
NH
•
OO
N
H
N
OO
20 mol% AgNO3, 
acetone, 18 h
1
4-26a, R = H, 56%
4-26b, R = p-C6H4F, 72%, 2 : 1 dr
RR
4-24a, R = H
4-24b, R = p-C6H4F, 2 : 1 dr
1
3 3
 
Scheme 4.4 Silver(I)-Catalyzed Allenic Cycloisomerization Reactions Affording Tetracyclic Indole Scaffolds 
The diastereomeric ratio of 4-26b was determined by the relative integrations of the 
resonances at 5.04 ppm and 5.51 ppm, which correspond to the protons at C-1 for the trans- and 
cis-isomers respectively (Scheme 4.5).  The trans- and cis-isomers were separated by column 
chromatography and characterized.  The alkenyl protons labeled Ha and Hb on structure           
cis-4-26b (Table 4.2) have identical vicinal and allylic coupling constants with Hc and Hd (Table 
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4.2).  Both Ha and Hb were split into a ddd with coupling constants of 6.3, 2.1, and 1.4 Hz.  For 
comparison, 1H NMR spectral assignments for cis-4-26b and pyrroline 4-27 reported by Mitasev 
are shown below (Tables 4.2 and 4.3, compare entries for Ha and Hb for each compound).55b  
These data are also similar to data reported by Rüeger and Benn, who observed that both olefinic 
resonances of 3,4-dehydroproline had nearly identical coupling constants [δ = 6.05 (dddd, J = 
6.5, 2, 2, 2 Hz, 1H), 5.92 (dddd, J = 6.5, 2.5, 2, 2 Hz, 1H)].77  Also of note, Hm exhibited 
coupling with Hl in structure cis-4-26b, as evidenced by the 1.4 Hz and 2.8 Hz couplings 
observed in the 1H NMR and COSY spectra. 
Table 4.2 1H NMR Spectral Assignment for cis-4-26b 
N
Hh
N
OO
CH3
F
cis-4-26b
Hc Hd
Ha
HbHe
HlHk
Hj
Hi
(Hg)
(Hf)
(Hm)
(Hn)
 
Entry Chemical Shift (ppm) Multiplicity Integration J Value (Hz) 
Ha, Hb 6.11, 6.01 ddd, ddd 1, 1 
6.3, 2.1, 1.4 and 
6.3, 2.1, 1.4 
Hc 3.73 – 3.71 m 1 - 
Hd 3.38 dt 1 13.3, 1.4 
He 5.51 s 1 - 
Hf 7.37 dd 2 JHF = 5.6, J = 8.4 
Hg 7.03 dd 2 JHF = 9.1, J = 8.4 
Hh 7.37 bs 1 - 
Hi 7.56 ddd 1 7.7, 1.4, 0.7 
Hj, Hk 7.14 – 7.10 m 2 - 
Hl 7.20 ddd 1 7.7, 1.4, 0.7 
Hm 3.70, 2.99 dd, dd 1, 1 
14.0, 1.4 and 
14.0, 2.8 
Hn 3.57 s 3 - 
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Table 4.3 1H NMR Spectral Assignment for 4-27 as Reported by Branko Mitasev 
N
He
CH3MeO2C
Ha Hb
Hd
(Hc)(Hf)
(Hh)
4-27
(Hg)
 
Entry Chemical Shift (ppm) Multiplicity Integration J Value (Hz) 
Ha, Hb 5.92, 5.86 dd, dd 1, 1 
5.8, 1.5 and 
5.7, 1.4 
Hc 1.11 d 3 6.6 
Hd 4.08 – 4.01 m 1 - 
He Not reported - - - 
Hf 3.79 s 3 - 
Hg 3.35, 3.09 d, d 1, 1 14.0 and 14.0 
Hh 7.45 – 7.20  m 5 - 
 
The silver(I)-catalyzed cycloisomerization reaction was successfully used to afford trans- 
and cis-4-26b, but obtaining a single isomer would make library synthesis and characterization 
more convenient.  Cook has reported that subjecting tertiary amino Pictet-Spengler adducts to 
trifluoroacetic acid for prolonged periods of time yielded only the thermodynamically favored 
isomer.72b  Thus, the 2 : 1 trans : cis mixture of 4-26b was subjected to 2.4 equivalents of 
trifluoroacetic acid in deuterated chloroform for 2.5 h to afford a 1 : 4 trans : cis mixture of       
4-26b, as determined by 1H NMR analysis, in 100% crude yield.72b  Further exposure to 
trifluoroacetic acid over 48 h did not change the product ratio, so we concluded that the 1 : 4 
ratio represented thermodynamic equilibrium.  We were now able to select either the trans- or 
cis-isomer of 4-26b as the desired major component of the product mixture. 
Efforts to assign the relative configurations of each isomer of 4-26b using various 
spectroscopic methods were unsuccessful.78  Accordingly, we used calculations to identify which 
isomer was the most stable.  Using the CAChe modeling package (Copyright © Fujitsu), cis- and 
trans-4-26b were independently optimized using conflex with MM3 geometry.  Heats of 
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formation were then calculated using the PM5 level of theory.  These calculations found that Hf 
cis = -38.8 kcal/mol, Hf trans = -37.8 kcal/mol, and ∆Hf = 1.0 kcal/mol.   The product ratio was 
thus calculated to be about 1 : 6 in favor of cis-4-26b at room temperature (Fig. 4.4).  Therefore 
the major product of the equilibration study, cis-4-26b, was the minor product of the Ag(I)-
catalyzed cycloisomerization reaction.  Because the Ag(I)-catalyzed cycloisomerization reaction 
did not effect the isomeric product ratio, we can conclude that trans-4-24b was the major product 
of the Pictet-Spengler reaction. 
 
N
H
N
OO
F
2 : 1 dr
trans-4-26b
N
H
N
OO
F
1 : 4 dr
cis-4-26b
∆Hf = 1.0 kcal/mol
~ 1 : 6 drHf trans = -37.8 kcal/mol Hf cis = -38.8 kcal/mol  
 
 
 
 
 
Figure 4.3 Cache Models of trans- and cis-4-26b 
Reacting tetrahydro-β-carboline 4-24a with 2-butynoic acid (4-28) and isobutyl 
chloroformate at room temperature for 18 h afforded allene-yne 4-29a in 72% yield after flash 
chromatography (Scheme 4.5).  Analysis of the 1H NMR spectrum revealed a new methyl group 
resonance at 1.99 ppm (s, 3H), the IR spectrum showed a C-C alkyne stretch at 2236 cm-1, and 
the molecular ion signal (m/z = 334) was present by mass spectroscopy.  Reaction of a 2 : 1  
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trans : cis mixture 4-24b with 2-butynoic acid (4-28) and EDC•HCl gave only unreacted starting 
material in 76% recovery (Scheme 4.5).79  Similarly, no product was observed when a 2 : 1  
trans : cis isomeric mixture of 4-24c was reacted with 2-butynoic acid (4-28) and isobutyl 
chloroformate, even in refluxing THF.  These results suggested that the steric bulk surrounding 
the N-2 position of tetrahydro-β-carbolines 4-24b and 4-24c was inhibiting the coupling 
reaction. 
N
H
NH
•
OO
R
1
2
3
4-24a, R = H
4-24b, R = p-C6H4F, (2 : 1 trans : cis)
4-24c, R = n-Pr (2 : 1 trans : cis)
HO
O
R = n-Pr, H
isobutyl chloroformate, 
N-methylmorpholine, THF,
rt (R = n-Pr, reflux)
or
R = p-C6H4F,
EDC⋅HCl, CH2Cl2, rt
(4-28)
N
H
N
•
OO
R O
4-29a, R = H, 72% 
4-29b, R = p-C6H4F, no rxn
4-29c, R = n-Pr, no rxn
1
2
3
 
Scheme 4.5 Synthesis of Allene-yne 4-29a 
With allene-yne 4-29a in hand, we proceeded with the allenic [2 + 2] cycloaddition 
reaction.  Recently Brummond, Painter, Davis, and Osbourn have eliminated the ionic liquid, 
used in Chen’s earlier studies, from the reaction mixture.   Instead, dimethyl formamide (DMF), 
an excellent microwave-absorbing solvent that is easily removed from the reaction mixture via 
an aqueous workup, was used.80  Employing DMF also circumvented the potential for explosions 
that have been reported when using ionic liquids in the presence of unsaturation under 
microwave conditions.81  Heating a DMF solution of 4-29a in the microwave at 225 °C for 7 min 
afforded fused pentacyclic indole 4-30a in 39% yield after flash chromatography (Scheme 4.6). 
The 1H NMR spectrum of bicyclo[4.2.0]octa-1,6-diene 4-30a showed resonances corresponding 
to Hh and Hi at 5.30 ppm (s, 1H) and at 3.22 and 3.17 ppm (AB pattern, 2H), respectively (Table 
4.4).   
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Scheme 4.6 Synthesis of Fused Pentacycle 4-30a 
Table 4.4 1H NMR Characterization of 4-30a 
N N
4-30a
O
CH3
Hi
Hh Hi
HeHd
Hc
Hb
Hk Hk
O
O
CH3
Ha
(Hf)
(Hg)
(Hj)
 
Proton Chemical Shift (ppm) Multiplicity Integration J-Value (Hz) 
Ha 8.22 bs 1 - 
Hb 7.50 d 1 7.5 
Hc, Hd 7.17, 7.12 t, t 1, 1 7.5 and 7.5 
He 7.34 d 1 7.5 
Hf 3.79, 3.03 d, dt 1, 1 15.3 and 15.3, 2.0 
Hg 3.59 s 3 - 
Hh 5.30 s 1 - 
Hi 
A 3.22 
B 3.17 
A of ABq, 
B of ABq 1, 1 16.5 and 16.5 
Hj 2.27 s 3 - 
Hk 5.55, 4.47 d, d 1, 1 17.5 and 17.5 
 
Unfortunately, the Rh(I)-catalyzed cyclocarbonylation reaction of 4-29a afforded only a 
brown precipitate that could not be characterized.  This result, combined with the low yielding   
[2 + 2] cycloaddition reaction limits the scope of the allene-yne-containing indoline as a 
precursor in the diverging DOS strategy. 
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4.2.2 Late-Stage Pictet-Spengler Route to Tryptophan-Derived Scaffolds 
Scheme 4.7 outlines the next endeavor, a late stage Pictet-Spengler strategy where 
cyclocarbonylation and carbocyclization reactions of the tryptophan-containing allene-ynes are 
performed first, followed by a tetrahydro-β-carboline forming Pictet-Spengler reaction.  The 
former has precedent in the Brummond group, the latter has precedent in the Grigg and 
Raghunathan laboratories.82 
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Scheme 4.7 Late Stage Pictet-Spengler Strategy to Diverse Tetrahydro-β-Carboline Scaffolds 
Starting with propargyl ester 4-21a, Boc-protection of the indolyl nitrogen using di-t-
butyldicarbonate (Boc2O) and DMAP in acetonitrile afforded 4-21b in 88% yield after flash 
chromatography.83  Next, dehydrative Claisen rearrangement/methanol addition of 4-21b 
afforded α-allenic amino-ester rac-4-22b in 67% yield.69,68  Finally, allenic amino-ester         
rac-4-22b was N-alkylated with 1-bromo-2-butyne (4-34) to afford allene-yne 4-35 in 72% yield 
after flash chromatography.69,68 
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Scheme 4.8 Synthesis of Allene-yne 4-35 
Cyclization of allene-yne 4-35 was now possible via the allenic [2 + 2] cycloaddition and 
Rh(I)-catalyzed cyclocarbonylation reactions.  Reacting 4-35 in DMF under microwave-
irradiation at 225 °C for 7 min gave bicyclo[4.2.0]octa-1,6-diene 4-36 in 50% yield after flash 
chromatography (Scheme 4.9).  Resonances corresponding to the alkene proton of the doubly 
allylic methylene group were observed at 5.10 ppm (s, 1H) and 2.99 ppm (unresolved AB 
pattern), respectively, in the 1H NMR spectrum.  This microwave-assisted reaction has been 
scaled from < 60 mg up to 0.5 g affording the same 50% yield, thus demonstrating the reliability 
of these conditions. 
Next, 4-35 was heated with 5 mol% [Rh(CO)2Cl]2 in dichloroethane at 50 °C under a 
carbon monoxide atmosphere for 1 h affording 4-alkylidene cyclopentenone 4-37b in 88% yield 
following column chromatography (Scheme 4.9).  The 1H NMR spectrum of 4-37b contained 
new resonances corresponding to the α-methylene unit at 3.04 and 2.95 ppm (AB pattern, 2H) 
and the IR spectrum contained no absorbances in the 2250 – 2050 cm-1 and 1960 cm-1 regions to 
indicate the presence of an alkyne or allene, respectively.  Finally, the indolyl Boc group of      
4-37b was removed under thermal conditions in DMSO to provide 4-37a in 78% yield (Scheme 
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4.9).  Other protocols to remove the Boc group (CH3OH/HCl; TFA/CH2Cl2) lead to 
decomposition of the starting material as observed by TLC analysis. 
N BzN
•
OO
Boc
5 mol% [Rh(CO)2Cl]2
N BzN
OO
R
O1 atm CO, DCE, 50 °C, 
1 h
4-35
4-37b, R = Boc, 88%
MWI, DMF,
two steps, 50% NH
BzN
OO
225 °C, 7 min
4-36
 DMSO, 180 °C, 
10 min 4-37a, R = H, 78%  
Scheme 4.9 Synthesis of 4-36 and 4-37a via [2 + 2] Cycloaddition and Cyclocarbonylation Reactions 
Removal of the benzoyl groups from 4-36 and 4-37a proved challenging.  A number of 
conditions were attempted including: Meerwein’s reagent,39 DIBAL-H,84 super hydride,85 and 
Schwartz’s reagent,86 none of which provided the desired secondary amine.  Reacting DIBAL-H 
with 4-37a produced only a complex mixture by TLC analysis.   Reaction of 4-36 with super 
hydride appeared to selectively reduce the ester as observed by 1H NMR analysis of the crude 
product.  
Reaction of 4-37a with Meerwein’s reagent provided only ring-opened amine adduct     
4-39 in 8% yield.  The benzoyl group had migrated to the 2-position of the indole ring, as 
observed by loss of the resonance at 6.95 ppm (d, 1H) and retention of the benzoyl resonances 
around 7.20 ppm in the 1H NMR spectrum.  Formation of 4-39 is thought to occur through 
Bischler-Napieralski-type intermediate 4-38.  Hydrolysis of 4-38 in the presence of acid afforded 
4-39 (Scheme 4.10).  
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Scheme 4.10 Reaction of 4-37a with Meerwein's Reagent 
Georg has shown that aldehydes could be obtained from amides using Schwartz’s 
reagent, and it was reasoned that this methodology could be adapted to amine deprotection.86  
When 4-alkylidene cyclopentenone 4-37a was treated with Schwartz’s reagent only alcohol 4-40 
was isolated as a 2 : 1 mixture of diastereomers (Scheme 4.11).  New resonances at 4.62 (d, J = 
5.1 Hz, 1H) and 4.44 ppm (d, J = 6.9 Hz, 1H) in the 1H NMR spectrum of 4-40, and a change 
from the AB quartet at 2.96 ppm in the 1H NMR spectrum of 4-37a into two sets of double 
doublets in the 3.04 ppm to 2.30 ppm region of the 1H NMR spectrum of 4-40 provided evidence 
for the product.  The relative integrations of the two resonances at 5.38 ppm and 5.35 ppm 
indicated a   2 : 1 diastereomeric ratio by 1H NMR analysis.  Bicyclo[4.2.0]octa-1,6-diene 4-36 
did not react with Schwartz’s reagent; and other methods to remove the benzoyl group have not 
yet been explored. 
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Scheme 4.11 Reaction of 4-37a with Schwartz's Reagent 
4.3 CONCLUSIONS 
We have developed two complementary strategies resulting in the synthesis of four novel indole-
alkaloid scaffolds.  The first strategy provided scaffolds 4-26 and 4-30, and employed a Pictet-
Spengler reaction early in the synthetic sequence to afford α-allenic tetrahydro-β-carbolines       
4-24.  The carboline scaffolds were further elaborated through a silver(I)-catalyzed allenic 
cycloisomerization reaction, affording tetracyclic fused indole-alkaloid derivatives 4-26.  
Alternatively, formation of a propiolamide from the tetrahydro-β-carboline provided an allene-
yne substrate 4-29a suitable for a microwave-assisted allenic [2 + 2] cycloaddition reaction, 
which gave a fused pentacyclic cyclobutane-containing indole-alkaloid 4-30a.  The second 
strategy provided two ring-opened indole-alkaloid scaffolds 4-36 and 4-37,68 via microwave-
assisted allenic [2 + 2] cycloaddition and Rh(I)-catalyzed allenic cyclocarbonylation reactions, 
respectively.  Removal of the benzoyl group remained a challenge in the late-stage strategy, but 
further development may lead to substrates that will result in better diastereoselectivity during 
the Pictet-Spengler reaction.   
The results from both strategies are summarized in Scheme 4.12, which provides a 
roadmap for further development through library synthesis.  The value of this methodology to 
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library synthesis is high as exemplified by the novelty and ease of construction of the scaffolds, 
and availability of starting materials. 
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Scheme 4.12 Summary of Scaffolds Synthesized from Indolyl α-Allenic Amino-Esters 
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5.0  EXPERIMENTAL SECTION 
5.1 GENERAL METHODS 
Unless otherwise noted, all reactions were carried out under nitrogen atmosphere.  All 
commercially available compounds were purchased and used as received, unless otherwise 
specified. Tetrahydrofuran (THF) and diethyl ether (Et2O) were purified by passing through 
alumina. Dichloromethane (CH2Cl2) was passed through alumina and Q5. Toluene and 
dichloroethane were freshly distilled from CaH2 prior to use. Purification of the compounds by 
flash chromatography was performed by using silica gel (32-63 µm particle size, 60 Å pore size).  
TLC analyses were performed on EM Science Silica Gel 60 F254 plates (250 µm thickness). All 
1H NMR and 13C NMR spectra were obtained on 300, 500, or 700 MHz Bruker Biospin NMR 
spectrometers with Topspin NMR software.  Chemical shifts (δ) are reported relative to residual 
solvent resonances as indicated.  All NMR spectra were obtained at room temperature unless 
otherwise specified.  IR spectra were obtained using a Nicolet Avatar E.S.P. 360 FT-IR. EI mass 
spectrometry was performed on a Micromass Autospec high resolution mass spectrometer. The 
glassware was typically oven-dried or flame-dried. 
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5.2 EXPERIMENTAL: CHAPTER 1 
O
O
N
1. CeCl3 
2. AcCl
MgBr
O
N
OAc
1-39 1-41  
Acetic acid 1-(2-dimethylcarbamoyl-ethyl)-1-methyl-prop-2-ynyl ester 1-41.  Cerium 
trichloride heptahydrate (23.6 g, 63.4 mmol) was dried at 140 ºC under vacuum (3 torr) in a 500 
mL round bottomed flask for 14 h.  The off-white solid was allowed to cool to rt, placed under a 
nitrogen atmosphere then suspended in THF (63 mL).  The suspension was cooled to 0 ºC and 
stirred for 20 min.  A THF solution of ethynyl magnesium bromide (127 mL of a 0.5 M solution, 
63.5 mmol) was then added slowly via syringe at 0 ºC.  The resultant orange-brown suspension 
was allowed to warm to rt over 1.5 h when it was cooled to 0º C and amide 1-39 (3.03 g, 21.1 
mmol) in a solution of THF (7 mL) was added via cannula.  The reaction was allowed to warm to 
rt.  After 4.5 h, acetyl chloride (7.54 mL, 106 mmol) was added via syringe.  After an additional 
3.5 h at ambient temperature the reaction mixture was diluted with ethyl acetate (300 mL) and 
water (200 mL).  The layers were separated the aqueous layer extracted with ethyl acetate (3x).  
The combined organic layers were dried over MgSO4, decolorized with charcoal, and filtered 
through a pad of silica gel.  The solvent was removed under vacuum and the residue 
chromatographed on silica gel (60% ethyl acetate/hexanes) to give a red-brown oil (4.33 g, 20.5 
mmol, 97%, yield avg. of two = 95%).   (Rf = 0.21, 60% ethyl acetate/hexanes); 1H NMR (300 
MHz, CDCl3) δ 3.05 (bs, 3H), 2.97 (bs, 3H), 2.58 (s, 1H), 2.57 (t, J = 7.8 Hz, 2H), 2.36-2.26 (m, 
1H), 2.17-2.11 (m, 1H), 2.04 (s, 3H), 1.74 (s, 3H); 13C NMR (75 MHz, benzene – d6) δ 170.9, 
168.4, 83.7, 74.3, 74.3, 37.6, 36.1, 34.9, 28.7, 26.6, 21.3; IR (thin film) υ 3262, 3211, 2940, 
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2110, 1737, 1639 cm -1; MS m/z (%) 196 (14, M - 15), 183 (28), 168 (16), 152 (50), 125 (18), 72 
(100); EI-HRMS calcd for C10H14NO3 m/z [M - 15+] 196.0974; found 196.0967. 
1.) CuBr, LiBr
 MeMgBr, -78 ºC 
2.) MeI
O
N
OAc
O
N
•
1-41 1-44  
3-Methyl-hexa-3,4-dienoic acid dimethylamide 1-44.  Copper bromide (2.82 g, 19.7 mmol) 
and lithium bromide (1.71 g, 19.7 mmol) were dried together at 140 ºC under vacuum (3 torr) in 
a 250 mL round bottomed flask for 14 h.  The salts were allowed to cool and placed under a 
nitrogen atmosphere.  THF (98 mL) was then added resulting in a pale light-green to yellow 
suspension that was cooled to -78 ºC. An ether solution of methyl magnesium bromide (6.56 mL 
of a 3 M solution, 19.7 mmol) was added slowly via syringe, producing a mustard yellow 
suspension.  The reaction mixture was allowed to warm to -40 ºC over a period of 1.5 – 2 h, 
cooled to -78 ºC, and the alkynylamide 1-41 (2.08 g, 9.84 mmol) in a solution of THF (10 mL) 
was added via cannula.  The reaction was allowed to warm to -30 ºC and methyl iodide (3.7 mL, 
59 mmol) was added rapidly via syringe, and the suspension slowly changed to a green-brown 
color.  After warming to -10 ºC over 35 min, the reaction mixture was poured into ether and a 
solution of sat’d aqueous NH4Cl : 3% aqueous NH4OH (1 : 1) in a 500 mL round bottomed flask.  
This was stirred vigorously until a dark blue color persisted in the aqueous phase.  The layers 
were separated and the aqueous layer extracted with ether (3x).  The combined organic layers 
were dried over MgSO4 and the solvent removed under vacuum.  The crude residue was 
chromatographed on silica gel (50% ethyl acetate/hexanes) to give a pale yellow oil (1.64 g, 9.80 
mmol, 100%, yield avg. of three = 94%). (Rf = 0.36, 60% ethyl acetate/hexanes) 1H NMR (300 
MHz, CDCl3) δ 5.07 – 4.97 (m 1H), 3.00 (bs, 3H), 2.93 (bs, 3H), 2.39 (dd, J = 9.3, 6.7 Hz, 2H), 
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2.28 – 2.19 (m, 2H), 1.69 (d, J = 2.7 Hz, 3H), 1.59 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 201.3, 172.5, 98.5, 85.9, 37.0, 35.2, 31.1, 28.7, 19.4, 14.7;  IR (thin film) υ 2976, 2925, 
1962, 1650 cm-1; MS m/z (%) 167 (15), 95 (13), 72 (100); EI-HRMS calcd for C10H17NO m/z 
[M+] 167.1310; found 167.1308. 
Substituted allene-ynones 1-48a – 1-48l 
1. 
nBuLi, BF3 ⋅ Et2O, -78 ºC 
2. BF3 ⋅ Et2O, AcOH
R
1-48
O
•
R
O
N
•
1-44  
General Procedure B: Preparation of 1-48a. 
1-48a
O
•
TMS
 
6-Methyl-1-(trimethylsilyl)nona-6,7-dien-1-yn-3-one 1-48a.  In a manner entirely analogous to 
Trost;  A solution of alkyne (R = TMS) (1.813 mmol) in THF (4.0 mL) was cooled to -78 ºC and 
n-butyl lithium (1.0 mL, 1.6 M solution in hexanes, 1.6 mmol) was added rapidly via syringe. 
After 5 min, boron trifluoride diethyl etherate (215 mL, 1.71 mmol) was added.  The resultant 
solution (or mixture) was stirred for 15 min then a solution of allenyl amide 1-44 (169 mg, 1.01 
mmol) in THF (3 mL) was added via cannula.  The reaction was allowed to stir for    1.5 h, after 
which time more boron trifluoride diethyl etherate (215 µL, 1.71 mmol) and acetic acid (98 μL, 
1.71 mmol) were added.  The reaction was allowed to warm to -20 ºC and quenched with sat’d 
aqueous NH4Cl (3.5 mL).  After warming to rt, the reaction mixture was diluted with ether and 
water. The layers were separated and the aqueous layer was extracted with ether (3x).  The 
combined organic layers were washed with water (2x) and dried over MgSO4. This mixture was 
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filtered through a pad of silica gel (30 mL fritted funnel, approximately half full), and 
concentrated under vacuum.  The crude residue was chromatographed on silica gel (3% ethyl 
acetate/hexanes) to give 1-48a (119 mg, 54%) as a faint yellow oil.  Average of three yields: 
63%. (Rf = 0.92, 60% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 5.06 – 4.98 (m, 1H), 
2.62 (dd, J = 7.5, 6.7 Hz, 2H), 2.28 – 2.21 (m, 2H), 1.66 (d, J = 2.7 Hz, 3H), 1.57 (d, J = 7.0 Hz, 
3H) 0.21 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 201.6, 187.1, 101.9, 97.5, 97.1, 87.0, 43.0, 27.8, 
19.3, 14.6, -0.9;  IR (thin film) ν 2962, 2900, 2151, 1967, 1679, 1252, 847 cm-1; MS m/z (%) 220 
(14), 205 (7), 178 (13), 163 (29), 73 (100), 61 (100); EI-HRMS calcd for C13H20OSi m/z [M+] 
220.1283; found 220.1289. 
1-48b
O
•
Me
 
7-Methyldeca-7,8-dien-2-yn-4-one 1-48b.  To a solution of 1-bromo-1-propene (100 µL, 1.17 
mmol), in THF (0.80 mL) at -78 °C was added n-butyl lithium (1.3 mL, 1.6 M solution in 
hexanes, 2.1 mmol).  The resultant white suspension was stirred for 2 h then diluted with THF 
(1.8 mL) to prepare the acetylide solution.  According to General Procedure B, 1-44 (109 mg, 
0.65 mmol) in THF (3.3 mL) was reacted with the acetylide (R = Me, 1.17 mmol as described 
above) in THF (2.6 mL as described above), borontrifluoride diethyl etherate (157 µL, 1.11 
mmol, 1st addition), borontrifluoride diethyl etherate (157 µL, 1.11 mmol, 2nd addition) and 
acetic acid (63 µL, 1.11 mmol) to afford allene-ynone 1-48b (98 mg, 93%) as a pale yellow oil 
(chromatographed on silica gel using 3% ethyl acetate/hexanes). Average of two yields: 89%.  
(Rf = 0.53, 10% ethyl acetate/hexanes eluted twice); 1H NMR (CDCl3, 300 MHz) δ 5.08 – 4.98 
(m, 1H), 2.61 (dd, J = 8.1, 6.7 Hz, 2H), 2.26 – 2.18 (m, 2H), 2.00 (s, 3H), 1.67 (d, J = 2.7 Hz, 
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3H), 1.59 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 201.6, 187.4, 97.6, 89.5, 86.8, 80.2, 
43.3, 27.8, 19.4, 14,7, 3.9; IR (thin film) ν 2980, 2922, 2853, 2217, 1962, 1675 cm-1; MS m/z 
(%) 162 (12), 147 (23), 120 (72), 105 (69), 95 (33), 79 (61), 67 (100); EI-HRMS calcd for 
C11H14O m/z [M+] 162.1045; found 162.1042. 
1-48c
O
•
OTBS
 
1-t-butyldimethlysilyloxy-9-methyldodeca-9,10-dien-4-yn-6-one 1-48c.  According to General 
Procedure B, 1-44 (88 mg, 0.53 mmol) in THF (2.6 mL) was reacted with the acetylide (R = 
(CH2)3OTBS, 188 mg, 0.95 mmol) in THF (2.1 mL), n-butyl lithium (0.53 mL, 1.6 M solution in 
hexanes, 0.84 mmol), borontrifluoride diethyl etherate (112 µL, 0.89 mmol, 1st addition), 
borontrifluoride diethyl etherate (112 µL, 0.89 mmol, 2nd addition), and acetic acid (51 µL, 0.89 
mmol) to afford allene-ynone 1-48c (54 mg, 32%) as a clear oil (chromatographed on silica gel 
using 3% ethyl acetate/hexanes). Average of two yields: 41%. (Rf = 0.66, 30% ethyl 
acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 5.09 – 5.01 (m, 1H), 3.70 (t, J = 5.9 Hz, 2H), 
2.64 (dd, J = 8.3, 6.8 Hz, 2H), 2.47 (t, J = 7.1 Hz, 2H), 2.28 – 2.22 (m, 2H), 1.82 – 1.73 (m, 2H), 
1.69 (d, J = 2.8 Hz, 3H), 1.61 (d, J = 6.9 Hz, 1H), 0.90 (s, 9H), 0.60 (s, 6H); 13C NMR (75 MHz, 
CDCl3) δ 201.6, 187.4, 97.6, 93.5, 86.8, 80.9, 61.1, 43.4, 30.8, 27.9, 25.8, 19.4, 18.2, 15.4, 14.7, 
-5.4; IR (thin film) ν 2954, 2929, 2898, 2857, 2212, 1967, 1676, 1256, 1106, 973, 835, 777 cm-1; 
MS m/z (%) 320 (9), 263 (14), 189 (19), 145 (58), 75 (100); EI-HRMS calcd for C19H32O2Si m/z 
320.2172 [M+]; found 320.2170. 
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1-48d
O
•
OTBS
 
1-t-butyldimethylsilyloxy-8-methylundeca-8,9-dien-3-yn-5-one 1-48d.  According to General 
Procedure B, 1-44 (144 mg, 0.86 mmol) in THF (4.3 mL) was reacted with the acetylide (R = 
(CH2)2OTBS, 286 mg, 1.55 mmol) in THF (3.4 mL), n-butyl lithium (0.86 mL, 1.6 M solution in 
hexanes, 1.38 mmol), borontrifluoride diethyl etherate (184 µL, 1.46 mmol, 1st addition), 
borontrifluoride diethyl etherate (184 µL, 1.46 mmol, 2nd addition), and acetic acid (83 µL, 1.46 
mmol) to afford allene-ynone 1-48d (262 mg, 99%) as a clear oil (chromatographed on silica gel 
using 3% ethyl acetate/hexanes).  Average of two yields: 98%. (Rf = 0.68, 30% ethyl 
acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 5.10 – 5.02 (m, 1H). 3.79 (t, J = 6.8 Hz, 2H), 
2.65 (dd, J = 8.2, 6.9 Hz, 2H), 2.59 (t, J = 6.8 Hz, 2H), 2.29 – 2.21 (m, 2H), 1.70 (d, J = 2.8 Hz, 
3H), 1.61 (d, J = 6.9 Hz, 3H), 0.91 (s, 9H), 0.09 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 201.5, 
187.2, 97.5, 90.7, 86.8, 81.4, 60.7, 43.2, 27.7, 25.8, 25.7, 23.3, 19.4, 18.1, 14.7, -5.5; IR (thin 
film) ν 2954, 2929, 2899, 2857, 2216, 1967, 1677, 1255, 1110, 837, 777 cm-1; MS m/z (%) 330 
(20, M + 23Na + H), 329 (100, M + 23Na); ESI-HRMS calcd for C18H30O2SiNa m/z [M + 
23Na+] 329.1913; found 329.1922. 
1-48e
O
•
OTHP
 
8-Methyl-1-(tetrahydro-2H-pyran-2-yloxy)undeca-8,9-dien-3-yn-5-one 1-48e. According to 
General Procedure B, 1-44 (97 mg, 0.58 mmol) in THF (2.9 mL) was reacted with the acetylide 
(R = (CH2)2OTHP, 160 mg, 1.04 mmol) in THF (2.3 mL), n-butyl lithium (0.58 mL, 1.6 M 
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solution in hexanes, 0.93 mmol), borontrifluoride diethyl etherate (124 µL, 0.99 mmol, 1st 
addition), borontrifluoride diethyl etherate (124 µL, 0.99 mmol, 2nd addition), and acetic acid (57 
µL, 0.99 mmol) to afford allene-ynone 1-48e (157 mg, 98%) as a clear oil (chromatographed on 
silica gel using 15% ethyl acetate/hexanes). (Rf = 0.46, 30% ethyl acetate/hexanes); 1H NMR 
(300 MHz, CDCl3) δ 5.08 – 4.98 (m, 1H), 4.64 (t, J = 3.2 Hz, 1H), 3.90 – 3.83 (m, 2H), 3.63 – 
3.48 (m, 2H), 2.67 (t, J = 6.8 Hz, 2H), 2.63 (dd, J = 8.6, 6.9 Hz, 2H), 2.29 – 2.21 (m, 2H), 1.83 – 
1.50 (m, 6H), 1.68 (d, J = 2.7 Hz, 3H), 1.59 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 
201.7, 187.3, 98.8, 97.6, 90.6, 86.8, 81.3, 64.6, 62.1, 43.4, 30.4, 27.9, 25.3, 20.5, 19.4, 19.2, 
14.7; IR (thin film) ν 2941, 2894, 2868, 2217, 1967, 1675, 1034 cm-1; MS m/z (%) 276 (5), 275 
(9), 261 (6), 231 (11), 219 (25), 174 (24), 85 (100); EI-HRMS calcd for C17H24O3 m/z 276.1725 
[M+]; found 276.1720. 
1-48f
O
•
 
1-Cyclohexenyl-6-methylnona-6,7-dien-1-yn-3-one 1-48f.  According to General Procedure B, 
1-44 (99 mg, 0.59 mmol) in THF (3.0 mL) was reacted with the acetylide (R = 1-cyclohexenyl, 
125 µL, 1.06 mmol) in THF (2.4 mL), n-butyl lithium (0.59 mL, 1.6 M solution in hexanes, 0.94 
mmol), borontrifluoride diethyl etherate (126 µL, 1.00 mmol, 1st addition), borontrifluoride 
diethyl etherate (126 µL, 1.00 mmol, 2nd addition), and acetic acid (57 µL, 1.00 mmol) to afford 
allene-ynone 1-48f (131 mg, 97%) (chromatographed on silica gel using 3% ethyl 
acetate/hexanes).  Average of two yields: 94%.  (Rf = 0.63, 30% ethyl acetate/hexanes); 1H NMR 
(300 MHz, CDCl3) δ 6.45 – 6.43 (m, 1H), 5.08 – 5.00 (m, 1H), 2.66 (dd, J = 7.9, 6.6 Hz, 2H), 
2.31 – 2.24 (m, 2H), 2.18 – 2.15 (m, 4H), 1.69 (d, J = 2.7 Hz, 3H), 1.67 – 1.61 (m, 4H), 1.60 (d, 
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J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 201.6, 187.7, 142.1, 118.9, 97.6, 93.0, 86.9, 86.0, 
43.2, 28.3, 28.0, 26.0, 21.9, 21.0, 19.4, 14.8; IR (thin film) ν 3027, 2979, 2932, 2859, 2185, 
1967, 1670, 1621, 1085 cm-1; MS m/z (%) 229 (7), 228 (42), 213 (20), 185 (35), 143 (73), 133 
(79), 91 (87), 77 (100); EI-HRMS calcd for C16H20O m/z [M+] 228.1514; found 228.1506. 
1-48g
O
•
OEt
 
1-Ethoxy-6-methylnona-6,7-dien-1-yn-3-one 1-48g. According to General Procedure B, 1-44 
(88 mg, 0.52 mmol) in THF (2.6 mL) was reacted with ethoxy acetylene (225 µL, 40% wt. 
solution in hexanes, 0.94 mmol) in THF (2.0 mL), n-butyl lithium (0.52 mL, 1.6 M solution in 
hexanes, 0.83 mmol), borontrifluoride diethyl etherate (111 µL, 0.88 mmol, 1st addition), 
borontrifluoride diethyl etherate (111 µL, 0.88 mmol, 2nd addition), and acetic acid (51 µL, 0.88 
mmol) to afford allene-ynone 1-48g (83 mg, 83%) (chromatographed on silica gel using 10% 
ethyl acetate/hexanes). (Rf = 0.46, 30% ethyl acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 
5.03 – 5.00 (m, 1H), 4.33 (q, J = 7.1 Hz, 2H), 2.60 (dd, J = 8.0, 6.9 Hz, 2H), 2.31 – 2.20 (m, 2H), 
1.69 (d, J = 2.8 Hz, 3H), 1.61 (d, J = 6.9 Hz, 3H), 1.47 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ 201.6, 187.4, 102.4, 97.7, 86.5, 77.2, 44.2, 43.3, 28.2, 19.4, 14.7, 14.3; IR (thin film) ν 
2982, 2901, 2226, 1666, 1443, 1393, 1068, 1004 cm-1; MS m/z (%) 192 (6), 164 (13), 149 (15), 
97 (100); EI-HRMS calcd for C12H16O2 m/z [M+] 192.1150; found 192.1138. 
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1-48a
O
•
TMS
1-48h
Sodium 
borate
MeOH
O
•
H
 
6-Methylnona-6,7-dien-1-yn-3-one 1-48h.  Using the method of Walton and Waugh; the TMS-
protected alkyne, 1-48a (60 mg, 0.27 mmol) was dissolved in methanol (3.4 mL) and sodium 
borate (0.4 mL, 0.01 M solution in H2O) was added via syringe.  After 10 min the reaction 
mixture was poured into HCl (10 mL, 1% by wt. in H2O) over dichloromethane (10 mL).  The 
layers were separated and the aqueous layer extracted with dichloromethane (3x).  The combined 
organic layers were dried over MgSO4, filtered through a pad of silica gel (10 mL fritted funnel 
approximately half full) using 10% ether/dichloromethane to elute, and concentrated under 
vacuum to give 1-48h as a pale yellow oil (36 mg, 0.24 mmol, 90%) that was pure enough for 
further use.  Due to the volatility of this compound, it was not concentrated under vacuum for 
more than 2 min.  A portion of the sample was purified by silica gel column chromatography 
(3% ethyl acetate/hexanes).  (Rf = 0.69, 30% ethyl acetate/hexanes); 1H NMR (300 MHz, CDCl3) 
δ 5.08 – 5.04 (m, 1H), 3.21 (s, 1H), 2.69 (dt, J = 2.3, 7.3 Hz, 2H), 2.31 – 2.26 (m, 2H), 1.69 (d, J 
= 2.8 Hz, 3H), 1.59 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 201.7, 186.6, 97.4, 87.4, 
81.4, 78.0, 43.3, 27.6, 19.3, 14.6; IR (thin film) ν 3259, 2982, 2924, 2854, 2093, 1967, 1682 cm-
1; MS m/z (%) 148 (23), 147 (15), 133 (26), 106 (81), 91 (100), 79 (98); EI-HRMS calcd for 
C10H12O m/z 148.0888 [M+]; found 148.0886. 
 
 
  
 81 
1-48i
O
•
 
6-Methyl-1-phenylnona-6,7-dien-1-yn-3-one 1-48i.  According to General Procedure B, 1-44 
(83 mg, 0.50 mmol) in THF (2.5 mL) was reacted with phenyl acetylene (92 mg, 0.90 mmol) in 
THF (2.0 mL), n-butyl lithium (0.50 mL, 1.6 M solution in hexanes, 0.80 mmol), 
borontrifluoride diethyl etherate (107 µL, 0.85 mmol, 1st addition), borontrifluoride diethyl 
etherate (107 µL, 0.85 mmol, 2nd addition), and acetic acid (49 µL, 0.85 mmol) to afford allene-
ynone 1-48i (95 mg, 85%) (chromatographed on silica gel using 3% ethyl acetate/hexanes).  
Note that a white suspension will form after addition of the first portion of borontrifluoride 
diethyl etherate.  Average of two yields: 92%. (Rf = 0.36, 10% ethyl acetate/hexanes); 1H NMR 
(CDCl3, 300 MHz) δ 7.59 – 7.56 (m, 2H), 7.48 – 7.35 (m, 3H) 5.12 – 5.04 (m, 1H), 2.78 (dd, J = 
7.5, 6.8 Hz, 2H), 2.39 – 2.32 (m, 2H), 1.73 (d, J = 2.8 Hz, 3H), 1.62 (dd, J = 6.9, 2.6 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δ 201.6, 187.5, 132.9, 130.6, 128.5, 120.0, 97.6, 90.3, 87.8, 87.0, 
43.3, 28.0, 19.4, 14.7; IR (thin film) ν 3058, 2976, 2914, 2894, 2853, 2203, 1962, 1670 cm-1; MS 
m/z (%) 224 (100), 209 (24); EI-HRMS calcd for C16H16O m/z [M+] 224.1201; found 224.1194. 
1-48j
O
• OMe
 
1-(4-Methoxyphenyl)-6-methylnona-6,7-dien-1-yn-3-one 1-48j.  According to General 
Procedure B, 1-44 (71 mg, 0.43 mmol) in THF (2.1 mL) was reacted with the p-methoxyphenyl 
acetylene (101 mg, 0.77 mmol) in THF (1.7 mL), n-butyl lithium (0.43 mL, 1.6 M solution in 
hexanes, 0.68 mmol), borontrifluoride diethyl etherate (91 µL, 0.72 mmol, 1st addition), 
  
 82 
borontrifluoride diethyl etherate (91 µL, 0.72 mmol, 2nd addition), and acetic acid (41 µL, 0.72 
mmol) to afford allene-ynone 1-48j (91 mg, 84%) (chromatographed on silica gel using 3% ethyl 
acetate in hexanes). Note that a white suspension will form after addition of the first portion of 
borontrifluoride diethyl etherate.  Average of two yields: 88%. (Rf = 0.26, 10% ethyl 
acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 7.54 (d, J = 8.9 Hz, 2H), 6.90 (d, J = 8.9 Hz, 
2H), 5.11 – 5.04 (m, 1H), 3.85 (s, 3H), 2.76 (dd, J = 8.1, 6.8 Hz, 2H), 2.39 – 2.31 (m, 2H), 1.73 
(d, J = 2.8 Hz, 3H), 1.62 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 201.7, 187.2, 161.5, 
134.9, 114.2, 111.8, 97.6, 91.4, 87.6, 86.8, 55.2, 43.2, 28.1, 19.3, 14.6; IR (thin film) ν 2979, 
2899, 2849, 2553, 2197, 1965, 1665, 1254, 1092 cm-1; MS m/z (%) 254 (26), 239 (41), 211 (42), 
197 (42), 159 (100); EI-HRMS calcd for C17H18O2  m/z [M+] 254.1307; found 254.1282. 
1-48k
O
• CF3
 
1-(4-(Trifluoromethyl)phenyl)-6-methylnona-6,7-dien-1-yn-3-one 1-48k.  According to 
General Procedure B, 1-44 (74 mg, 0.44 mmol) in THF (2.2 mL) was reacted with p-
trifluoromethyl acetylene (0.13 mL, 0.80 mmol) in THF (1.8 mL), n-butyl lithium (0.44 mL,    
1.6 M solution in hexanes, 0.71 mmol), borontrifluoride diethyl etherate (94 µL, 0.75 mmol, 1st 
addition), borontrifluoride diethyl etherate (94 µL, 0.75 mmol, 2nd addition),  and acetic acid   
(43 µL, 0.75 mmol) to afford allene-ynone 1-48k (111 mg, 86%) (chromatographed on silica gel 
using 3% ethyl acetate/hexanes). Average of two yields: 89%. (Rf = 0.38, 10% ethyl 
acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 7.68 (d, J = 8.6 Hz, 2H), 7.64 (d, J = 8.6 Hz, 
2H), 5.13 – 5.04 (m, 1H), 2.80 (dd, J = 8.6, 7.0, 2H), 2.42 – 2.32 (m, 2H), 1.72 (d, J = 2.8 Hz, 
3H), 1.61 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 201.6, 186.9, 133.0, 132.5 (q, JC-F = 
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32.6 Hz), 125.5 (q, JC-F = 3.6 Hz), 123.9, 123.5 (q, JC-F = 271.0 Hz), 97.5, 89.0, 87.6, 87.1, 43.3, 
27.9, 19.3, 14.7; IR (thin film) ν 2982, 2901, 2860, 2209, 1969, 1677, 1615, 1323, 843 cm-1; MS 
m/z (%)  292 (21), 277 (11), 250 (41), 235 (24), 197 (100), 165 (23), 79 (25); EI-HRMS calcd for 
C17H15OF3 m/z [M+] 292.1075; found 292.1073. 
1-48d
O
•
1-48l
1. KHSO4, 30% 
aq. MeOH, rt
2. 2-butynoic             
 acid, DCC,      
DMAP, DCM, rt
O
•
OTBS O
O
 
8-Methyl-5-oxoundeca-8,9-dien-3-ynyl but-2-ynoate 1-48l.  Using the method of Perumal; the 
TBS ether, 1-48d (164 mg, 0.54 mmol) was suspended in MeOH : H2O (1.6 mL, 7 : 3, v/v) and 
stirred vigorously, forming an emulsion.  KHSO4 (29 mg, 0.21 mmol) was added and the 
reaction stirred at rt for 1.5 h when there was an absence of starting material observed by TLC.  
The reaction mixture was diluted with ethyl acetate, dried over MgSO4, and filtered through a 
pad of silica gel (30 mL fritted funnel, approximately half full).  The solvent was removed under 
vacuum to afford a thick pale yellow residue (102 mg, 0.53 mmol, 99%).  The crude product was 
redissolved in CH2Cl2 (1 mL), cooled to 0 °C, and 4-(dimethylamino)pyridine (7 mg, 0.06 
mmol) and N,N′-dicyclohexylcarbodiimide (126 mg, 0.61 mmol) were added.  A solution of 2-
butynoic acid (48 mg, 0.57 mmol) in CH2Cl2 (0.50 mL) was then added via syringe.  The 
reaction progress was monitored by TLC.  After 1.5 – 2h, he reaction mixture was diluted in 
CH2Cl2 and filtered through a pad of silica gel (30 mL fritted funnel, approximately half full) 
eluting with CH2Cl2.  The solvent was removed under vacuum and the residue chromatographed 
on silica gel (15% ethyl acetate/hexanes) to give the product as a pale yellow oil (113 mg, 0.44 
mmol, 82% over two steps). (Rf = 0.60, 30% ethyl acetate/hexanes); 1H NMR (300 MHz, 
CDCl3) δ 5.11 – 5.01 (m, 1H), 4.30 (t, J = 6.7 Hz, 2H), 2.76 (t, J = 6.7 Hz, 2H), 2.65 (dd, J = 6.8, 
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7.4 Hz, 2H), 2.30 – 2.23 (m, 2H), 2.01 (s, 3H), 1.70 (d, J = 2.8 Hz, 3H), 1.61 (d, J = 6.9 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δ 201.5, 187.1, 153.1, 97.5, 87.9, 86.9, 86.5, 81.6, 71.8, 62.1, 43.2, 
27.7, 19.3, 19.2, 14.7, 3.7; IR (thin film) ν 2980, 2900, 2243, 2223, 1967, 1715, 1675, 1252, 
1083 cm-1; MS m/z (%)  258 (8), 240 (5), 174 (100), 159 (27), 132 (62), 67 (97); EI-HRMS calcd 
for C16H18O3 m/z 258.1256 [M+]; found 258.1256. 
3-Vinyl-2-alkylidene-3-cyclohexen-1-ones 
1-48
O
•
R
O R
1-49
[Rh(CO)2Cl]2
Toluene
H
H
 
General Procedure A: Preparation of 1-49a 
O TMS
1-49a  
(2Z)-4-Methyl-2-((trimethylsilyl)methylene)-3-vinylcyclohex-3-enone 1-49a.  A solution of 
allene-ynone 1-48a (64.1 mg, 0.29 mmol) in toluene (0.97 mL) was degassed by bubbling argon 
through the stirred solution for 20 min.  Rhodium biscarbonyl chloride dimer (3.4 mg, 0.009 
mmol, 3 mol%) was added at 0 °C.  The reaction was followed by TLC an after 5 min the reation 
was complete.  The reaction mixture was diluted with a 10% ethyl acetate/hexanes solution and 
filtered through a pad of silica gel (10 mL fritted funnel, approximately half full), further eluting 
with 10% ethyl acetate/hexanes solution.  The resultant yellow solution was concentrated under 
vacuum to give 1-49a (60.9 mg, 95%) as a yellow oil without further purification. Average of 
two yields: 90%. (A 92% yield was obtained when the reaction was performed in DCE under the 
same conditions during optimization experiments). 1H NMR (300 MHz, CDCl3) δ 6.27 (dd, J = 
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17.7, 11.3 Hz, 1H), 6.01 (s, 1H), 5.45 (dd, J = 11.3, 2.1 Hz, 1H), 5.15 (dd, J = 17.7, 2.1 Hz, 1H), 
2.61 – 2.51 (m, 4H), 1.95 (s, 3H), 0.13 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 200.6, 145.6, 
139.1, 135.3, 134.0, 133.7, 119.8, 37.8, 30.8, 21.8, -0.2; IR (thin film) ν 2945, 1701, 1542, 1245, 
856 cm-1; MS m/z (%) 220 (6), 205 (100); EI-HRMS calcd for C13H20OSi m/z [M+] 220.1283; 
found 220.1281. 
O Me
1-49b  
(2Z)-2-Ethylidene-4-methyl-3-vinylcyclohex-3-enone 1-49b. According to General Procedure 
A, allene-ynone 1-48b (40.1 mg, 0.25 mmol) in toluene (0.82 mL) was reacted with rhodium 
biscarbonyl chloride dimer (2.9 mg, 0.007 mmol, 3 mol%) to afford 1-49b (30.3 mg, 76%).  The 
reaction was performed at room temperature and was complete after 1.5 h as observed by TLC. 
Average of two yields: 73%. (Rf = 0.22, 10% ethyl acetate/hexanes eluted twice); 1H NMR 
(CDCl3, 300 MHz) δ 6.22 (dd, J = 11.2, 17.7 Hz, 1H), 6.02 (q, J = 7.5 Hz, 1H), 5.37 (dd, J = 1.4, 
11.2 Hz, 1H), 5.13 (dd, J = 1.4, 17.7) Hz, 1H), 2.55 – 2.40 (m, 4H), 2.06 (d, J = 7.5 Hz, 3H), 
1.88 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 202.3, 134.5, 133.8, 133.7, 132.5, 131.9, 119.1, 39.2, 
31.0, 21.0, 15.8;  IR (thin film) ν 3078, 2916, 2851, 1697, 1596 cm-1; MS m/z (%) 163 (10), 162 
(81), 147 (96), 119 (58), 105 (98), 91 (100); ESI-HRMS calcd for C11H14O m/z 162.1045 [M+]; 
found 162.1042. 
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O
1-49c
OTBS
 
(2Z)-2-(4-t-Butyldimethylsilyloxybutylidene)-4-methyl-3-vinylcyclohex-3-enone 1-49c.  
According to General Procedure A, allene-ynone 1-48c (23.8 mg, 0.19 mmol) in toluene        
(0.25 mL) was reacted with rhodium biscarbonyl chloride dimer (1.0 mg, 0.002 mmol, 3 mol%) 
to afford 1-49c (19.3 mg, 81%). The reaction was performed at roo temperature and was 
complete after 1.5 h as observed by TLC.  Average of two yields: 80%.  1H NMR (300 MHz, 
CDCl3) δ 6.24 (dd, J = 11.2, 17.7 Hz, 1H), 5.93 (t, J = 7.4 Hz, 1H), 5.39 (dd, J = 2.0, 11.2 Hz, 
1H), 5.15 (dd, J = 2.0, 17.7 Hz, 1H), 3.62 (t, J = 6.6 Hz, 2H), 2.60 (q, J = 7.5 Hz, 2H), 2.55 – 
2.45 (m, 4H), 1.90 (s, 3H), 1.70 – 1.59 (m, 2H), 0.88 (s, 9H), 0.04 (s, 6H); 13C NMR (75 MHz, 
CDCl3) δ 202.1, 139.3, 133.8, 133.7, 132.6, 132.2, 119.2, 62.9, 61.1, 39.2, 33.0, 31.1, 25.9, 21.0, 
18.3, -5.3; IR (thin film) ν 2954, 2928, 2856, 1693, 1588, 1255, 1098, 836 cm-1; MS m/z (%) 320 
(7), 291 (6), 263 (39), 160 (60), 75 (100); EI-HRMS calcd for C19H32O2Sim/z 320.2172 [M+]; 
found 320.2171. 
O
1-49d
OTBS
 
(2Z)-2-(3-t-Butyldimethylsiyloxypropylidene)-4-methyl-3-vinylcyclohex-3-enone 1-49d.  
According to General Procedure A, allene-ynone 1-48d (90.2 mg, 0.29 mmol) in toluene (1.0 
mL) was reacted with rhodium biscarbonyl chloride dimer (3.4 mg, 0.009 mmol, 3 mol%) to 
afford 1-49d (80.1 mg, 89%). The reaction was performed at room temperature and was 
complete after 20 min as observed by TLC.  Average of four yields: 88%. (Rf = 0.63, 30% ethyl 
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acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 6.25 (dd, J = 11.2, 17.7 Hz, 1H), 6.04 (t, J = 7.2 
Hz, 1H), 5.40 (dd, J = 2.0, 11.2 Hz, 1H), 5.16 (dd, J = 2.0, 17.7 Hz, 1H), 3.70 (t, J = 6.3 Hz, 2H), 
2.78 (q, J = 6.6 Hz, 2H), 2.57 – 2.46 (m, 4H), 1.91 (s, 3H), 0.88 (s, 9H), 0.05 (s, 6H); 13C NMR 
(75 MHz, CDCl3) δ 202.1, 136.2, 134.5, 133.6, 132.7, 132.7, 119.3, 62.7, 39.2, 33.0, 31.1, 25.8, 
21.1, 18.3, -5.3;  IR (thin film) ν 2950, 2925, 2853, 1696, 1255, 1091, 835 cm-1; MS m/z (%) 330 
(20, M + 23Na + H), 329 (100, M + 23Na); ESI-HRMS calcd for C18H30O2SiNa m/z [M + 
23Na+] 329.1913; found 329.1900. 
O
1-49e
OTHP
 
(2Z)-4-Methyl-2-(3-(tetrahydro-2H-pyran-2-yloxy)propylidene)-3-vinylcyclohex-3-enone   
1-49e. According to General Procedure A, allene-ynone 1-48e (40.5 mg, 0.15 mmol) in toluene           
(0.49 mL) was reacted with rhodium biscarbonyl chloride dimer (1.7 mg, 0.004 mmol, 3 mol%) 
to afford 1-49e (37.8 mg, 93%). The reaction was performed at room temperature and was 
complete after 15 min as observed by TLC.  Average of two yields: 88%. (Rf = 0.46, 30% ethyl 
acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 6.24 (dd, J = 11.2, 17.7 Hz, 1H), 6.00 (t, J = 7.2 
Hz, 1H), 5.37 (dd, J = 2.1, 11.2 Hz, 1H), 5.15 (dd, J = 2.1, 17.7 Hz, 1H), 4.60 (dd, J = 2.7, 3.8 
Hz, 1H), 3.87 – 3.74 (m, 2H), 3.51 – 3.44 (m, 2H), 2.85 (q, J = 6.7 Hz, 2H), 2.55 – 2.45 (m, 4H), 
1.89 (s, 3H), 1.84 – 1.76 (m, 1H), 1.72 – 1.65 (m, 1H), 1.57 – 1.47 (m, 4H); 13C NMR (75 MHz, 
CDCl3) δ 202.3, 136.1, 134.8, 133.9, 132.9, 132.8, 119.5, 98.8, 67.2, 62.3, 39.5, 31.4, 30.9, 30.4, 
25.8, 21.4, 19.7; IR (thin film) ν 2940, 2870, 1697, 1032 cm-1; MS m/z (%) 276 (9), 258 (30), 
228 (37), 202 (69), 192 (86), 174 (100), 159 (77), 91 (59); EI-HRMS calcd for C17H24O3 m/z 
[M+] 276.1725; found 276.1723. 
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O
1-49i  
(2Z)-2-Benzylidene-4-methyl-3-vinylcyclohex-3-enone 1-49i.  According to General Procedure 
A, allene-ynone 1-49i (42.4 mg, 0.19 mmol) in toluene (0.63 mL) was reacted with rhodium 
biscarbonyl chloride dimer (5.9 mg, 0.015 mmol, 8 mol%) to afford 1-49i (34.0 mg, 80%). The 
reaction mixture was placed into a preheated oil bath at 50 °C after addition of [Rh(CO)2Cl]2 and 
the reaction was complete after 5 min as observed by TLC.  Average of three yields: 76%. (Rf = 
0.326, 10% ethyl acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 7.40 (d, J = 7.5 Hz, 2H), 7.32 
– 7.25 (m, 3H), 6.67 (s, 1H), 6.35 (dd, J = 11.2, 17.7 Hz, 1H), 5.52 (dd, J = 2.0, 11.2 Hz, 1H), 
5.29 (dd, J = 2.0, 17.7 Hz, 1H), 2.74 – 2.60 (m, 4H), 1.95 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
202.8, 136.1, 135.7, 134.6, 133.5, 133.4, 132.1, 129.3, 127.9, 127.8, 120.1, 39.6, 32.6, 21.2; IR 
(thin film) ν 2919, 2851, 1704, 1593, 1492, 928, 757 cm-1; MS m/z (%) 224 (100), 209 (44), 181 
(57), 167 (74); EI-HRMS calcd for C16H16O m/z [M+] 224.1201; found 224.1199. 
O
1-49j
OMe
 
(2Z)-2-(4-Methoxybenzylidene)-4-methyl-3-vinylcyclohex-3-enone 1-49j.  According to 
General Procedure A, allene-ynone 1-48j (39.2 mg, 0.15 mmol) in toluene (0.51 mL) was 
reacted with rhodium biscarbonyl chloride dimer (4.8 mg, 0.012 mmol, 8 mol%) to afford 1-49j 
(29.8 mg, 76%).  The reaction mixture was placed into a preheated oil bath 50 °C after addition 
  
 89 
of [Rh(CO)2Cl]2 and the reaction was complete after 5 min as observed by TLC.  Average of 
three yields: 76%. (Rf = 0.17, 10% ethyl acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 7.44 
(d, J = 8.7 Hz, 2H), 6.83 (d, J = 8.8 Hz), 6.56 (s, 1H), 6.34 (dd, J = 17.7, 11.2, 1H), 5.49 (dd, J = 
11.2, 2.1 Hz, 1H), 5.27 (dd, J = 17.8, 21. Hz, 1H), 3.81 (s, 3H), 2.71 – 2.59 (m, 4H), 1.94 (s, 
3H); 13C NMR (75 MHz, CDCl3) δ 202.6, 159.5, 133.7, 133.6, 132.7, 132.5, 131.3, 128.4, 119.7, 
113.3, 55.1, 39.6, 32.3, 21.1; IR (Thin film) ν 3081, 2908, 2836, 1698, 1603, 1509, 1254, 1032, 
829  cm-1; MS m/z (%) 277 (100, M + 23Na), 255 (55); ESI-HRMS calcd for C17H18O2Na m/z 
[M + 23Na+] 277.1204; found 277.1215. 
O
1-49k
CF3
 
(2Z)-2-(4-(Trifluoromethyl)benzylidene)-4-methyl-3-vinylcyclohex-3-enone 1-49k.   
According to General Procedure A, allene-ynone 1-48k (30.5 mg, 0.10 mmol) in toluene (0.35 
mL) was reacted with rhodium biscarbonyl chloride dimer (3.0 mg, 0.008 mmol, 8 mol%) to 
afford 1-49k (23.3 mg, 76%).  The reaction mixture was placed into a preheated oil bath at 50 °C 
after addition of [Rh(CO)2Cl]2 and the reaction was complete after 5 min as observed by TLC. 
(Rf = 0.23, 10% ethyl acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 7.54 (d, J = 8.4 Hz, 2H), 
7.44 (d, J = 8.4 Hz, 2H), 6.66 (s, 1H), 6.34 (dd, J = 17.8, 11.2, 1H), 5.54 (dd, J = 11.2, 2.0 Hz, 
1H), 5.29 (dd, J = 17.8, 2.0 Hz), 2.74 – 2.63 (m, 4H), 1.97 (s, 3H); 13C NMR (75 MHz, CDCl3)  
δ 202.1, 140.2, 137.1, 136.2, 133.3, 133.2, 130.2, 129.3, 129.1 (q, JC-F = 32.7 Hz), 124.7 (q, JC-F 
= 3.2 Hz), 124.2 (q, JC-F = 270.4 Hz), 120.5, 39.8, 32.5, 21.3; 19F NMR (470 MHz, CDCl3) δ -
60.5; IR (Thin film) ν 3085, 2911, 2844, 1704, 1611, 1324, 835 cm-1; MS m/z (%) 293 (20), 292 
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(100), 275 (43), 250 (60), 235 (49), 181 (54), 165 (49); EI-HRMS calcd for C17H15OF3 m/z [M+] 
292.1075; found 292.1055. 
O
1-49l
O
O
 
(3Z)-3-(3-Methyl-6-oxo-2-vinylcyclohex-2-enylidene)propyl but-2-ynoate 1-49l.  According 
to General Procedure A, allene-ynone 1-48l (32.4 mg, 0.13 mmol) in toluene (0.42 mL) was 
reacted with rhodium biscarbonyl chloride dimer (3.9 mg, 0.010 mmol, 8 mol%) to afford 1-49l 
(22.6 mg, 70%).  The reaction mixture was placed into a preheated oil bath at 100 °C after 
addition of [Rh(CO)2Cl]2 and the reaction was complete after 20 min as observed by TLC.  
Average of two yields: 76%.  Alternatively, allene-ynone 1-48l (74.5 mg, 0.29 mmol) in toluene 
(28.8 mL, 0.01 M) can be reacted with rhodium biscarbonyl chloride dimer (3.4 mg, 0.009 
mmol, 3 mol%) to afford 1-49l (70.6 mg, 95%).  The reaction mixture was placed into a 
preheated oil bath at    50 °C after addition of [Rh(CO)2Cl]2 and the reaction was complete after 
1 h as observed by TLC. (Rf = 0.60, 30% ethyl acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 
6.23 (dd, J = 11.2, 17.7 Hz, 1H), 5.87 (t, J = 7.3 Hz, 1H), 5.42 (dd, J = 2.1, 11.2 Hz, 1H), 5.16 
(dd, J = 2.1, 17.7 Hz, 1H), 4.22 (t, J = 6.5 Hz, 2H), 2.92 (q, J = 6.8 Hz, 2H), 2.57 – 2.47 (m, 4H), 
1.98 (s, 3H), 1.91 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 201.9, 153.7, 135.4, 133.5, 133.3, 
132.7, 132.3, 119.6, 85.5, 72.4, 65.3, 39.1, 31.0, 28.8, 21.1, 3.7; IR (thin film) ν 2962, 2921, 
2851, 2242, 1708, 1596, 1256, 1070 cm-1; MS m/z (%) 282 (15, M + 23Na + H), 281 (100, M + 
23Na); ESI-HRMS calcd for C16H18O3Na m/z 281.1154 [M + 23Na+]; found 281.1149. 
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1-48f
O
•
O
1-50
[Rh(CO)2Cl]2
Toluene
 
6,7,8,10a-Tetrahydro-2-methyl-1-vinyl-5H-xanthene 1-50. 
According to General Procedure A, allene-ynone 1-48f (32.1 mg, 0.14 mmol) in toluene (2.8 mL, 
0.05 M) was reacted with rhodium biscarbonyl chloride dimer (1.6 mg, 0.004 mmol, 3 mol%) to 
afford 1-50 (23.3 mg, 29%) as a green solid.  The reaction mixture was placed into a preheated 
oil bath at 50 °C after addition of [Rh(CO)2Cl]2 and the reaction was complete after 3 h as 
observed by TLC.  Purification was performed by silica gel column chromatography (2% ethyl 
acetate/hexanes, pretreated with 1% triethylamine/hexanes). (Rf = 0.70, 30% ethyl 
acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 6.85 (d, J = 8.1 Hz, 1H), 6.63 (dd, J = 11.4, 17.8 
Hz, 1H), 6.56 (d, J = 8.1 Hz, 1H), 6.39 (s, 1H), 5.58 (dd, J = 2.0, 11.4 Hz, 1H), 5.23 (dd, J = 2.0, 
17.8 Hz, 1H), 4.86 (dd, J = 5.7, 10.9 Hz, 1H), 2.60 – 1.19 (m, 8H), 2.18 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 151.3, 137.5, 134.4, 133.7, 128.8, 127.8, 120.4, 119.1, 114.9, 113.5, 76.1, 34.7, 
33.2, 26.5, 24.2, 19.8; IR (thin film) ν 3078, 3058, 2932, 2857, 1582, 1468, 1235, 1041, 811 cm-
1; MS m/z (%) 226 (100), 225 (90), 209 (28), 198 (70), 115 (60); EI-HRMS calcd for C16H18O 
m/z [M+] 226.1358; found 226.1353. 
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Allenyl Methylpropargyl Ethers 1-57 
1-48
O
•
1-57
1. CeCl3 7H2O, 
NaBH4, MeOH
2. NaH, THF,
MeI, rt
R
H
• R
MeO
 
General Procedure C: Preparation of 1-57j 
1-57j
OMe
• OMe
 
1-Methoxy-4-(3-methoxy-6-methylnona-6,7-dien-1-ynyl)benzene 1-57j.  To a solution of the 
ketone, 1-48j (R = OMe) (91 mg, 0.38 mmol) in methanol (14 mL) was added cerium trichloride 
heptahydrate (200 mg, 0.54 mmol).  This suspension was allowed to stir for 10 min at rt then 
cooled to -70 °C.  Sodium borohydride (27 mg, 0.71 mmol) was added in one portion and the 
reaction allowed to stir for another 10 min.  Next, water (0.7 ml) was added and the reaction 
mixture was further diluted with water (5 mL) and CH2Cl2 (5 mL).  The organic layer was 
separated and the aqueous layer extracted with CH2Cl2 (3x).  The combined organic layers were 
dried over MgSO4, filtered though a pad silica gel, and concentrated under vacuum to give a 
yellow residue.  This was dissolved in THF (0.6 mL) and carried on directly to the next step.  
The THF solution was added via syringe to a suspension of sodium hydride (8 mg, 0.34 mmol) 
in THF (1.2 mL) at rt via syringe.  After 10 min a solution of iodomethane (43 μL, 0.69 mmol) in 
THF (0.9 mL) was added via syringe.  The reaction was stirred for an additional 10 min and 
quenched with water (0.75 mL).  The reaction mixture was diluted with water and CH2Cl2, the 
organic layer separated, and the aqueous layer extracted with CH2Cl2.  The combined organic 
layers were dried over MgSO4, filtered, and concentrated under vacuum.  The residue was 
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chromatographed on silica gel (3% ethyl acetate/hexanes) to give 1-57j as a pale yellow oil (79 
mg, 0.32 mmol, 84% over two steps). (Rf = 0.66, 30% ethyl acetate/hexanes); 1H NMR (300 
MHz, CDCl3) δ 7.40 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 5.09 – 4.99 (m, 1H), 4.21 (t, 
6.5 Hz, 1H), 3.80 (s, 3H), 3.47 (s, 3H), 2.14 (dt, J = 7.3, 2.9 Hz, 2H), 2.01 – 1.87 (m, 2H), 1.71 
(d, J = 2.8 Hz, 3H), 1.64 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 201.8, 159.6, 133.1, 
114.9, 113.8, 98.0, 86.5, 85.8, 85.4, 71.2, 56.4, 55.2, 33.7, 29.5, 19.4, 14.8; IR (thin film) ν 2980, 
2934, 2837, 2220, 1961, 1607, 1509, 1291, 1249, 1105, 1033, 832 cm-1; MS m/z (%) 271 (9), 
270 (47), 239 (100), 223 (51), 212 (83), 159 (95); EI-HRMS calcd for C18H22O2 m/z 270.1620 
[M+]; found 270.1615. 
1-57i
OMe
•
 
1-(3-Methoxy-6-methylnona-6,7-dien-1-ynyl)benzene 1-57i. According to General Procedure 
C, allene-ynone 1-48i was reacted with cerium trichloride heptahydrate (212 mg, 0.57 mmol) and 
sodium borohydride (29 mg, 0.76 mmol) to afford a crude alcohol.  The crude residue was then 
reacted with sodium hydride (13 mg, 0.55 mmol) and iodomethane (35 µL, 0.55 mmol) to afford 
1-57i (80 mg, 87% over two steps) as a pale yellow oil. (Rf = 0.45, 10% ethyl acetate/hexanes) 
1H NMR (300 MHz, CDCl3) δ 7.49 – 7.44 (m, 2H), 7.35 – 7.31 (m, 3H), 5.10 – 5.00 (m, 1H), 
4.23 (t, J = 6.5 Hz, 1H), 3.49 (s, 3H), 2.16 (dd, J = 10.2, 7.3 Hz, 2H), 2.00 – 1.89 (m, 2H), 1.72 
(d, J = 2.8 Hz, 3H), 1.65 (d, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 201.8, 131.7, 128.2, 
122.8, 97.9, 88.0, 85.9, 85.5, 71.2, 56.4, 33.6, 29.5, 19.4, 14.8; IR (thin film) ν 3052, 2980, 2933, 
2821, 2226, 1965, 1717, 1598, 1105, 917, 757, 691 cm-1; MS m/z (%) 240 (11), 225 (20), 215 
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(46), 158 (53), 129 (69), 105 (100); EI-HRMS calcd for C17H20O m/z 240.1514 [M+]; found 
240.1507. 
Allylmethoxy trienes 1-58. 
1-57
•
1-58
[Rh(CO)2Cl]2
Toluene
MeO H
R
HMeO
R
 
General Procedure A was followed. 
1-58i
HMeO
 
1-((1Z)-(6-Methoxy-3-methyl-2-vinylcyclohex-2-enylidene)methyl)benzene 1-58i.   
According to General Procedure A, allenic methylpropargyl ether 1-57i (25.8 mg, 0.11 mmol) in 
toluene (0.36 mL) was reacted with rhodium biscarbonyl chloride dimer (3.3 mg, 0.009 mmol, 8 
mol%) at 50 °C to afford 1-58i (24.8 mg, 96%). The reaction mixture was placed into a 
preheated oil bath at 50 °C after addition of [Rh(CO)2Cl]2 and the reaction was complete after 5 
min as observed by TLC.  Average of two yields: 95%. (Rf = 0.34, 10% ethyl acetate/hexanes); 
1H NMR (300 MHz, CDCl3) δ 7.39 – 7.22 (m, 5H), 6.65 (s, 1H), 6.35 (dd, J = 17.7, 11.1 Hz, 
1H), 5.46 (dd, J = 11.1, 2.3 Hz, 1H), 5.21 (dd, J = 17.7, 2.3 Hz, 1H), 4.34 (dd, J = 3.4, 2.0 Hz, 
1H), 3.35 (s, 3H), 2.50 – 2.40 (m, 1H), 2.19 (dt, J = 10.4, 3.7 Hz, 1H), 2.08 (dd, J = 18.5, 5.8 
Hz, 1H), 1.92 (s, 3H), 1.60 (tdd, J = 14.2, 5.9, 2.0 Hz, 1H);  13C NMR (7 5  MHz,  CDCl3 ) δ 
137.9, 137.1, 135.4, 134.9, 130.6, 128.9, 128.0, 127.8, 126.5, 119.3, 72.0, 54.5, 27.4, 25.0, 21.7; 
IR (thin film) ν 3078, 2923, 2817, 1626, 1192, 1084, 919, 760, 701 cm-1; MS m/z (%) 241 (15), 
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240 (75), 225 (8), 208 (64), 193 (100), 182 (58), 165 (52), 115 (77); EI-HRMS calcd for 
C17H20O m/z [M+] 240.1514; found 240.1515. 
1-58j
HMeO
OMe
 
1-Methoxy-4-((1Z)-(6-methoxy-3-methyl-2-vinylcyclohex-2-enylidene)methyl)benzene       
1-58j.  According to General Procedure A, allenic methylpropargyl ether 1-57j (26.3 mg, 0.10 
mmol) in toluene (0.34 mL) was reacted with rhodium biscarbonyl chloride dimer (3.0 mg, 0.008 
mmol, 8 mol%) at 50 °C to afford 1-58j (22.3 mg, 80%).  The reaction mixture was placed into a 
preheated oil bath at 50 °C after addition of [Rh(CO)2Cl]2 and the reaction was complete in     < 
10 min as observed by TLC.  Average of two yields: 80%. (Rf = 0.63, 30% ethyl 
acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 7.26 (d, J = 8.7 Hz, 2H), 6.89 (d, J = 8.7 Hz, 
2H), 6.57 (s, 1H), 6.32 (dd, J = 17.7, 11.1 Hz, 1H), 5.44 (dd, J = 11.1, 2.4 Hz, 1H), 5.19 (dd, J = 
17.7, 2.4, 1H), 4.32 (dd, J = 3.2, 2.0, 1H), 3.82 (s, 3H), 3.35 (s, 3H), 2.48 – 2.38 (m, 1H), 2.19 
(dt, J = 14.1, 3.7, 1H), 2.05 (dd, J = 18.4, 5.7, 1H), 1.90 (s, 3H), 1.59 (tdd, J = 14.2, 5.8, 2.0 Hz, 
1H); 13C NMR (75 MHz, CDCl3) δ 158.4, 136.0, 135.0, 134.7, 130.8, 130.5, 130.1, 127.5, 119.2, 
113.6, 72.1, 55.2, 54.5, 27.4, 24.9, 21.8; IR (thin film) ν 3077, 2927, 2834, 1606, 1509, 1248, 
1035, 831 cm-1; MS m/z (%) 271 (22), 270 (100), 238 (53), 223 (68), 212 (37), 121 (69); EI-
HRMS calcd for C16H18O m/z [M+] 270.1620; found 270.1621. 
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5.3 EXPERIMENTAL: CHAPTER 2 
O
OTBS
HO
2-12e
R
OMeR =
MgBr
CeCl3, 71% OH
OTBS
HO
R
E2-1
THF, 0 °C
 
Propargyl Alcohol E2-1.  Cerium trichloride heptahydrate (2.91 g, 7.8 mmol) was dried under 
vacuum (~4 torr) at 140 – 150 °C for approximately 5 h.  The flask was cooled, filled with 
nitrogen, and the dried salt suspended in THF (52 mL) and stirred for 16 h overnight.  The 
suspension was cooled to 0 °C and ethynyl magnesium bromide (15.6 mL of a 0.5 M solution in 
THF, 7.8 mmol) was added via syringe.  The mixture was stirred for 1.5 h and then a solution of 
2-12e (523 mg, 1.3 mmol) in THF (8.7 mL) was added via cannula.  The reaction mixture was 
stirred for 30 – 40 min until no starting material was evident by TLC (Starting material and 
product Rf values are both approximately 0.53, 30% ethyl acetate/hexanes.  Using p-
anisaldehyde TLC stain the starting material spot is black and the product spot is brown).  The 
reaction mixture was quenched with water (8 mL) and diluted with ether.  The mixture was 
poured into a separatory funnel and solid citric acid was added with swirling until the emulsion 
had dissipated.  The layers were separated and the aqueous layer extracted into ether (3x).  The 
combined organic layers were dried over MgSO4, filtered, and concentrated under vacuum.  The 
residue was chromatographed on silica gel (15% ethyl acetate/hexanes) to afford E2-1 (393 mg, 
71%).  1H NMR (CDCl3, 300 MHz) δ 7.34 (d, 8.7 Hz, 2H), 6.85 (d, 8.7 Hz, 2H), 5.02 (s, 1H), 
4.49 (s, 1H), 3.82 (s, 3H), 3.29 (s, 1H), 2.43 (s, 1H), 1.62 – 1.56 (m, 4H), 1.45 – 1.29 (m, 4H), 
1.02 – 0.89 (m, 11H), 0.26 (s, 3H), 0.22 (s, 3H).  Impurities: 5.31 (s, 1H), 1.63 – 1.56 (m, 1H), 
1.45 – 1.29 (m, 1H), 1.02 – 0.89 (m, 3H). 
  
 97 
O
OTBS
HO
2-12d
O O H3C
OTBS
t-BuLi, -78 °C
2-10
2-11b
H3C
OH
2-11c TBS
 
1-(t-Butyldimethylsilyl)but-2-yn-1-ol 2-11c.  (Isolated as the only product from attempted 
addition reaction).  To a solution of 2-11b (214 mg, 1.16 mmol) in THF (2 mL) at -78 °C was 
added t-butyl lithium (0.61 mL of a 1.7 M solution in pentane, 1.04 mmol) dropwise via syringe 
over 2-3 min.  The yellow reaction mixture was stirred for 1 h, at which point it was colorless, 
and then a solution of 2-10 (105 mg, 0.83 mmol) in THF (2 mL) was added via cannula.  The 
reaction mixture was stirred for 2.5 h.  Water (3 mL) was then added at -78 °C, the mixture was 
warmed to room temperature and then diluted with water (5 mL) and ether (5 mL).  The layers 
were separated and the aqueous layer extracted into ether (3x).  The combined organic layers 
were dried over MgSO4, filtered, and concentrated under vacuum.  The residue was 
chromatographed on silica gel (2% to 6% ethyl acetate/hexanes) to afford 2-11c (83 mg, 39%).  
No starting material was recovered. (Rf = 0.33, 10% ethyl acetate/hexanes); 1H NMR (CDCl3, 
300 MHz) δ 4.19 (q, J = 2.4 Hz, 1H), 1.89 (d, J = 2.4 Hz, 3H), 0.98 (s, 9H), 0.11 (s, 3H), 0.08 (s, 
3H); 13C NMR (75 MHz, CDCl3) δ 84.0, 80.2, 55.1, 26.9, 16.9, 3.81, -8.0, -8.6 (minor impurities 
at 25.6, 25.5, -3.6, -4.8); IR (thin film) ν  3445, 2929, 2954, 2884, 2857, 2245, 1696, 1463, 1249, 
975, 838, 781 cm-1. 
2-12c
O
OTBS
HO
2-12b
O
OTBS
HO
K2CO3
MeOH
TMS
 
1-(1-((2R,3R)-2-hydroxy-3-t-Butyldimethylsilyloxypent-4-yn-2-yl)cyclopropyl)ethanone      
2-12c. To a solution of TMS alkyne 2-12b (3.75 g, 10.2 mmol) in MeOH (102 mL), was added 
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K2CO3 (1.83 g, 13.2 mmol).  The reaction mixture was stirred for 2 h until no starting material 
was evident by TLC.  The mixture was diluted with ether, vacuum filtered through a pad of silica 
gel (60 mL fritted funnel approximately half full), and concentrated under vacuum.  The residue 
was chromatographed on silica gel (10% EtOAc/Hexanes) to give 2-12c (2.41 g, 80%).  (Rf = 
0.45, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 5.24 (d, J = 2.1 Hz, 1H), 2.77 
(s, 1H), 2.43 (d, J = 2.1 Hz, 1H), 1.84 (s, 3H), 1.38 (s, 3H), 1.29 – 1.12 (m, 3H), 1.10 – 1.01 (m, 
1H), 0.92 (s, 9H), 0.15 (s, 3H), 0.05 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 208.3, 83.1, 74.2, 
73.4, 67.6, 37.3, 25.7, 24.7, 22.3, 18.0, 13.5, 10.7, -4.7, -5.1; IR (thin film) ν 3520, 3309, 2955, 
2932, 2887, 2858, 2114, 1679, 1361, 1320, 1254, 1072, 838, 779 cm-1; MS m/z (%) 240 (6), 239 
(35), 221 (37), 197 (10), 147 (28), 127 (100), 113 (81); EI-HRMS calcd for C12H19O3Si m/z [M – 
(t-Bu)+] 239.1103; found 239.1097. 
O
OTBS
HO
2-12e
OMe
1 mol% Pd(PPh3)2Cl2,
CuI, HN(i-Pr)2, THF
I O
O
OTBS
HO
O
OTBS
OH
2-12c
O
OTBS
HO
+
2-21  
1-(1-((2R,3R)-2-Hydroxy-3-t-butyldimethylsilyloxy-5-(4-methoxyphenyl)pent-4-yn-2-
yl)cyclopropyl)ethanone 2-12e and Dialkyne 2-21.  In a 50 mL round bottomed flask was 
charged 2-12c (505 mg, 1.70 mmol), Pd(PPh3)2Cl2 (12 mg, 0.017 mmol), copper iodide (7 mg, 
0.034 mmol), and 4-iodoanisole (286 mg, 5.10 mmol).  The flask was evacuated and filled with 
nitrogen.  The mixture was suspended in THF (8.5 mL) and to the resultant mixture was added 
freshly distilled diisopropyl amine (2.4 mL, 17.0 mmol) via syringe.  The reaction mixture 
became a clear orange color that slowly changed to a cloudy yellow.  After 2 h no starting 
material was evident by TLC.   The reaction mixture was concentrated under vacuum and the 
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resultant brick red residue chromatographed on silica gel (5% ethyl acetate/hexanes to 30% ethyl 
acetate/hexanes) to give 2-12e (524 mg, 77%) and 2-22 (48 mg, 8%).   
2-12c: (Rf = 0.62, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 7.36 (d, J = 8.7 
Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 5.43 (s, 1H), 3.82 (s, 3H), 2.91 (s, 1H), 1.88 (s, 3H), 1.45 (s, 
3H), 1.29 – 1.06 (m, 4H), 0.93 (s, 9H), 0.20 (s, 3H), 0.11 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
208.4, 159.6, 132.9, 115.1, 113.9, 87.1, 86.1, 73.8, 68.4, 55.3, 37.4, 25.8, 24.9, 22.6, 18.1, 13.4, 
10.8, -4.5, -5.0; IR (thin film) ν 3548, 3310, 2932, 2858, 2115, 1681, 1468, 1362, 1320, 1254, 
1068, 838, 778 cm-1; MS m/z (%) 425 (100, M + 23Na), 365 (10); ESI-HRMS calcd for 
C23H34O3Si Na m/z [M + 23Na+] 425.2124; found 425.2104.  
2-21: (Rf = 0.54, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 5.31 (s, 2H), 2.83 
(s, 2H), 1.84 (s, 6H), 1.35 (s, 6H), 1.30 – 1.07 (m, 8H), 0.90 (s, 18H), 0.15 (s, 6H), 0.06 (s, 6H); 
13C NMR (75 MHz, CDCl3) δ 208.5, 78.5, 73.9, 70.5, 68.4, 37.3, 25.7, 24.7, 22.1, 18.0, 13.4, 
10.8, -4.7, -5.1; IR (thin film) ν 3521, 2932, 2857, 2148, 1679, 1469, 1360, 1320, 1254, 1067, 
838, 778 cm-1; MS m/z (%) 614 (32, M + 23Na + H), 613 (100, M + 23Na), 527 (30), 441 (26); 
ESI-HRMS calcd for C32H54O6Si2Na m/z [M + H+] 613.3357; found 613.3338. 
OH
OTBS
HO
R
E2-1 OMeR =
Ac2O, 
DMAP, 
NEt3
OAc
OTBS
HO
R
2-13b  
Propargyl Acetate 2-13b. To a solution of E2-1 (305 mg, 0.71 mmol) and 4-
(dimethylamino)pyridine (43 mg, 0.36 mmol) in triethylamine (1 mL, 7.1 mmol) was added 
acetic anhydride (0.33 mL, 3.6 mmol).  The reaction mixture was stirred for 3 h until no starting 
material was evident by TLC.  The mixture was diluted with ethyl acetate and vacuum filtered 
through a pad of florisil (30 mL fritted funnel approximately half full).  The filtrate was 
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concentrated under vacuum and the residue chromatographed on florisil (10% ethyl 
acetate/hexanes) to give 2-13b (312 mg, 93%).  
Allene-ynes 2-18a and 2-18e 
OTBS
HO
•
2-18
R
OAc
OTBS
HO
R CuCN, MeLi
THF, - 40 °C
2-13
R = TMS or
R = p-C4H4OMe  
General Procedure G: Preparation of 2-18a 
OTBS
HO
•
2-18a
TMS
 
3-t-Butyldimethylsilyloxy-5-(Trimethylsilyl)-2-(1-(penta-2,3-dien-2-yl)cyclopropyl)pent-4-
yn-2-ol 2-18a.  Using the method of Krause; to a suspension of copper(I) cyanide (367 mg, 4.10 
mmol) in diethyl ether (20 mL) at -40 ºC is added n-butyl lithium (2.55 mL of a 1.6 M solution 
in hexanes, 4.07 mmol).  The resultant cloudy gray/white suspension was stirred for 20 min and 
then a solution of acetate 2-13a (332 mg, 0.76 mmol) in diethyl ether (3 mL) was added slowly 
via syringe over 5 min.  The resultant yellow mixture was stirred for 20 – 30 min until no starting 
material was evident by TLC.  The mixture was poured into a suspension of diethyl ether over 
aqueous 3% NH4OH : sat’d NH4Cl (1 : 1) and stirred vigorously until a deep blue color persisted 
in the aqueous layer.  The layers were separated and the aqueous layer extracted with ether (3x).  
The combined organic layers were dried over MgSO4, filtered, and concentrated under vacuum.  
The crude residue was chromatographed on silica gel (1% ethyl acetate/hexanes) to give 2-18a as 
a pale yellow oil (204 mg, 68%).  (Rf = 0.62, 10% ethyl acetate/hexanes); 1H NMR (300 MHz, 
CDCl3) δ 4.97 – 4.93 (m, 1H), 4.51 (s, 1H), 2.27 (s, 1H), 1.73 (d, J = 2.7 Hz, 3H), 1.62 (d, J = 
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6.9 Hz, 3H), 1.26 (s, 3H), 1.25 – 1.20 (m, 1H), 0.96 – 0.81 (m, 1H), 0.92 (s, 9H), 0.58 – 0.51 (m, 
1H), 0.44 – 0.37 (m, 1H), 0.19 (s, 3H), 0.17 (s, 9H), 0.15 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
206.6, 105.4, 100.2, 91.6, 83.9, 74.9, 69.9, 29.3, 25.8, 23.8, 19.2, 18.3, 14.1, 11.2, 9.2, -0.4, -4.4, 
-5.1; IR (thin film) υ 3575, 2957, 2930, 2897, 2858, 2177, 1961, 1251, 1065, 843, 778 cm-1; MS 
m/z (%) 392 (15), 377 (20), 335 (11), 319 (25), 261 (43), 242 (51), 201 (36), 151 (64), 147 (100), 
133 (68);  EI-HRMS calcd for C22H40O2Si2 m/z [M+] 392.2568; found 392.2567.  
OTBS
HO
•
2-18e
OMe
 
(2R,3R)-3-t-butyldimethylsilyloxy-5-(4-methoxyphenyl)-2-(1-(penta-2,3-dien-2-
yl)cyclopropyl)pent-4-yn-2-ol 2-18e.  According to General Procedure G, 2-13b (184 mg, 0.39 
mmol) was reacted with copper(I) cyanide (350 mg, 3.91 mmol), and methyl lithium (2.44 mL of 
a 1.6 M solution in ether, 3.91).  The crude product was chromatographed on silica gel (5% ethyl 
acetate/hexanes) to afford 2-18e (79 mg, 47%).  (Rf = 0.66, 30% ethyl acetate/hexanes); 
*Denotes minor diastereomer. 1H NMR (CDCl3, 700 MHz) δ 7.34 (d, J = 9.1 Hz, 1.2H), *7.33 
(d, J = 9.1 Hz, 0.8H), 6.84 (d, J = 9.1 Hz, 2H), 4.99 – 4.94 (m, 1H), *4.87 (s, 0.4H), 4.82 (s, 
0.6H), 3.82 (s, 3H), 2.63 (s, 0.6H), *2.60 (s, 0.4H), *1.80 (d, J = 2.8 Hz, 1.2H), 1.79 (d, J = 2.8 
Hz, 1.8H), 1.63 (d, J = 7.0 Hz, 1.8H), *1.61 (d, J = 7.0 Hz, 1.2H), 1.25 (s, 1.8H), *1.22 (s, 1.2H), 
0.98 – 0.97 (m, 1H), *0.96 (s, 3.6H), 0.95 (s, 5.4H), 0.90 – 0.88 (m, 1H), 0.61 – 0.47 (m, 2H), 
0.25 (s, 3H), *0.22 (s, 1.2H), 0.21 (s, 1.8H); IR (thin film) ν  3543, 2954, 2930, 2895, 2857, 
2224, 1735, 1605, 1510, 1251, 1067, 835, 778 cm-1; MS m/z (%) 426 (21), 411 (8), 369 (11), 318 
(15), 276 (53), 275 (63), 151 (63); EI-HRMS calcd for C26H38O3Si m/z [M+] 426.2590; found 
426.2585. 
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OTBS
HO
•
2-18a
TMS
KHSO4
MeOH, 40 h, 80%
OH
HO
•
2-18b
TMS
 
(2R,3R)-5-(Trimethylsilyl)-2-(1-(penta-2,3-dien-2-yl)cyclopropyl)pent-4-yne-2,3-diol 2-18b.  
To a solution of 2-18b (55 mg, 0.14 mmol) in freshly distilled methanol (0.5 mL) was added 
KHSO4 (19 mg, 0.14 mmol).  The resultant brown mixture was stirred for 7 h and then diluted 
with ethyl acetate and filtered through a pad of silica gel (10 mL fritted funnel approximately 
30% full).  The filtrate was concentrated under vacuum and the crude residue was 
chromatographed on silica gel (10% ethyl acetate/hexanes) to give an off white solid (23 mg, 
0.083 mmol, 59%) and remaining starting material (26% recovery, 85% yield brsm).  (Rf = 0.30, 
30% ethyl acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 5.04 – 4.97 (m, 1H), 4.52 (d, J = 7.8 
Hz, 1H), 2.33 (d, J = 7.8 Hz, 1H), 1.81 (s, 1H), 1.77 (d, J = 3.0 Hz, 3H), 1.64 (d, J = 7.2 Hz, 3H), 
1.29 (s, 3H), 1.04 – 0.97 (m, 1H), 0.82 – 0.76 (m, 1H), 0.61 – 0.47 (m, 2H), 0.19 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 206.1, 104.2, 100.6, 92.1, 84.6, 75.4, 69.8, 29.9, 21.9, 19.1, 14.0, 10.8, 
9.9, -0.24; IR (thin film) υ 3447, 2960, 2926, 2177, 1960, 1250, 1042, 1005, 841, 761 cm-1; MS 
m/z (%) 279 (8), 278 (23), 260 (49), 245 (17), 170 (22), 151 (75), 109 (49), 72 (100); EI-HRMS 
calcd for m/z C16H26O2Si [M+] 278.1702; found 278.1709. 
OTBS
HO
•
2-18a
TMS
K2CO3, MeOH
OTBS
HO
•
2-18c  
(2R,3R)-3-t-Butyldimethylsilyloxy-2-(1-(penta-2,3-dien-2-yl)cyclopropyl)pent-4-yn-2-ol     
2-18c.  To a solution of 2-18a (90 mg, 0.23 mmol), in methanol (2.2 mL) and water (0.3 mL) at     
0 ºC was added K2CO3 (63 mg, 0.46 mmol).  After 10 min the reaction was warmed to rt and 
stirred for 2.5 h until no starting material was evident by TLC.  The mixture was diluted with 
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ether (10 mL) and water (10 mL) and the layers separated.  The aqueous layer was extracted into 
ether (3x) and the combined organic layers dried over MgSO4, filtered, and concentrated under 
vacuum.  The crude residue was chromatographed on silica gel (2% ethyl acetate/hexanes) to 
give a pale yellow oil (30 mg, 0.094 mmol, 41%).  (Rf = 0.39, 30% ethyl acetate/hexanes); 1H 
NMR (300 MHz, CDCl3) δ 5.02 – 4.93 (m, 1H), 4.56 (d, J = 2.1 Hz, 1H), 2.45 (d, J = 2.1 Hz, 
1H), 2.28 (s, 1H), 1.72 (d, J = 3.0 Hz, 3H), 1.63 (d, J = 7.2 Hz, 3H), 1.28 (s, 3H), 1.26 – 1.22 (m, 
1H), 0.93 (s, 9H), 0.91 – 0.83 (m, 1H), 0.60 – 0.54 (m,1H), 0.47 – 0.41 (m, 1H), 0.20 (s, 3H), 
0.15 (s, 3H);  13C NMR (75 MHz, CDCl3) δ 206.5, 100.1, 84.2, 83.5, 75.1, 74.8, 69.3, 29.2, 25.8, 
23.7, 19.1, 18.2, 14.2, 11.0, 9.2, -4.4, -5.1;  IR (thin film) υ 3578, 3311, 2955, 2930, 2896, 2858, 
2118, 1960, 1252, 1067, 837, 778 cm-1; MS m/z (%) 344 (25, M + 23Na + H), 343 (100, M + 
23Na); ESI-HRMS calcd for C19H32O2NaSi m/z [M + 23Na+] 343.2069; found 343.2069. 
OTBS
HO
•
2-18a
TMS
TBAF, THF
OH
HO
•
2-18d  
(2R,3R)-2-(1-(Penta-2,3-dien-2-yl)cyclopropyl)pent-4-yne-2,3-diol 2-18d.  To a solution of   
2-18a (95 mg, 0.24 mmol) in THF (1.2 mL) at 0 °C was added tetrabutylammonium fluoride 
(0.29 mL of a 1 M solution in THF, 0.29 mmol).  The mixture was stirred for 30 min until no 
starting material was evident by TLC.  The mixture was diluted with ether, vacuum filtered 
through a pad of silica gel (30 mL fritted filter approximately 30% full) and concentrated under 
vacuum.  The residue was chromatographed on silica gel (30% ethyl acetate/hexanes) to afford 
2-18d (46 mg, 93%). Subsequent yields for this reaction did not exceed 19%.  Characterization 
data is listed below. The 1H NMR characterization data matched that vide infra.     
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OH
HO
•
2-18b
TMS
OH
HO
•
2-18d
K2CO3, MeOH
 
(2R,3R)-2-(1-(Penta-2,3-dien-2-yl)cyclopropyl)pent-4-yne-2,3-diol 2-18d.  To a solution of   
2-18b (73 mg, 0.26 mmol) in methanol (2.6 mL) at 0 ºC was added K2CO3 (47 mg, 0.34 mmol).  
After 1h the ice bath was removed and the reaction mixture stirred for an additional 3 h until no 
starting material was evident by TLC.  The reaction mixture was diluted with ether, filtered 
through a pad of silica gel (10 mL fritted funnel approximately 30% full) and concentrated under 
vacuum.  The crude residue was chromatographed on silica gel (25% ethyl acetate/ hexanes) to 
give an off-white solid (32 mg, 0.16 mmol, 62%).  (Rf = 0.34, 30% ethyl acetate/hexanes); 1H 
NMR (300 MHz, CDCl3) δ 5.06 – 4.98 (m, 1H), 4.57 (d, J = 5.1 Hz, 1H), 2.52 (d, J = 2.1 Hz, 
1H), 2.47 (d, J = 7.2 Hz, 1H), 1.85 (s, 1H), 1.77 (d, J = 3.0 Hz, 3H), 1.63 (d, J = 7.2 Hz, 3H), 
1.27 (s, 3H), 1.04 – 1.00 (m, 1H), 0.82 – 0.77 (m, 1H), 0.60 – 0.53 (m, 2H); 13C NMR (75 MHz, 
CDCl3) δ 205.8, 100.5, 84.8, 82.6, 75.6, 75.1, 69.1, 29.8, 21.4, 19.1, 14.0, 10.3, 10.2;  IR (thin 
film) υ 3420, 3287, 2982, 2924, 2115, 1959, 1372, 1082, 1031, 776 cm-1; MS m/z (%) 206 (21), 
205 (6), 187 (17), 173 (44), 159 (30), 151 (91), 131 (58), 109 (64), 105 (67), 93 (94), 91 (100); 
EI-HRMS calcd for m/z C13H18O2 [M+] 206.1307; found 206.1307. 
OTBS
HO
•
2-18e
TBAF, THF
OH
HO
•
2-18f
OMeOMe
 
(2R,3S)-5-(4-Methoxyphenyl)-2-(1-(penta-2,3-dien-2-yl)cyclopropyl)pent-4-yne-2,3-diol      
2-18f.  To a solution of 2-18e (79 mg, 0.19 mmol) in THF (1.9 mL) at 0 °C was added 
tetrabutylammonium fluoride (0.56 mL of a 1 M solution in THF, 0.56 mmol).  The mixture was 
stirred for 1 h, then the ice bath was removed and the mixture stirred for an additional 2 h until 
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no starting material was evident by TLC.  The reaction mixture was concentrated under vacuum 
and the residue chromatographed on silica gel (30% ethyl acetate/hexanes) to afford 2-18f (50 
mg, 84%).  
Spiro[2.5]octatrienes 
OR1
HO
•
2-18
R2
6 mol% 
[Rh(CO)2Cl]2
0.05 M in toluene, rt HO
OR1 R2
2-19  
General Procedure H: Preparation of 2-19c 
OTBS
HO
2-19c  
Spiro[2.5]octatriene 2-19c. A solution of allene-yne 2-18c (41.4 mg, 0.129 mmol) in toluene 
(2.6 mL) was degassed by bubbling argon through the solution for 20 min.  Rhodium biscarbonyl 
chloride dimer (3.0 mg, 0.008 mmol, 6 mol%) was then added. The reaction mixture was stirred 
for 1.5 h until no starting material was evident by TLC.  The reaction mixture was diluted with 
10% ethyl acetate/hexanes solution and vacuum filtered through a pad of silica gel (10 mL fritted 
funnel approximately half full), eluting with 10% ethyl acetate/hexanes solution.  The filtrate 
was concentrated under vacuum and the residue chromatographed on silica gel (2% ethyl acetate 
in hexanes) to afford 2-19c (26.3 mg, 64%). (Rf = 0.36, 10% ethyl acetate/hexanes); 1H NMR 
(300 MHz, CDCl3) δ 6.29 (dd, J = 17.7, 11.4 Hz, 1H), 5.39 (dd, J = 11.4, 2.4 Hz, 1H), 5.17 (d, J 
= 1.2 Hz, 1H), 5.13 (dd, J = 17.7, 2.4 Hz, 1H), 5.04 (d, J = 0.9 Hz, 1H), 4.00 (s, 1H), 2.45 (d, J = 
0.6 Hz, 1H), 1.51 (s, 3H), 1.04 (s, 3H), 1.04 – 1.00 (m, 1H), 0.87 (s, 9H), 0.85 – 0.79 (m, 1H), 
0.76 – 0.66 (m, 2H), 0.12 (s, 3H), 0.01 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 144.4, 136.6, 
135.2, 128.5, 118.7, 114.6, 80.6, 71.2, 28.9, 25.8, 22.3, 18.1, 15.0, 10.0, 4.8, -3.8, -4.8; IR (thin 
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film) υ 3564, 3088, 2954, 2930, 2885, 2857, 1617, 1378, 1250, 1074, 837, 777 cm-1; MS m/z (%) 
321 (9), 320 (36), 305 (51), 287 (26), 263 (78), 245 (26), 171 (64), 145 (60), 131 (56), 75 (100); 
EI-HRMS calcd for m/z [M+] 320.2172; found 320.2167. 
HO
TMS
2-19b
OH
 
Spiro[2.5]octatriene 2-19b. According to General Procedure H, 2-18b (29.4 mg, 0.106 mmol) 
in toluene (2.0 mL) was reacted with rhodium biscarbonyl chloride dimer (123 µL, of a 1 mg/0.1 
mL stock solution in toluene, 0.003 mmol, 3 mol%).  Upon completion, the mixture was diluted 
with 30% ethyl acetate/hexanes solution and filtered through silica gel.  The residue was 
chromatographed on silica gel using 15% ethyl acetate/hexanes solution to afford 2-19b (21.6 
mg, 73%).  (Rf = 0.30, 30% ethyl acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 6.22 (dd, J = 
17.8, 11.2 Hz, 1H), 5.76 (s, 1H), 5.42 (dd, J = 11.2, 2.3 Hz, 1H), 5.05 (dd, J = 17.8, 2.3 Hz, 1H), 
4.14 (d, J = 7.1 Hz, 1H), 2.48 (s, 1H), 1.82 (d, J = 7.6 Hz, 1H), 1.55 (s, 3H), 1.19 – 1.13 (m, 1H), 
1.10 (s, 3H), 0.91 – 0.86 (m, 1H), 0.78 – 0.71 (m, 2H), 0.20 (s, 9H); 13C NMR (75 MHz, CDCl3) 
δ 151.1, 136.3, 135.6, 131.2, 130.6, 119.9, 70.9, 27.8, 22.9, 15.9, 9.6, 4.6, 0.7; IR (thin film) υ 
3443, 3082, 2954, 1588, 1378, 1249, 854 cm-1; MS m/z (%) 278 (14), 263 (4), 245 (28), 231 
(23), 200 (22), 173 (100), 159 (44), 145 (42); EI-HRMS calcd for m/z [M+] 278.1702; found 
278.1692.   
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OH
HO
2-19d  
Spiro[2.5]octatriene 2-19d. According to General Procedure H, 2-18d (45.0 mg, 0.218 mmol) 
in toluene (4.4 mL) was reacted with rhodium biscarbonyl chloride dimer (5 mg, 0.013 mmol,    
6 mol%).  After addition of the Rh(I) catalyst, the reaction mixture was placed into an oil bath, 
preheated to 50 °C.  Upon completion, the mixture was diluted with 30% ethyl acetate/hexanes 
solution and filtered through silica gel.  The residue was chromatographed on silica gel (30% 
ethyl acetate/hexanes) to afford 2-19d (24.9 mg, 55%). (Rf = 0.17, 30% ethyl acetate/hexanes); 
1H NMR (300 MHz, CDCl3) δ 6.29 (dd, J = 17.7, 11.1 Hz, 1H), 5.41 (dd, J = 11.1, 2.1 Hz, 1H), 
5.21 (s, 1H), 5.17 (s, 1H), 5.14 (dd, J = 17.7, 2.1 Hz, 1H), 3.96 (d, J = 4.8 Hz, 1H), 2.39 (s, 1H), 
1.96 (d, J = 7.2 Hz, 1H), 1.54 (s, 3H), 1.19 – 1.11 (m, 1H), 1.10 (s, 3H), 0.91 – 0.84 (m, 1H), 
0.80 – 0.71 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 143.9, 135.9, 134.7, 128.9, 119.6, 114.9, 
79.3, 71.0, 28.0, 22.8, 15.3, 9.1, 5.0; IR (thin film) υ 3420, 3081, 3014, 2975, 2931, 1616, 1378, 
1104, 1031, 919, 899 cm-1; MS m/z (%) 207 (5), 206 (37), 191 (26), 188 (46), 173 (74), 161 (75), 
145 (100), 131 (68), 117 (73); EI-HRMS calcd for m/z [M+] 206.1307; found 206.1303. 
TBSO
HO
2-19e
OMe  
Spiro[2.5]octatriene 2-19e. According to General Procedure H, 2-18e (52.2 mg, 0.122 mmol) in 
toluene (2.4 mL) was reacted with rhodium biscarbonyl chloride dimer (2.8 mg, 0.007 mmol, 6 
mol%).  Upon completion, the mixture was diluted with 30% ethyl acetate/hexanes solution and 
filtered through silica gel.  The residue was chromatographed on silica gel (10% ethyl 
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acetate/hexanes) to afford 2-19e (28.2 mg, 54%). (Rf = 0.54, 30% ethyl acetate/hexanes); 1H 
NMR (CDCl3, 300 MHz) δ 7.30 (d, J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 6.80 (d, J = 8.7 
Hz, 1H), 6.39 (dd, J = 17.7, 11.1 Hz, 1H), 5.46 (dd, J = 11.1, 2.4 Hz, 1H), 5.23 (dd, J = 17.7, 2.4 
Hz, 1H), 4.73 (s, 1H), 3.83 (s, 3H), 1.95 (s, 1H), 1.54 (s, 3H), 1.06 (s, 3H), 0.98 – 0.83 (m, 4H), 
0.77 (s, 9H), -0.22 (s, 3H), -0.34 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 158.5, 136.5, 135.6, 
133.8, 130.7, 130.1, 129.9, 129.2, 119.2, 113.5, 74.0, 71.4, 55.2, 28.7, 25.6, 20.9, 18.0, 14.7, 
12.7, 5.5, -4.4, -5.5; IR (thin film) ν 3442, 2953, 2930, 2855, 1607, 1509, 1463, 1250, 1177, 
1083, 1042, 858, 776 cm-1; MS m/z (%) 427 (14), 426 (42), 383 (21), 305 (26), 251 (37), 121 
(100); EI-HRMS calcd for C26H38O3Si m/z [M+] 426.2590; found 426.2579. 
OH
HO
2-19f
OMe  
Spiro[2.5]octatriene 2-19f. According to General Procedure H, 2-18f (17.8 mg, 0.057 mmol) in 
toluene (1.1 mL) was reacted with rhodium biscarbonyl chloride dimer (1.3 mg, 0.003 mmol, 6 
mol%).  Upon completion, the mixture was diluted with 30% ethyl acetate/hexanes solution and 
filtered through silica gel.  The residue was chromatographed on silica gel (15% ethyl 
acetate/hexanes) to afford 2-19f (9.5 mg, 53%).  (Rf = 0.24, 30% ethyl acetate/hexanes)1H NMR 
(CDCl3, 300 MHz) δ 7.39 (d, J = 8.7 Hz, 2H), 6.90 (d, J = 8.7 Hz, 2H), 6.80 (s 1H), 6.34 (dd, J = 
17.7, 11.1 Hz, 1H), 5.50 (dd, J = 11.1 Hz, 1H), 5.20 (dd, J = 17.7, 2.1 Hz, 1H), 4.40 (d, J = 9.0 
Hz, 1H), 3.83 (s, 1H), 1.96 (d, J = 9.3 Hz, 1H), 1.90 (s, 1H), 1.59 (s, 1H), 1.08 (s, 1H), 1.04 – 
0.84 (m, 4H); 13C NMR (75 MHz, CDCl3) δ 158.8, 135.4, 134.5, 133.7, 131.1, 130.8, 130.5, 
129.6, 120.3, 113.8, 73.2, 72.3, 55.3, 27.2, 20.5, 15.6, 11.5, 5.5; IR (thin film) ν 3441, 3080, 
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2933, 2836, 1606, 1509, 1250, 1178, 1032 cm-1; MS m/z (%) 313 (10), 312 (47), 279 (23), 265 
(24), 251 (26), 121 (100); EI-HRMS calcd for C20H24O3 m/z [M]+ 312.1725; found 312.1718. 
TBAF, THF
OTBS
HO
OH
HO
2-19c 2-19d  
Spiro[2.5]octatriene 2-19d.  Preparation of 2-19d from 2-19c.  To a solution of 2-19c (61 mg, 
0.19 mmol) in THF (4.8 mL) at 0 ºC was added tetrabutylammonium fluoride (0.42 mL of a 1 M 
solution in THF, 0.42 mmol).  The orange/yellow solution was stirred of 1.5 h when no starting 
material was evident by TLC.  The reaction mixture was concentrated under vacuum and 
chromatographed on silica gel (30% ethyl acetate/hexanes) to afford 2-19d (39 mg, 0.19 mmol, 
100%).  The 1H NMR characterization data matched that vide supra. 
TBAF, THF
TBSO
HO HO
2-19e 2-19f
OMe OMe
OH
 
Spiro[2.5]octatriene 2-19d.  Preparation of 2-19f from 2-19e. To a solution of 2-19e (24 mg, 
0.056 mmol) in THF (1.4 mL) was added tetrabutylammonium fluoride (0.12 mL of a 1 M 
solution in THF, 0.12 mmol).  The reaction mixture was stirred for 2 h, then more 
tetrabutylammonium fluoride (0.12 mL of a 1 M solution in THF, 0.12 mmol) was added and the 
mixture was stirred for an additional 1 h at room temperature, then heated to reflux for 1 h.  The 
progress of the reaction was monitored by TLC.  The reaction mixture was concentrated under 
vacuum and the residue chromatographed on silica gel (30% ethyl acetate in hexanes) to afford 
2-19f (11 mg, 63%).  The 1H NMR characterization data matched that vide supra. 
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2-19f 2-22f
OH
HO
Dess-Martin
O
O
OMe OMe
CH2Cl2
 
(2Z,3Z)-2-(4-Methoxybenzylidene)-3-(1-(1-acetylcyclopropyl)ethylidene)pent-4-enal 2-22f. 
To a suspension of Dess-Martin periodinane (20 mg, 0.046 mmol) in CH2Cl2 (2 mL) was added a 
solution of 2-19f (13.0 mg, 0.042 mmol) in CH2Cl2 (0.5 mL) via cannula.  After 2 h the reaction 
mixture was diluted with ether and filtered through a pad of silica gel (10 mL fritted funnel 
approximately 30% full).  The filtrate was concentrated under vacuum and the residue 
chromatographed on silica gel (20% ethyl acetate/hexanes) to afford 2-22f (6.5 mg, 50%). (Rf = 
0.18, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 9.89 (s, 1H), 7.39 (s, 1H), 7.29 
(d, J = 6.9 Hz, 2H), 6.95 (d, J = 6.9 Hz, 2H), 6.83 (dd, J = 17.1, 10.5 Hz, 1H), 5.14 (d, J = 10.5 
Hz, 1H), 4.97 (d, J = 17.1 Hz, 1H), 3.86 (s, 3H), 2.10 (s, 3H), 2.07 (s, 3H), 1.34 (dd, J = 7.2, 4.2 
Hz, 2H), 1.03 (dd, J = 7.2, 4.2 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 207.5, 192.1, 161.0, 
148.7, 139.2, 136.9, 136.7, 134.0, 131.8, 126.5, 116.4, 114.1, 55.4, 39.3, 26.2, 19.5, 19.0; IR 
(thin film) ν 3009, 2933, 2839, 1673, 1602, 1509, 1256, 1177, 1030, 833 cm-1; MS m/z (%) 333 
(100), 321 (20), 281 (35), 272 (60), 191 (55); ESI-HRMS calcd for C20H22O3Na m/z [M+23Na]+ 
333.1467; found 333.1453. 
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5.4 EXPERIMENTAL: CHAPTER 3 
O
O
•
O
O
•
1. LDA
2. MeI
E3-13-18  
Ethyl 2,2-dimethylhexa-3,4-dienoate E3-1.  A solution of LDA was prepared by addition of   
n-butyl lithium (18 mL, 1.6 M solution in hexanes, 29 mmol) to a solution of diisopropylamine 
(4.1 mL, 29 mmol) in THF (45 mL) at 0 ºC.  The solution was allowed to stir for 1 h then cooled 
to -78 °C and ethyl ester 3-18 (1.5 g, 9.8 mmol) in THF (33 mL) was added via cannula.  After 1 
h, iodomethane (1.8 mL, 29 mmol) was slowly added neat.  After the addition was complete, a 
precipitate was observed and the reaction was slowly warmed to rt.  After stirring for 18 h a 
solution of sat’d aqueous NH4Cl (30 mL) was added followed by dilution with ether (50 mL).  
The layers were separated and the aqueous layer extracted with ether (3x).  The combined 
organic layers were dried over MgSO4, filtered, and concentrated under vacuum.  The residue 
was chromatographed on silica gel (5% ethyl acetate/hexanes) to give the product E3-1 as a pale, 
brown oil (1.30 g, 79%).  1H NMR (300 MHz, CDCl3) δ 5.29 (dq, J = 7.0, 3.2 Hz, 1H), 5.18 (p, 
J = 7.0 Hz, 1H), 4.11 (q, J = 7.1 Hz, 2H), 1.65 (dd, J = 7.0, 3.2 Hz, 3H), 1.26 (s, 3H), 1.26 (s, 
3H), 1.23 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 203.0, 176.4, 97.0, 88.8, 60.6, 42.3, 
25.4, 25.3, 14.3, 14.1; IR (thin film) ν 2980, 2933, 2872, 1965, 1731, 1254, 1138 cm-1; MS m/z 
(%) 167 (6), 153 (56, M - 15), 125 (77), 95 (49), 73 (100); EI-HRMS calcd for C9H13O2 m/z [M - 
15+] 153.0916; found 153.0916. 
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O
O
•
O
OH
•
E3-1
2 M KOH
MeOH
3-19  
2,2-Dimethylhexa-3,4-dienoic acid 3-19.  Ester E3-1 (847 mg, 5.03 mmol) was dissolved in a 
solution of KOH (6.3 mL, 2 M in CH3OH).  The reaction mixture was heated to 60 °C for 48 h 
until no starting material was observed by TLC.  The reaction mixture was diluted with ether   
(20 mL) and water (20 mL) and the layers separated.  The organic layer was washed with water 
(2x) and a solution of KOH (10 mL, 2 M in H2O) (1x).  The combined aqueous layers were 
acidified with a solution of HCl (10% by wt., H2O) to a pH < 2.  The acidified aqueous phase 
was extracted with ether (3x) and the combined organic layers were dried over MgSO4, filtered, 
and concentrated under vacuum to afford the product 3-19 as a brown oil (696 mg, 99%).  This 
was taken on directly to the next step.  1H NMR (300 MHz, CDCl3) δ 11.39 (bs, 1H), 5.36–5.22 
(m, 2H), 1.69 (ddd, J = 6.9, 3.2, 1.0 Hz), 1.32 (s, 3H), 1.32 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ 203.2, 183.3, 96.6, 89.1, 42.2, 25.2, 25.1, 14.1;  IR (thin film) ν 3077, 2979, 2930, 1961, 1703, 
1296, 1168 cm-1; MS m/z (%) 140 (4), 139 (24), 125 (100), 107 (21); EI-HRMS calcd for 
C8H12O2 m/z [M+] 140.0837; found 140.0831. 
H2N Bn
O
OH
•
3-19
O
O
•
-10 °C to rt
THF 3-21
Cl
O
O
O
O
THF
O
NHBn
•O N
 
N-Benzyl-2,2-dimethylhexa-3,4-dienamide 3-21.  To a solution of allenic acid 3-19 (102.0 mg, 
0.73 mmol) in THF (3.6 mL) at -10 °C was added N-methylmorpholine (89 μL, 0.80 mmol) and 
isobutyl chloroformate (0.11 mL, 0.80 mmol).  The resultant cloudy brown suspension was 
stirred for 5 min and then benzyl amine (0.1 mL, 0.87 mmol) was added.  The resultant white 
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suspension was stirred for 2 h and then reaction was quenched with sat’d aqueous NaHCO3    
(0.8 mL).  The reaction mixture was diluted with enough water to dissolve the salts and the 
layers were separated.  The aqueous layer was extracted with ether (4 x 5 mL) and the combined 
organic layers were dried over MgSO4, filtered, and concentrated under vacuum.  The crude 
residue was chromatographed on silica gel (15% ethyl acetate/hexanes) to afford 3-21 as a clear, 
colorless oil (130.1 mg, 0.57 mmol, 78%). (Rf = 0.38, 30% ethyl acetate/hexanes); 1H NMR (300 
MHz, CDCl3) δ 7.36 – 7.24 (m, 5H), 6.29 (bs, 1H), 5.28 – 5.23 (m, 2H), 4.43 (d, J = 5.7 Hz, 
2H), 1.66 (dd, J = 6.0, 4.2 Hz, 3H), 1.32 (s, 3H), 1.31 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
203.9, 176.3, 138.5, 128.6, 127.4, 127.3, 97.2, 88.9, 43.5, 42.8, 25.9, 25.7, 14.2; IR (thin film) ν 
3348, 3031, 2968, 2928, 1960, 1647, 1525 cm -1; MS m/z (%) 229 (10), 215 (26), 214 (87), 150 
(26), 91 (100); EI-HRMS calcd for C15H19NO m/z 229.1467 [M+]; found 229.1469. 
Allenic propargyl Amides and Ester 3-23 
O
OH
•
3-19
(COCl)2
O
Cl
•Cat. DMF,
THF DMAP, TEA
O
•
Z
3-23a-i
3-24a-i
 
General Procedure E: Preparation of 3-23a 
O
•
N
Bn
H
3-23a  
N-Benzyl-2,2-dimethyl-N-(prop-2-ynyl)hexa-3,4-dienamide 3-23a.  In a round bottomed flask 
sealed with a rubber septum, allenic acid 3-19 (302 mg, 2.16 mmol) was dissolved in THF         
(7 mL) under N2, and one drop of DMF was added via syringe.  Oxalyl chloride (0.24 mL, 2.8 
mmol) was added dropwise via syringe to control the gas evolution.  The reaction mixture was 
  
 114 
allowed to stir 3 h and was then concentrated under vacuum to remove the excess oxalyl 
chloride.  To a solution of amine 3-24a (470 mg, 3.24 mmol) in THF (32 mL) was added 
triethylamine (0.90 mL, 6.5 mmol) and 4-(dimethylamino)pyridine (26 mg, 0.22 mmol).  The 
crude acid chloride was redissolved in THF (7 mL) and added to the solution of amine 3-24a via 
cannula.  The progress of the reaction was monitored by TLC and upon disappearance of the 
starting material (18 h), the solution was diluted with ether, filtered through celite (60 mL fritted 
funnel approximately half full), and concentrated under vacuum.  The crude residue was 
chromatographed on silica gel (10% ethyl acetate/hexanes) to afford amide 3-23a (519 mg, 90%) 
as a pale yellow oil. (Rf = 0.49, 30% ethyl acetate/hexanes); 1H NMR (300 MHz, DMSO-d6, 75 
°C) δ 7.36–7.22 (m, 5H), 5.43 (dq, J = 6.9, 3.2 Hz, 1H), 5.28 (dq, J = 6.9, 6.9 Hz, 1H), 4.76 (A 
of an ABq, J = 15.6 Hz, 1H), 4.67 (B of an ABq, J = 15.6 Hz, 1H), 4.18 (A of an ABq, d, 17.8, 
2.0 Hz, 1H), 4.09 (B of an ABq, d, J = 17.8, 2.0 Hz, 1H), 3.05–3.03 (m, 1H), 1.58 (dd, J = 6.9, 
3.2 Hz, 3H), 1.31 (s, 6H); 13C NMR (75 MHz, DMSO-d6, 75 °C) δ 201.9, 173.8, 136.6, 127.9, 
126.8, 126.6, 97.3, 88.6, 79.0, 73.8, 48.9, 41.8, 36.0, 26.9, 26.7, 13.0; IR (thin film) ν 3292, 
3240, 2977, 2117, 1962, 1643, 1409, 1360 cm-1; MS m/z (%) 253 (4), 252 (29, M - 15), 95 (28), 
91 (100); EI-HRMS calcd for C17H18NO2 m/z [M - 15+] 252.1388; found 252.1385. 
O
•
N
H
H
3-23b  
2,2-Dimethyl-N-(prop-2-ynyl)hexa-3,4-dienamide 3-23b.  According to General Procedure E, 
3-19 (97 mg, 0.69 mmol) in THF (2.3 mL) was reacted with oxalyl chloride (0.08 mL, 0.90 
mmol) and DMF (1 drop via syringe).  The resultant acid chloride was then reacted with amine 
3-24b (71 μL, 1.0 mmol), triethylamine (0.29 mL, 2.1 mmol), and 4-(dimethylamino)pyridine 
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(8.4 mg, 0.07 mmol) in THF (10 mL) to afford propargyl amide 3-23b (99 mg, 81%).  1H NMR 
(300 MHz, toluene-d8) δ 6.22 (bs, 1H), 5.20 (dq, J = 7.0, 3.2 Hz, 1H), 5.06 (p, J = 7.0 Hz, 1H), 
3.88 (dd, J = 5.3, 2.4 Hz, 2H), 1.91 (t, J = 2.4 Hz, 1H), 1.50 (dd, J = 7.0, 3.2 Hz, 3H), 1.26 (s, 
3H), 1.25 (s, 3H); 13C NMR (75 MHz, toluene-d8) δ 204.2, 175.4, 97.8, 88.9, 80.8, 71.3, 42.9, 
29.5, 26.1, 26.0, 14.4; IR (thin film) ν 3346, 3307, 2971, 2929, 2869, 2120, 1961, 1651, 1515, 
1275, 1174 cm-1; MS m/z (%) 176 (8), 163 (11), 162 (100), 95 (18), 73 (28); EI-HRMS calcd for 
C11H14NO m/z [M - H+] 176.1075; found 176.1078. 
O
•
NH
3-23c  
N-Allyl-2,2-dimethylhexa-3,4-dienamide 3-23c. According to General Procedure E, 3-19       
(87 mg, 0.62 mmol) in THF (2.1 mL) was reacted with oxalyl chloride (0.07 mL, 0.81 mmol) 
and DMF (1 drop via syringe).  The resultant acid chloride was then reacted with amine 3-24c 
(70 μL, 0.93 mmol), triethylamine (0.26 mL, 1.9 mmol), and 4-(dimethylamino)pyridine (8.0 
mg, 0.06 mmol) in THF (9 mL) to afford propargyl amide 3-23c (96 mg, 86%) as a pale yellow 
oil. (Rf = 0.34, 30% ethyl acetate/hexanes); 1H NMR (300 MHz, CDCl3) δ 6.04 (bs, 1H), 5.84 – 
5.71 (m, 1H), 5.26 – 5.03 (m, 4H), 3.79 (t, J = 5.4 Hz, 2H), 1.65 – 1.61 (m, 3H), 1.21 (s, 6H); 
13C NMR (75 MHz, CDCl3) δ 203.8, 176.1, 134.3, 115.6, 97.2, 88.7, 42.7, 41.8, 25.8, 25.6, 14.0; 
IR (thin film) ν 3348, 3082, 2970, 2928, 1961, 1643, 1525, 1275, 1176, 915 cm-1; MS m/z (%) 
165 (11), 164 (100), 95 (43), 81 (55); EI-HRMS calcd for C11H17NO m/z [M+] 179.1310; found 
179.1295. 
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O
•
N
3-23d
Bn
 
N-allyl-N-benzyl-2,2-dimethylhexa-3,4-dienamide 3-23d. According to General Procedure E, 
3-19 (84 mg, 0.60 mmol) in THF (2.0 mL) was reacted with oxalyl chloride (0.07 mL, 0.78 
mmol) and DMF (1 drop via syringe).  The resultant acid chloride was then reacted with amine 
3-24d (132 mg, 0.89 mmol), triethylamine (0.25 mL, 1.8 mmol), and 4-(dimethylamino)pyridine 
(8.0 mg, 0.06 mmol) in THF (9 mL) to afford propargyl amide 3-23d (130 mg, 81%). (Rf = 0.53, 
30% ethyl acetate/hexanes); 1H NMR (300 MHz, (CD3)2SO, 60 °C) δ 7.34 – 7.17 (m, 5H), 5.80 – 
5.71 (m, 1H), 5.43 (dq, J = 6.9, 3.2 Hz, 1H), 5.25 (p, J = 6.9 Hz, 1H), 5.16 (d, J = 10.3 Hz, 1H), 
5.09 (d, J = 17.3 Hz, 1H), 4.62 (A of an ABq, J = 15.7, 1H), 4.54 (B of an ABq, J = 15.7 Hz, 
1H), 4.02 – 3.90 (m, 2H), 1.56 (dd, J = 6.9, 3.2 Hz, 3H), 1.28 (s, 3H), 1.27 (s, 3H); 13C NMR (75 
MHz, (CD3)2SO, 60 °C) δ 201.8, 174.0, 137.4, 133.5, 128.0, 126.8, 126.5, 116.8, 97.7, 88.5, 
48.7, 48.7, 41.8, 27.2, 26.9, 13.1;  IR (thin film) ν 3060, 2981, 2929, 2860, 1961, 1636, 1409, 
925, 726, 699; MS m/z (%) 254 (26, M - 15), 95 (25), 91 (100); EI-HRMS calcd for C17H20NO 
m/z [M - 15+] 254.1545; found 254.1547. 
O
•
O
3-23e  
Prop-2-ynyl 2,2-dimethylhexa-3,4-dienoate 3-23e.  According to General Procedure E, 3-19 
(92 mg, 0.66 mmol) in THF (2.2 mL) was reacted with oxalyl chloride (0.08 mL, 0.86 mmol) 
and DMF (1 drop via syringe).  The resultant acid chloride was then reacted with propargyl 
alcohol (58 μL, 0.99 mmol), triethylamine (0.28 mL, 2.0 mmol), and 4-(dimethylamino)pyridine 
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(8.0 mg, 0.07 mmol) in THF (10 mL) to afford propargyl ester 3-23e (82 mg, 69%).  1H NMR 
(300 MHz, CDCl3) δ 5.32 (dq, J = 6.9, 3.3 Hz, 1H), 5.25 (p, J = 6.9 Hz, 1H), 4.68 (d, J = 2.4 
Hz, 2H), 2.46 (t, J = 2.4 Hz, 1H), 1.68 (dd, J = 6.9, 3.3 Hz, 3H), 1.32 (s, 3H), 1.31 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 203.2, 175.5, 96.6, 89.1, 77.7, 74.6, 52.2, 42.4, 25.3, 25.2, 14.2; IR 
(thin film) ν 3297, 2979, 2934, 2868, 2130, 1963, 1738, 1469, 1248, 1127 cm -1; MS m/z (%) 164 
(13), 163 (100), 135 (26), 95 (78); EI-HRMS calcd for C11H14O2 m/z [M+] 178.0993; found 
178.1005. 
O
•
N
H
3-23f
OTBS
 
N-(2-t-Butyldimethylsilyloxyethyl)-2,2-dimethyl-N-(prop-2-ynyl)hexa-3,4-dienamide 3-23f.  
According to General Procedure E, 3-19 (250 mg, 1.78 mmol) in THF (6 mL) was reacted with 
oxalyl chloride (0.20 mL, 2.3 mmol) and DMF (1 drop via syringe).  The resultant acid chloride 
was then reacted with amine 3-24f (569 mg, 2.67 mmol), triethylamine (0.75 mL, 5.3 mmol), and 
4-(dimethylamino)pyridine (22 mg, 0.18 mmol) in THF (27 mL) to afford propargyl amide 3-23f 
(576 mg, 96%) as a pale yellow oil.  1H NMR (500 MHz, toluene-d8, 60 °C) δ 5.27 (dq, J = 7.0, 
3.2 Hz, 1H), 5.09 (p, J = 7.0 Hz, 1H), 4.33 (d, J = 2.4 Hz, 2H), 3.73 (t, J = 5.8 Hz, 2H), 3.65 (t, 
J = 5.8 Hz, 2H), 1.85 (t, J =2.4 Hz, 1H), 1.51 (dd, J = 7.0, 3.2 Hz, 3H), 1.35 (s, 3H), 1.35 (s, 
3H);  13C NMR (75 MHz, toluene-d8, 60 °C) δ 203.1, 174.2, 98.8, 89.3, 80.4, 72.1, 61.8, 49.4, 
42.9, 38.7, 27.6, 26.1, 18.4, 13.9, -5.3; IR (thin film) ν 3311, 3240, 2930, 2120, 1961, 1642, 
1470, 1407, 1256, 1106, 837, 778 cm-1; MS m/z (%) 321 (8), 320 (34, M - 15), 278 (100), 240 
(31), 95 (82), 73 (79); EI-HRMS calcd for C18H30NO2Si m/z [M - 15+] 320.2046; found 
320.2043. 
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O
•
N
H
3-23g
O
 
N-((Furan-2-yl)methyl)-2,2-dimethyl-N-(prop-2-ynyl)hexa-3,4-dienamide 3-23g. According 
to General Procedure E, 3-19 (149 mg, 1.06 mmol) in THF (3.5 mL) was reacted with oxalyl 
chloride (0.12 mL, 1.4 mmol) and DMF (1 drop via syringe).  The resultant acid chloride was 
then reacted with amine 3-24g (215 mg, 1.59 mmol), triethylamine (0.44 mL, 3.2 mmol), and 4-
(dimethylamino)pyridine (13 mg, 0.11 mmol) in THF (16 mL) to afford propargyl amide 3-23g 
(216 mg, 79%) as a pale yellow oil. (Rf = 0.59, 30% ethyl acetate/hexanes); 1H NMR (300 MHz, 
toluene-d8, 60 °C) δ 7.05 (dd, J = 1.8, 0.8 Hz, 1H), 6.08–6.05 (m, 2H), 5.22 (dq, J = 7.0, 3.2 Hz, 
1H), 5.02 (p, J = 7.0 Hz, 1H), 4.76 (A of an ABq, J = 15.7 Hz, 1H), 4.69 (B of an ABq, J = 15.7 
Hz, 1H), 4.18 (A of an ABq, d, J = 17.7, 2.4 Hz, 1H), 4.11 (B of an ABq, d, J = 17.7, 2.4 Hz, 
1H), 1.94 (t, J = 2.4 Hz, 1H), 1.44 (dd, J = 7.0, 3.2 Hz, 3H), 1.33 (s, 6H); 13C NMR (75 MHz, 
toluene-d8, 60 °C) δ 203.1, 174.1, 151.7, 142.2, 110.6, 108.8, 98.7, 89.4, 79.8, 72.2, 43.1, 43.0, 
36.6, 27.6, 27.6, 13.8; IR (thin film) ν 3294, 3240, 2978, 2929, 2112, 1961, 1644, 1407, 1160, 
734 cm-1; MS m/z (%) 258 (14), 257 (60), 242 (48), 95 (40), 81 (100); EI-HRMS calcd for 
C16H19NO2 m/z [M+] 257.1416; found 257.1413. 
O
•
N
Bn
Me
3-23h  
N-Benzyl-N-(but-2-ynyl)-2,2-dimethylhexa-3,4-dienamide 3-23h.  According to General 
Procedure E, 3-19 (105 mg, 0.751 mmol) in THF (2.5 mL) was reacted with oxalyl chloride 
(0.08 mL, 0.98 mmol) and DMF (1 drop).  The resultant acid chloride was then reacted with 
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amine 3-24h (180 mg, 1.13 mmol), triethylamine (0.31 mL, 2.3 mmol), and 4-
(dimethylamino)pyridine (9 mg, 0.1 mmol) in THF (11 mL) to afford propargyl amide 3-23h 
(175 mg, 83%) as a pale yellow oil. (Rf = 0.38, 30% ethyl acetate/hexanes); 1H NMR (300 MHz, 
DMSO-d6, 60 °C) δ 7.35–7.21 (m, 5H), 5.43 (dq, J = 7.0, 3.2 Hz, 1H), 5.27 (p, J = 7.0, 1H), 
4.73 (A of an ABq, J = 15.5 Hz, 1H), 4.64 (B of an ABq, J = 15.5 Hz, 1H), 4.15 (A of an ABq, J 
= 17.3 Hz, 1H), 4.05 (B of an ABq, J = 17.3 Hz, 1H), 1.77 (s, 3H), 1.57 (dd, J = 7.0, 3.2 Hz, 
3H), 1.29 (s, 6H); 13C NMR (75 MHz, DMSO-d6, 60 °C) δ 201.9, 173.7, 137.0, 128.0, 126.9, 
126.6, 97.5, 88.7, 79.6, 74.3, 48.8, 41.9, 36.4, 27.0, 26.9, 13.2, 2.6; IR (thin film) ν 3027, 2976, 
2923, 2214, 1961, 1703, 1640, 1410, 1237, 1163 cm-1; MS m/z (%) 266 (22), 143 (5), 95 (17), 91 
(100); EI-HRMS calcd for C19H23NO m/z [M+] 281.1780; found 281.1776. 
O
•
N
Bn
3-23i OMe  
 N-Benzyl-N-(3-(4-methoxyphenyl)prop-2-ynyl)-2,2-dimethylhexa-3,4-dienamide 3-23e.   
According to General Procedure E, 3-19 (67 mg, 0.48 mmol) in THF (1.6 mL) was reacted with 
oxalyl chloride (0.05 mL, 0.62 mmol) and DMF (1 drop).  The resultant acid chloride was then 
reacted with amine 3-24i (180 mg, 0.72 mmol), triethylamine (0.20 mL, 1.4 mmol), and 4-
(dimethylamino)pyridine (6.0 mg, 0.05 mmol) in THF (7.2 mL) to afford propargyl amide 3-23i 
(156 mg, 88%) as a pale yellow oil. (Rf = 0.48, 30% ethyl acetate/hexanes); 1H NMR (300 MHz, 
DMSO-d6, 60 °C) δ 7.36 (m, 7H), 6.90 (d, J = 7.0 Hz, 2H), 5.48 (dq, J = 7.0, 3.2 Hz, 1H), 5.30 
(p, J = 7.0 Hz, 1H), 4.80 (A of an ABq, J = 15.6 Hz, 1H), 4.71 (B of an ABq, J = 15.6 Hz, 1H), 
4.42 (A of an ABq, J = 17.9 Hz, 1H), 4.31 (B of an ABq, J = 17.9 Hz, 1H), 3.76 (s, 3H), 1.58 
(dd, J = 7.0, 3.2 Hz, 3H), 1.32 (s, 6H); 13C NMR (75 MHz, DMSO-d6, 60 °C) δ 202.0, 173.9, 
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159.2, 137.0, 132.6, 128.1, 127.0, 126.7, 114.0, 113.8, 97.5, 88.7, 83.4, 83.3, 55.0, 49.4, 42.0, 
37.1, 27.1, 26.9, 13.2; IR (thin film) ν  2974, 2210, 1965, 1702, 1640, 1509, 1408, 1249, 1171, 
1031 cm-1; 374 (9), 373 (34), 358 (91), 282 (12), 145 (100); EI-HRMS calcd for C25H27NO2 m/z 
[M+] 373.2042; found 373.2039. 
2.) 3-35, DMAP, 
TEA, THF, rt, 18 h
•
O
OH
•
O
N
3-23k
1.) (COCl)2, cat. DMF, 
THF, rt, 3 h
3-19
TIPS
•
O
N
3-23j
TBAF, THF
0 °C
 
1-((S)-2-Ethynylpyrrolidin-1-yl)-2,2-dimethylhexa-3,4-dien-1-one 3-23j.  According to 
General Procedure E, 3-19 (43 mg, 0.31 mmol) in THF (1 mL) was reacted with oxalyl chloride 
(0.04 mL, 0.4 mmol) and DMF (1 drop via syringe).  The resultant acid chloride was then 
reacted with amine 3-35 (52 mg, 0.21 mmol), triethylamine (0.09 mL, 0.62 mmol), and 4-
(dimethylamino)pyridine (3.0 mg, 0.02 mmol) in THF (2 mL) to afford propargyl amide 3-23k 
(64 mg, 83%) as a pale yellow oil.  Amide 3-23k (54 mg, 0.15 mmol) is then dissolved in THF 
(0.5 mL) and cooled to 0 ºC.  A solution of TBAF (0.19 mL of a 1 M solution in THF) was then 
added and the reaction mixture was warmed to rt over 1.5 h.  The reaction mixture was then 
diluted with 30% ethyl acetate/hexanes solution, filtered through a pad of silica gel (10 mL 
fritted funnel approximately half full), and concentrated under vacuum.  The residue was 
chromatographed on silica gel (10% ethyl acetate/hexanes) to afford amide 3-23j as a colorless 
oil as a 1 : 1 mixture of diastereomers (29 mg, 87%). (Rf = 0.35, 30% ethyl acetate/hexanes); 1H 
NMR (300 MHz, DMSO-d6, 60 °C) δ 5.32–5.28 (m, 2H), 4.71 (bs, 1H), 3.64–3.50 (m, 2H), 2.94 
(s, 1H), 1.99–1.88 (m, 4H), 1.64 (d, J = 5.1 Hz, 1.5), 1.62 (d, J = 5.1 Hz, 1.5), 1.22 (dd, 6H); 13C 
NMR (75 MHz, DMSO-d6, 60 °C) δ 202.2, 172.1, 96.9, 88.2, 84.4, 71.6, 48.4, 46.4, 46.3, 42.0, 
31.3, 26.1, 25.8, 13.3; IR (thin film) ν 3233, 2975, 2929, 2110, 1962, 1630, 1391 cm-1; MS m/z 
  
 121 
(%) 216 (12), 203 (11), 202 (77), 174 (29), 147 (36), 122 (84), 77 (100); EI-HRMS calcd for 
C14H19NO m/z [M - 15+] 202.1232; found 202.1233. 
Secondary Propargyl Amines 3-24f and 3-24i. 
All secondary amines were prepared using a known procedure.87  Propargyl amines that were not 
commercially available were characterized. 
3-24f
HN
H
OTBS
H2N
OTBS
Br
NaI, NEt3
THF, reflux
E3-2  
N-(2-t-butyldimethylsilyloxyethyl)prop-2-yn-1-amine 3-24f. In a manner analogous to 
Hsung;h to a solution of amine E3-2 (2.05 g, 11.7 mmol), sodium iodide (176 mg, 1.17 mmol), 
and triethylamine (4.90 mL, 35.0 mmol) in THF (115 mL) was added propargyl bromide (1.24 
mL, 80% wt. solution in toluene, 11.1 mmol).  The mixture was heated to reflux for ~ 18 h when 
no starting material was observed by TLC.  The mixture was diluted with ether (100 mL), 
filtered through celite (150 mL fritted filter approximately half full), and the filtrate concentrated 
under vaccum.  The residue was chromatographed on silica gel (30% ethyl acetate/hexanes to 
100% ethyl acetate) to afford 3-24f (570 mg, 24%) as a pale yellow oil.  (Rf = 0.44, ethyl 
acetate); 1H NMR (CDCl3, 300 MHz) δ 3.64 (t, J = 5.2 Hz, 2H), 3.35 (d, J = 2.4 Hz, 2H), 2.69 
(t, J = 5.2 Hz, 2H), 2.13 (t, J = 2.4 Hz, 1H), 1.56 (bs, 1H), 0.80 (s, 9H), -0.03 (s, 6H);  13C NMR 
(75 MHz, CDCl3) δ 82.1, 71.2, 62.3, 50.5, 38.1, 25.9, 18.2, -5.4; IR (thin film) ν 3311, 2955, 
2930, 2857, 2104, 1463, 1256, 1106, 836, 777 cm-1; MS m/z (%) 157 (18, M – (t-Bu)), 156 
(100), 130 (72), 68 (100); EI-HRMS calcd for C7H14NOSi m/z 156.0845 [M - (t -Bu)+]; found 
156.0838. 
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2. BnNH2, NaI, NEt3
THF, reflux 3-24i
HN
Bn
OMe
E3-3
HO
OMe
1. MsCl, Net3, THF
 
N-benzyl-3-(4-methoxyphenyl)prop-2-yn-1-amine 3-24i. To a solution of alcohol E3-388 (507 
mg, 3.13 mmol) and triethylamine (0.61 mL, 4.4 mmol) in THF (16 mL) at 0 ºC was added 
methane sulfonylchloride (0.29 mL, 3.8 mmol).  The reaction mixture warmed slowly to room 
temperature over 2 h and then diluted with EtOAc (30 mL).  The layers were separated and the 
organic layer was washed with brine (2x).  The organic layer was dried over MgSO4, filtered, 
and concentrated under vacuum to afford the mesylate (747 mg, 99%) as a yellow oil that was 
immediately used in the next step.  The mesylate (747 mg, 3.11 mmol) was dissolved in THF (39 
mL), and added via cannula to a 100 mL round bottomed flask containing sodium iodide (47.0 
mg, 0.311 mmol).  Benzyl amine (0.430 mL, 3.89 mmol) and triethylamine (1.30 mL, 9.33 
mmol) were added and the solution heated to reflux for ~ 18 h when no starting material was 
observed by TLC.  The mixture was diluted with ether (100 mL), filtered through celite (150 mL 
fritted filter approximately half full), and the filtrate concentrated under vaccum.  The residue 
was chromatographed on silica gel (40% ethyl acetate/hexanes) to afford 3-24i (200 mg, 26%) as 
a pale yellow oil.  1H NMR (CDCl3, 300 MHz) δ 7.45–7.27 (m, 7H), 6.87 (d, J = 8.8 Hz, 2H), 
3.96 (s, 2H), 3.79 (s, 3H), 3.66 (s, 2H), 1.64 (br, s, 1H); 13C NMR (75 MHz, CDCl3) δ 159.2, 
139.5, 132.8, 128.1, 126.8, 115.2, 113.7, 85.9, 83.3, 54.9, 52.3, 38.1;  IR (thin film) ν 3306, 
3031, 2837, 2230, 1606, 1509, 1246, 1031, cm-1; MS m/z (%) 251 (61), 250 (69), 236 (7), 174 
(31), 145 (81), 91 (100); EI-HRMS calcd for C17H16NO m/z [M - H+] 250.1232; found 250.1234. 
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HN
H
O
OH
•
3-19
O
O
•
O
O N
H
3-25
Cl
O
O
O
O
THF
-10 °C to rt
THF
O N
3-24a
 
Isobutyl benzylprop-2-ynylcarbamate 3-25.  To a solution of allenic acid 3-18 (92.0 mg, 0.66 
mmol) in THF (2.6 mL) at -10 °C was added N-methylmorpholine (80 μL, 0.72 mmol) and 
isobutyl chloroformate (95 μL, 0.72 mmol).  The resultant cloudy brown suspension was stirred 
for 5 min then amine 3-24a (110 mg, 0.76 mmol) in a solution of THF (0.6 mL) was added via 
syringe.  The resultant white suspension was allowed to stir for 1 h and then the reaction was 
quenched with sat’d aqueous NaHCO3 (0.8 mL).  The reaction mixture was diluted with enough 
water to dissolve the salts and the layers were separated.  The aqueous layer was extracted with 
ether (3x) and the combined organic layers were dried over MgSO4, filtered, and concentrated 
under vacuum.  The crude residue was chromatographed on silica gel (10% ethyl 
acetate/hexanes) to afford the product 3-25 as a clear, colorless oil (163 mg, 100%).  1H NMR 
(300 MHz, DMSO-d6, 60 °C) δ 7.36–7.24 (m, 5H), 4.53 (s, 2H), 4.03 (d, J = 2.4 Hz, 2H), 3.88 
(d, J = 6.4 Hz, 2H), 3.03 (t, J = 2.4 Hz, 1H), 1.91 – 1.86 (m, 1H), 0.88 (d, J = 6.6 Hz, 6H); 13C 
NMR (75 MHz, DMSO-d6, 60 °C) δ 155.0, 137.0, 128.0, 127.1, 126.8, 79.1, 73,7, 71.0, 49.2, 
35.6, 27.2, 18.4; IR (thin film) ν 3293, 3250, 2962, 2874, 2116, 1701, 1237, 769, 699 cm-1; MS 
m/z (%) 246 (16), 245 (56), 206 (14), 188 (37), 150 (88), 91 (100); EI-HRMS calcd for 
C15H19NO2 m/z [M]+ 245.1416; found 245.1412. 
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ε-Lactams 3-26. 
O
•
N
R2
R3
3-23
[Rh(CO)2Cl]2
10 mol%
toluene, 50 °C, 
1.5 - 2 h
N
O
R2
R3
3-26  
General Procedure D: Preparation of 3-26 
N
O
3-26g
O
 
(Z)-1-((Furan-2-yl)methyl)-6,7-dihydro-3,3-dimethyl-6-methylene-5-vinyl-1H-azepin-
2(3H)-one 3-26g.  A solution of amide 3-23g (96 mg, 0.37 mmol) in toluene (7.5 mL, 0.05 M) 
was degassed by bubbling argon through the solution for 20 min.  Rhodium biscarbonylchloride 
dimer (15 mg, 0.04 mmol) was then added all at once and the reaction flask immediately 
immersed in an oil bath preheated to 50 °C.  The reaction was stirred for 1.5 h.  The reaction 
mixture was cooled to rt and diluted with a solution of 30% ethyl acetate/hexanes.  This solution 
was filtered through a pad of silica gel (30 mL fritted funnel approximately half full), eluting 
with 30% ethyl acetate/hexanes solution.  The solvent was removed under vacuum and the 
residue was chromatographed on silica gel (10% ethyl acetate/hexanes) to afford lactam 3-26g 
(60 mg, 63%) as a clear oil that solidifies in the freezer. (Rf = 0.50, 30% ethyl acetate/hexanes); 
1H NMR (CDCl3, 300 MHz) δ 7.34–7.33 (m, 1H), 6.34 (dd, J = 17.0, 10.7 Hz, 1H), 6.31–6.23 
(m, 2H), 5.63 (s, 1H), 5.32 (dd, J = 17.0, 1.7 Hz, 1H), 5.08 (dd, J = 10.7, 1.7 Hz, 1H), 5.07 (s, 
1H), 4.96 (s, 1H), 4.63 (s, 2H), 4.02 (s, 2H), 1.46 (s, 6H);  13C NMR (75 MHz, CDCl3) δ 175.1, 
151.2, 141.9, 139.1, 137.8, 137.2, 135.1, 116.2, 115.9, 110.3, 108.4, 52.3, 44.6, 43.9, 28.9;  IR 
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(thin film) ν 3115, 2981, 2959, 1632, 1477, 923 cm-1; MS m/z (%) 258 (5), 257 (32), 187 (24), 81 
(100); EI-HRMS calcd for C16H19NO2 m/z [M+] 257.1420; found 257.1416. 
N
O
Bn
3-26a  
(Z)-1-Benzyl-6,7-dihydro-3,3-dimethyl-6-methylene-5-vinyl-1H-azepin-2(3H)-one 3-26a. 
According to General Procedure D, 3-23a (108 mg, 0.403 mmol) in toluene (8 mL, 0.05 M) was 
reacted with [Rh(CO)2Cl]2 (16 mg, 0.04 mmol).  Isolated yield (69 mg, 65%) as a clear oil that 
solidifies in the freezer. (Rf = 0.41, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 
7.35–7.24 (m, 5H), 6.36 (dd, J = 17.0, 10.6 Hz, 1H), 5.69 (s, 1H), 5.36 (d, J = 17.0 Hz, 1H), 
5.12 (d, J = 10.6 Hz, 1H), 5.09 (s, 1H), 4.95 (s, 1H), 4.68 (s, 2H), 3.93 (s, 2H), 1.52 (s, 6H); 13C 
NMR (75 MHz, CDCl3) δ 175.4, 139.1, 137.7, 137.6, 137.2, 135.3, 128.4, 128.0, 127.2, 116.3, 
115.9, 52.5, 50.8, 44.5, 29.0; IR (thin film) ν 3081, 3023, 2973, 2925, 2860, 1641 cm-1;  MS m/z 
(%) 268 (25), 267 (88), 252 (25), 240 (5), 197 (62), 176 (11), 119 (60), 91 (100); ESI-HRMS 
calcd for C18H21NO m/z [M+] 267.1623; found 267.1628. 
N
O
3-26f
OTBS
 
(Z)-6,7-Dihydro-1-(2-t-butyldimethylsilyloxyethyl)-3,3-dimethyl-6-methylene-5-vinyl-1H-
azepin-2(3H)-one 3-26f. According to General procedure D, 3-23f (101 mg, 0.302 mmol) in 
toluene (6 mL, 0.05 M) was reacted with [Rh(CO)2Cl]2 (12 mg, 0.03 mmol).  Reaction time was 
2 h.  Isolated yield (67 mg, 67%) as a clear oil that solidifies in the freezer.  1H NMR (CDCl3, 
300 MHz) δ 6.35 (dd, J = 17.0, 10.6 Hz, 1H), 5.62 (s, 1H), 5.32 (d, J = 17.0 Hz, 1H), 5.14–5.07 
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(m, 3H), 4.13 (s, 2H), 3.75 (t, J = 5.5 Hz, 2H), 3.54 (t, J = 5.5 Hz, 2H), 1.44 (s, 6H), 0.89 (s, 
9H), 0.05 (s, 6H);  13C NMR (75 MHz, CDCl3) δ 174.9, 139.7, 137.8, 137.1, 135.2, 116.2, 115.5, 
61.6, 55.2, 51.4, 44.4, 29.0, 25.8, 18.1, -5.5;  IR (thin film) ν 3085, 2955, 2929, 2857, 1644, 
1473, 1252, 1104, 836 cm-1;  MS m/z (%) 336 (4), 335 (17), 320 (6), 279 (22), 278 (100), 204 
(3), 73 (53); ESI-HRMS calcd for C19H33NO2Si m/z [M+] 335.2281; found 335.2278. 
N
O
Bn
3-26h  
(4Z,6Z)-1-Benzyl-6-ethylidene-6,7-dihydro-3,3-dimethyl-5-vinyl-1H-azepin-2(3H)-one        
3-26h. According to General procedure D, 3-23h (42 mg, 0.15 mmol) in toluene (3 mL, 0.05 M) 
was reacted with [Rh(CO)2Cl]2 (5.9 mg, 0.015 mmol).  Isolated yield (21 mg, 50%) as a clear oil 
that solidifies in the freezer. (Rf = 0.28, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) 
δ 7.36–7.25 (m, 5H), 6.32 (dd, J = 17.0, 10.5 Hz, 1H), 5.69 (q, J = 7.0 Hz, 1H), 5.55 (s, 1H), 
5.32 (d, J = 17.0 Hz, 1H), 5.09 (d, J = 10.5 Hz, 1H), 4.68 (s, 2H), 3.99 (s, 2H), 1.68 (d, J = 7.0 
Hz, 3H), 1.51 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 176.0, 139.1, 138.6, 137.9, 133.0, 132.4, 
128.6, 127.7, 127.2, 126.1, 116.2, 51.3, 45.0, 44.6, 29.3, 22.6, 13.9; IR (thin film) ν 3081, 3023, 
2972, 2928, 2856, 1641 cm-1; MS m/z (%) 282 (5), 281 (35), 280 (3), 266 (5), 211 (25), 133 (39), 
91 (100); ESI-HRMS calcd for C19H23NO m/z [M]+ 281.1780; found 281.1774. 
N
O
Bn
3-26i
OMe
 
(4Z,6Z)-6-(4-Methoxybenzylidene)-1-benzyl-6,7-dihydro-3,3-dimethyl-5-vinyl-1H-azepin-
2(3H)-one 3-26i.  According to General Procedure D, 3-23i (62 mg, 0.17 mmol) in toluene (3.3 
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mL, 0.05 M) was reacted with [Rh(CO)2Cl]2 (6.4 mg, 0.017 mmol).  Isolated yield (40 mg, 65%) 
as a clear oil that solidifies in the freezer. (Rf = 0.40, 30% ethyl acetate/hexanes); 1H NMR 
(CDCl3, 300 MHz) δ 7.20–7.18 (m, 3H), 7.08 (d, J = 8.6 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 
6.78–6.76 (m, 2H), 6.71 (s, 1H), 6.45 (dd, J = 17.0, 10.5 Hz, 1H), 5.72 (s, 1H), 5.41 (dd, J = 
17.0, 1.6 Hz, 1H), 5.17 (dd, J = 10.5, 1.6 Hz, 1H), 4.30 (s, 2H), 4.12 (s, 2H), 3.87 (s, 3H), 1.53 
(s, 6H);  13C NMR (75 MHz, CDCl3) δ 175.7, 158.9, 139.2, 138.5, 137.6, 134.7, 132.8, 130.7, 
129.9, 129.4, 128.5, 128.2, 128.1, 127.0, 116.7, 113.9, 55.3, 50.5, 44.9, 44.4, 29.0; IR (thin film) 
ν 3023, 2970, 2929, 1642, 1509, 1249, 1033 cm-1; MS m/z (%) 374 (19), 373 (68), 372 (4), 304 
(22), 303 (95), 225 (48), 121 (43), 91 (100); EI-HRMS calcd for C25H27NO2 m/z [M+] 373.2042; 
found 373.2040. 
N
O
3-26j  
(Z)-2,3,9,9a-Tetrahydro-6,6-dimethyl-9-methylene-8-vinyl-1H-pyrrolo[1,2-a]azepin-5(6H)-
one 3-23j.  According to General Procedure D, 3-23j (28 mg, 0.13 mmol) in toluene (2.5 mL, 
0.05 M) was reacted with [Rh(CO)2Cl]2 (5.0 mg, 0.013 mmol).  Isolated yield (17 mg, 62%) as a 
clear oil that solidifies in the freezer. (Rf = 0.18, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 
300 MHz) δ 6.32 (dd, J = 17.1, 10.6 Hz, 1H), 5.60 (s, 1H), 5.31 (dd, J = 17.0, 1.6 Hz, 1H), 5.24 
(s, 1H), 5.17 (s, 1H), 5.08 (dd, J = 10.5, 1.6 Hz, 1H), 4.54 (dd, J = 7.3, 4.2 Hz, 1H), 3.71–3.63 
(m, 1H), 3.58–3.49 (m, 1H), 2.31–2.08 (m, 2H), 1.97–1.80 (m, 2H), 1.43 (s, 3H), 1.38 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 173.8, 142.2, 139.0, 137.9, 135.3, 115.8, 113.0, 58.6, 47.8, 44.0, 
30.8, 29.6, 26.7, 22.5; IR (thin film) ν 3090, 2972, 2879, 1634, 1426 cm-1; MS m/z (%) 217 (41), 
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202 (24), 147 (66), 146 (56), 86 (87), 84 (100); EI-HRMS calcd for C14H19NO m/z [M+] 
217.1467; found 217.1464. 
Trienyl Azepines 3-27 
N
O
R1
R2
3-26
LiAlH4
Et2O, 0 °C to rt
N
R1
R2
3-27  
General Procedure F: Preparation of 3-27f 
N
3-27f
OTBS
 
(Z)-2,3,6,7-Tetrahydro-1-(2-dimethyl-t-butoxysilylethyl)-3,3-dimethyl-6-methylene-5-vinyl-
1H-azepine 3-26f.  To a suspension of LiAlH4 (29 mg, 0.76 mmol) in diethyl ether (3.8 mL) at 0 
°C was added caprolactam 3-26f (R1 = (CH2)2OTBS, R2 = H) (64 mg, 0.19 mmol) in a solution 
of diethyl ether (0.6 mL) via syringe.  After 5 min the ice bath was removed and the reaction 
allowed to warm to rt.  After 1.5 h, an absence of starting material was observed by TLC and the 
reaction was quenched slowly via syringe by sequential addition of H2O (0.06 mL), 10% NaOH 
solution (0.12 mL), and sat’d aqueous KF solution (0.24 mL).  This resulted in precipitation of a 
white, granular solid.  The mixture was dried over MgSO4, celite was added, and the whole 
mixture filtered through a pad of silica gel (10 mL fritted funnel, approximately 30% full).  The 
solvent was removed under vacuum to give 3-27f (45 mg, 74%) as a clear oil without further 
purification.  The product solidified in the freezer.  (Rf = 0.58, 30% ethyl acetate/hexanes); 1H 
NMR (CDCl3, 300 MHz) δ 6.28 (dd, J = 17.1, 10.5 Hz, 1H), 5.37 – 5.20 (m, 3H), 5.00 (s, 1H), 
4.95 (d, J = 10.5 Hz, 1H), 3.73 (t, J = 6.6 Hz, 2H), 3.37 (s, 2H), 2.72 (t, J = 6.6 Hz, 2H), 2.52 (s, 
2H), 1.04 (s, 6H), 0.90 (s, 9H), 0.06 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 142.0, 140.5, 139.6, 
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136.8, 117.6, 113.0, 63.9, 63.7, 61.7, 60.6, 38.7, 28.2, 25.9, 18.2, -5.3; IR (thin film) ν 3081, 
2954, 2928, 2857, 1605, 1471, 1255, 1102, 836, 775 cm-1; MS m/z (%) 323 (6), 322 (9), 321 
(21), 265 (17), 176 (100); ESI-HRMS calcd for C19H36NOSi m/z [M + H+] 322.2566; found 
322.2572. 
N
Bn
3-27a  
(Z)-1-Benzyl-2,3,6,7-tetrahydro-3,3-dimethyl-6-methylene-5-vinyl-1H-azepine 3-27a.  
According to General Procedure F, 3-26a (59 mg, 0.22 mmol) in diethyl ether (0.75 mL) was 
reacted with lithium aluminum hydride (34 mg, 0.88 mmol) to afford 3-27a (34 mg, 60%). (Rf = 
0.73, 30% ethyl acetate/hexanes) 1H NMR (CDCl3, 300 MHz) δ 7.43 – 7.26 (m, 5H), 6.34 (dd, J 
= 17.2, 10.6 Hz, 1H), 5.50 (s, 1H), 5.29 (d, J = 17.2, 1H), 5.28 (s,1H), 5.08 (s, 1H), 5.01 (d, J = 
10.6 Hz, 1H), 3.73 (s, 2H), 3.26 (s, 2H), 2.50 (s, 2H), 1.07 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 
142.0, 140.7, 139.6, 137.4, 128.9, 128.1, 126.8, 117.9, 113.2, 64.1, 63.3, 62.9, 37.1, 28.3; IR 
(thin film) ν 3085, 3026, 2955, 2864, 2786, 1609, 1453, 904, 739, 698 cm-1; MS m/z (%) 253 
(44), 238 (42), 197 (53), 119 (52), 91 (100); ES-HRMS calcd for C17H20NO m/z [M - 15+] 
238.1596; found 238.1599. 
N
H TIPS
3-35
N
3-33
Boc
1. n-BuLi, TIPSCl, 
THF, -78 °C
2. 50% TFA / DCM
 
(S)-2-(2-(Triisopropylsilyl)ethynyl)pyrrolidine 3-35.  To a solution of Boc-protected amine   
3-33 (209 mg, 1.1 mmol) in THF (11 mL) at -78 ºC was added n-butyl lithium (0.77 mL of a    
1.6 M solution in hexanes, 1.2 mmol).  The resultant brown solution was stirred for 30 min then 
a solution of TIPSCl (350 μL, 1.6 mmol) in THF (8 mL) was added via syringe.  After 1 h the 
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reaction mixture was allowed to warm to rt and a sat’d, aqueous solution of NH4Cl (2 mL) was 
added.  The reaction mixture was partitioned between ether and water and the layers separated.  
The aqueous phase was extracted with ether and the combined organic layers dried over MgSO4, 
filtered, and concentrated under vacuum.  The residue was chromatographed on silica gel (5% 
ethyl acetate/hexanes) to afford the TIPS protected alkyne (342 mg, 91%).  The alkyne (342 mg, 
1.07 mmol) was then redissolved in CH2Cl2 (2.5 mL) and trifluoroacetic acid (2.5 mL) was 
added.   After 20 min the reaction mixture was quenched with sat’d, aqueous Na2CO3 (10 mL) 
then diluted with ether and water and the layers separated.  The organic layer was washed with 
sat’d aqueous Na2CO3 (10 mL) and the combined aqueous layers were extracted with ether.  The 
combined organic layers were dried over MgSO4, filtered and concentrated under vacuum.  The 
residue was chromatographed on silica gel (40% ethyl acetate/hexanes) to give the product 3-35 
(128 mg, 48% from 3-33). (Rf = 0.12, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 
3.87 (dd, J = 7.2, 4.7 Hz, 1H), 3.15–3.09 (m, 1H), 2.95–2.89 (m, 1H), 2.17 (bs, 1 H), 2.10–1.71 
(m, 4H), 1.06 (s, 3H) 1.05 (s, 18H); 13C NMR (75 MHz, CDCl3) δ 1110.5, 82.5, 49.5, 45.8, 33.4, 
24.5, 18.6, 11.1;  IR (thin film) ν 3266, 2943, 2866, 2160, 1463, 883 cm-1; MS m/z (%) 252 (7), 
251 (29), 209 (47), 208 (100), 180 (15), 83 (36); EI-HRMS calcd for C15H29NSi m/z [M+] 
251.2069; found 251.2069. 
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5.5 EXPERIMENTAL: CHAPTER 4 
N
H
NHBz
O
OH
HO
DCC, DMAP,
CH2Cl2, THF N
H
NHBz
O
O
E4-1 4-21a
N
H
O
O
4-20
N NEt3, THF
HO
 
Prop-2-ynyl 2-(benzamido)-3-(1H-indol-3-yl)propanoate 4-21a.  To a solution of propargyl 
alcohol (1.73 mL, 29.7 mmol), dicyclohexylcarbodiimide (5.10 g, 24.7 mmol), and 4-
dimethylaminopyridine (152 mg, 1.24 mmol) in CH2Cl2 (150 mL) was added a solution of E4-1 
(7.62 g, 24.7 mmol) in THF : CH2Cl2 (1 : 1) (82 mL) via cannula over 5-10 min.  The resultant 
suspension was stirred for 16 h overnight until no starting material was evident by TLC (Rf 4-20 
= 0.28, 30% ethyl acetate/hexanes).  The mixture was filtered through a pad of silica gel (150 mL 
fritted funnel approximately half full) eluting with 250 mL of a 50% ethyl acetate/hexanes 
solution and the filtrate concentrated under vacuum.  The residue (crude 4-20, assumed 100% 
from E4-1) was dissolved in THF (40 mL) and to this solution was added propargyl alcohol 
(0.87 mL, 12.4 mmol) and triethylamine (7 mL, 50.4 mmol).  The solution was stirred for 1 h, 
when full conversion to the product from the intermediate oxazolidinone was observed by TLC.  
The reaction mixture was filtered through celite (150 mL fritted funnel approximately half full), 
eluting with ethyl acetate, and the filtrate concentrated under vacuum.  The crude residue was 
chromatographed on silica gel (30% to 50% ethyl acetate/hexanes) to afford 4-21a (6.82 g, 84%) 
as an amorphous, brown solid. (Rf = 0.15, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 
MHz) δ 8.49 (bs, 1H), 7.68 (d, J = 7.2 Hz, 2H), 7.59 (d, J = 7.8 Hz, 1H), 7.50 – 7.45 (m, 1H), 
7.39 – 7.34 (m, 3H), 7.20 (dt, J = 6.9, 0.9 Hz, 1H), 7.09 (dt, J = 6.9, 0.9 Hz, 1H), 7.05 (d, J = 2.9 
Hz, 1H), 6.73 (d, J = 7.8 Hz, 1H), 5.21 (dt, J = 7.8, 5.1 Hz, 1H), 4.77 (A of an ABq, d, J = 15.6, 
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2.4 Hz, 1H), 4.67 (B of an ABq, d, J = 15.6, 2.4 Hz, 1H), 3.49 (d, J = 5.1 Hz, 2H), 2.54 (t, J = 
2.4 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 171.1, 167.0, 136.1, 133.6, 131.7, 128.5, 127.6, 
127.0, 123.1, 122.2, 119.7, 118.5, 111.4, 109.5, 77.1, 75.5, 53.5, 52.8, 27.4; IR (thin film) ν 
3412, 3293, 3057, 2932, 2129, 1745, 1648, 1521, 1182, 743 cm-1; MS m/z (%) 347 (15), 346 
(64), 325 (13), 225 (29), 130 (100); EI-HRMS calcd for C21H18N2O3 m/z [M+] 346.1317; found 
346.1391. 
N
H
NHBz
•
OO
N
H
NHBz
O
O NEt3, CCl4, PPh3
4-21a rac-4-22a
N
H
O
O
N
MeOH, NEt3
CH3CN
•
E4-2  
Methyl 2-((1H-indol-3-yl)methyl)-2-(benzamido)penta-3,4-dienoate rac-4-22a.89 
To a solution of propargyl ester 4-21a (6.33 g, 18.3 mmol) in freshly distilled CH3CN (91 mL) 
was added triethylamine (10.7 mL, 76.7 mmol), carbon tetrachloride (6.2 mL, 64.0 mmol), and 
triphenylphosphine (14.7 g, 56.6 mmol).  The reaction mixture was stirred for 20 h until no 
starting material was evident by TLC (Rf E4-2 = 0.59, 30% ethyl acetate/hexanes).  The mixture 
was poured into a solution of ether : hexanes (350 mL : 100 mL) and the yellow/white solid 
precipitate was removed by vacuum filtration through celite (150 mL fritted funnel 
approximately half full).  The filtrate was concentrated under vacuum and the residue dissolved 
in a solution of methanol (150 mL) and triethylamine (15 mL).  The reaction mixture was stirred 
for another 20 h when TLC showed full conversion from E4-2 to the product and an impurity 
spot (Rf = 0.35, 30% ethyl acetate/hexanes).  The solvent was removed under vacuum and the 
residue chromatographed on silica gel (25% ethyl acetate/ hexanes) to afford pure rac-4-22a 
(664 mg, ~10%), and rac-4-22a contaminated with triphenylphosphine oxide (> 8 g, mass ratio ~ 
29% based upon isolated product.  See below).  The contaminated material was dissolved in 
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ether and stored in a freezer (-20 °C) overnight.  The mixture was filtered through celite (150 mL 
fritted funnel approximately half full) to remove precipitated triphenylphosphine oxide and the 
filtrate concentrated under vacuum.  The residue was chromatographed on silica gel (40% to 
50% ether/pentane) to afford pure 4-22a (2.35 g, 36%) as an amorphous, off-white solid.  
[Performing the reaction on 1.25 g of 4-21a affords 673 mg (52%) of rac-4-22a and the second 
triphenylphosphine oxide precipitation step was not necessary.] (Rf = 0.31, 30% ethyl 
acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 8.49 (bs, 1H), 7.66 (d, J = 7.8 Hz, 2H), 7.62 (d, 
J = 7.8 Hz, 2H), 7.49 – 7.44 (m 1H), 7.37 (d, J = 7.8 Hz, 2H), 7.32 (d, J = 7.8 Hz, 1H), 7.15 (t, J 
= 7.8 Hz, 1H), 7.06 (t, J = 7.8 Hz, 1H), 6.97 (d, J = 3.0 Hz, 1H), 6.96 (s, 1H), 5.79 (t, J = 6.6 Hz, 
1H), 4.95 (dd, J = 11.1, 6.6 Hz, 1H), 4.85 (dd, J = 11.1, 6.6 Hz, 1H), 3.90 (A of an ABq, J = 14.7 
Hz, 1H), 3.76 (s, 3H), 3.70 (B of an ABq, J = 14.7 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 207.1, 
172.5, 166.6, 135.8, 134.5, 131.5, 128.5, 127.9, 126.9, 124.0, 121.8, 119.5, 118.8, 111.2, 109.2, 
93.2, 79.7, 62.9, 52.9, 31.0; IR (thin film) ν 3404, 3325, 3057, 2950, 1958, 1736, 1655, 1515, 
1484, 1248, 1099, 739 cm-1; MS m/z (%) 361 (12), 360 (35), 255 (25), 240 (62), 239 (98), 105 
(100); EI-HRMS calcd for C22H20N2O3 m/z [M+] 360.1474; found 360.1471. 
1. Et3OBF4, 
CH2Cl2, reflux, 5 h
2. 1:1 THF : 5% 
AcOH, 18 h N
H
NH2
•
OO
rac-4-22a 4-23
N
H
NHBz
•
OO
 
Methyl 2-((1H-indol-3-yl)methyl)-2-aminopenta-3,4-dienoate 4-23.  To a solution of 4-22a 
(1.00 g, 2.77 mmol) in CH2Cl2 (2.8 mL) was added Et3OBF4 (9.90 mL of a 1.4 M solution in 
CH2Cl2, 13.9 mmol).90  The mixture was heated to reflux (cold finger) for 5 h when no starting 
material was evident by TLC (baseline iminium salt intermediate and impurity Rf = 0.78, 60% 
ethyl acetate/hexanes).  The reaction mixture was cooled to room temperature then concentrated 
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under vacuum.  The residue was dissolved in THF (2.5 mL) and 5% aqueous acetic acid (2.5 
mL) and stirred open to the atmosphere at room temperature for 16 h.  The mixture was 
quenched with sat’d K2CO3 and stirred for 5 – 10 min then diluted with ethyl acetate and water.  
An emulsion forms that dissipates over ~ 5 min.  The layers were separated and the aqueous 
layer was extracted with ethyl acetate (3x) and the combined organic layers were washed with 
brine (1x), dried over MgSO4, filtered, and concentrated under vacuum.  The residue was 
chromatographed on silica gel (20% to 40% to 80% ethyl acetate/hexanes) to afford 4-23 (421 
mg, 59%) as a viscous, red/brown oil.  Yields consistently ranged from 36% to 46% when using 
less than 1 g of starting benzamide rac-4-22a. (Rf = 0.08, 60% ethyl acetate/hexanes); 1H NMR 
(CDCl3, 300 MHz) δ 8.38 (bs, 1H), 7.66 (d, J = 7.5 Hz, 1H), 7.34 (d, J = 7.5 Hz, 1H), 7.18 (dt, J 
= 7.5, 1.2 Hz, 1H), 7.12 (dt, J = 7.5, 1.2 Hz, 1H), 7.06 (d, J = 2.1 Hz, 1H), 5.62 (t, J = 6.6 Hz, 
1H), 4.96 (d, J = 6.6 Hz, 2H), 3.69 (s, 3H), 3.46 (A of an ABq, J = 14.1 Hz, 1H), 3.14 (B of an 
ABq, J = 14.1 Hz, 1H), 1.92 (bs, 2H); 13C NMR (75 MHz, CDCl3) δ 206.5, 175.5, 135.9, 128.0, 
123.6, 122.0, 119.5, 119.2, 111.1, 110.0, 96.4, 79.4, 61.1, 52.4, 35.7; IR (thin film) ν 3365, 3176, 
3057, 2950, 2872, 1956, 1732, 1242, 1203, 859, 744 cm-1; MS m/z (%) 256 (74), 239 (37), 196 
(16), 130 (100); EI-HRMS calcd for C15H16N2O2 m/z [M+] 256.1212; found 256.1215. 
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H
O
R
4Å mol sieves, 
TFA (1 eq), CH2Cl2, rt NH
NH
•
OO
R
N
H
NH2
•
OO
4-23
R = p-C6H4F or propyl
4-24  
Allenic Tetrahydro-β-Carbolines 4-24. 
General Procedure I: Preparation of 4-24b. 
N
H
NH
•
OO
4-24b
F  
Methyl 1-(4-fluorophenyl)-2,3,4,9-tetrahydro-3-(propa-1,2-dienyl)-1H-pyrido[3,4-b]indole-
3-carboxylate 4-24b.  To a solution of 4-23 (204 mg, 0.79 mmol) in CH2Cl2 (7.9 mL, use 
MeOH for formation of 4-24a, see below) was added and activated powdered 4 Å molecular 
sieves (373 mg, 470 mg/mmol), p-fluorobenzaldehyde (0.09 mL, 0.83 mmol), and trifluoroacetic 
acid (0.06 mL, 0.79 mmol).  The reaction mixture was stirred for 3 h when an absence of starting 
material was observed by TLC.  The mixture was quenched with sat’d NaHCO3 (~ 2 – 3 mL) 
and stirred for 5 min. (Alternatively, the molecular sieves can be removed by gravity filtration 
through filter paper prior to NaHCO3 workup with no change in yield).  The layers were 
separated and the aqueous layer extracted with CH2Cl2 (3x).  The combined organic layers were 
washed with water (1x) and brine (1x), dried over MgSO4, filtered, and concentrated under 
vacuum.  The residue was chromatographed on silica gel (10% to 20% ethyl acetate hexanes; the 
residual p-fluorobenzaldehyde can be observed by UV on the TLC plate and removed) to afford 
4-24b (200 mg, 70%) in a 2 : 1 mixture of diastereomers as an amorphous white solid.  *Denotes 
minor diastereomer.  (Rf  = 0.44, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 7.57 
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– 7.55 (m, 1H), 7.41 – 7.37 (m, 3H), 7.25 – 7.02 (m, 5H), *5.48 (t, J = 6.6 Hz, 0.3H), *5.43 (bs, 
0.3H), 5.35 (t, J = 6.6 Hz, 0.7H), 5.24 (bs, 0.7H), *5.01 (d, J = 6.6 Hz, 0.7H), 4.92 (dd, J = 11.4, 
6.6 Hz, 0.7H), 4.73 (dd, J = 11.1, 6.6 Hz, 0.7H), 3.83 (s, 2.1H), *3.66 (s, 0.9H), *3.64 (A of an 
ABq, d, J = 15.3, 2.7 Hz, 0.3H), 3.28 – 3.26 (m, 1.3H), *3.04 (B of an ABq, d, J = 15.3, 2.7 Hz, 
0.3H), 2.80 (bs, 0.7H), *2.65 (bs, 0.3H); 13C NMR (75 MHz, CDCl3) δ 207.9, *206.9, *174.2, 
173.5, 162.8 (d, JCF = 245.3 Hz), *137.7 (d, JCF = 3.0 Hz), 136.8 (d, JCF = 3.0 Hz), *133.6, 
133.4, 130.5 (d, JCF = 8.3 Hz), *130.3 (d, JCF = 8.3 Hz), 127.4, *127.0, 121.9, 119.5, *118.4, 
118.2, 115.7 (d, JCF = 21.0 Hz), 110.8, *107.9, 107.8, *95.5, 92.6, *79.6, 78.7, 77.2, *76.8, 
*62.4, 60.9, *55.1, 54.0, 52.6, *52.4, *29.9, 29.1; IR (thin film) ν 3391, 3057, 2951, 2847, 1952, 
1732, 1604, 1508, 1253, 1224, 1153, 842, 742 cm-1; MS m/z (%) 363 (11), 362 (45), 323 (9), 303 
(52), 239 (81), 236 (100); EI-HRMS calcd for C22H19FN2O2 m/z [M]+ 362.1431; found 362.1427. 
N
H
NH
•
OO
4-24a  
Methyl 2,3,4,9-Tetrahydro-3-(propa-1,2-dienyl)-1H-pyrido[3,4-b]indole-3-carboxylate    
4-24a.  According to General Procedure I, 4-23 (57 mg, 0.22 mmol), activated powdered 4 Å 
molecular sieves (207 mg, 940 mg/mmol), formaldehyde (0.02 mL of a 37% aqueous solution, 
0.26 mmol), and trifluoroacetic acid (16 µL, 0.22 mmol) were reacted in MeOH (5.5 mL) for 6 h 
to afford 4-24a (42 mg, 71%) as an amorphous brown solid. (Rf = 0.08, 60% ethyl 
acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 8.13 (bs, 1H), 7.50 (d, J = 7.2 Hz, 1H), 7.30 (d, 
J = 7.2 Hz, 1H), 7.19 – 7.08 (m, 2H), 5.39 (t, J = 6.6 Hz, 1H), 4.98 (dd, J = 11.1, 6.6 Hz, 1H), 
4.90 (dd, J = 11.4, 6.6 Hz, 1H), 4.25 (A of an ABq, J = 15.6 Hz, 1H), 4.12 (B of an ABq, J = 
15.6 Hz, 1H), 3.71 (s, 3H), 3.37 (A of ABq, t, J = 15.3, 1.5 Hz, 1H), 3.01 (B of ABq, t, J = 15.3, 
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1.5 Hz, 1H), 2.49 (bs, 1H), minor inseparable impurities: 7.4 (d, J = 8.1 Hz, 0.19H), 5.33 (s, 
0.26H), 3.19 (s, 0.39H); 13C NMR (75 MHz, CDCl3) δ 207.3, 173.9, 136.2, 131.0, 127.2, 121.4, 
119.2, 117.8, 110.7, 106.7, 94.1, 79.2, 60.6, 52.4, 39.8, 29.7; IR (thin film) ν  3395, 3175, 3058, 
2949, 2849, 1954, 1732, 1453, 1258, 857, 743 cm-1; MS m/z (%) 268 (13), 267 (5), 239 (55), 143 
(100); EI-HRMS calcd for C16H16N2O2 m/z [M+] 268.1212; found 268.1210. 
N
H
NH
•
OO
4-24c  
Methyl 2,3,4,9-tetrahydro-3-(propa-1,2-dienyl)-1-propyl-1H-pyrido[3,4-b]indole-3- 
carboxylate 4-24.  According to General Procedure I, 4-23 (51 mg, 0.20 mmol), activated 
powdered 4 Å molecular sieves (93 mg, 470 mg/mmol), butyraldehyde (19 µL, 0.21 mmol), and 
trifluoroacetic acid (15 µL, 0.20 mmol) were reacted in CH2Cl2 (2 mL) for 50 min to afford     
4-24c (41 mg, 68%) as a 2 : 1 mixture of diastereomers.  The diastereomers were separated by 
chromatography on silica gel (25% ethyl acetate/hexanes).  Trans-isomer (off-white solid, 
contains ~ 10% cis-isomer by 1H NMR): (Rf = 0.28, 30% ethyl acetate/hexanes); 1H NMR 
(CDCl3, 500 MHz) δ 7.80 (bs, 1), 7.51 (d, J = 7.5 Hz, 1H), 7.33 (d, J = 7.5 Hz, 1H), 7.17 (t, J = 
7.5 Hz, 1H), 7.12 (t, J = 7.5 Hz, 1H), 5.25 (t, J = 6.5 Hz, 1H), 4.84 (dd, J = 11.0, 6.5 Hz, 1H), 
4.69 (dd, J = 11.5, 6.5 Hz, 1H), 4.25 – 4.24 (m, 1H), 3.85 (s, 3H), 3.20 (A of an ABq, J = 15.5 
Hz, 1H), 3.08 (B of an ABq, d, J = 15.5, 2.5 Hz, 1H), 2.57 (bs, 1H), 1.93 – 1.87 (m, 1H), 1.79 – 
1.71 (m, 1H), 1.59 – 1.51 (m, 2H), 1.02 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 207.8, 
173.9, 136.2, 134.6, 127.6, 121.5, 119.4, 117.9, 110.7, 106.9, 92.8, 78.5, 60.4, 52.5, 48.4, 37.1, 
29.5, 18.7, 14.1; IR (thin film) ν  3402, 3056, 2956, 2932, 2870, 1952, 1732, 1452, 1257, 1156, 
852, 742 cm-1; MS m/z (%) 311 (7), 310 (20), 267 (23), 239 (39), 207 (46), 180 (70), 119 (94); 
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EI-HRMS calcd for C19H22N2O2 m/z [M+] 310.1681; found 310.1691.  Cis-isomer (yellow oil, 
contains ~ 4% major diastereomer by 1H NMR): (Rf = 0.34, 30% ethyl acetate/hexanes); 1H 
NMR (CDCl3, 500 MHz) δ 7.71 (bs, 1), 7.52 (d, J = 7.5 Hz, 1H), 7.30 (d, J = 7.5 Hz, 1H), 7.17 – 
7.09 (m, 2H), 5.48 (t, J = 6.5 Hz, 1H), 5.07 – 5.00 (m, 2H), 4.40 – 4.38 (m, 1H), 3.60 (s, 3H), 
3.55 (A of an ABq, d, J = 15.0, 2.0 Hz, 1H), 2.87 (B of an ABq, d, J = 15.0, 2.0 Hz, 1H), 2.47 
(bs, 1H), 1.88 – 1.82 (m, 1H), 1.77 – 1.68 (m, 1H), 1.58 – 1.51 (m, 2H), 1.02 (t, J = 7.5 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δ 206.9, 174.2, 136.2, 134.7, 127.2, 121.5, 119.43, 118.2, 110.6, 
107.3, 95.7, 79.5, 61.8, 52.3, 49.7, 38.1, 29.9, 18.6, 14.1; IR (thin film) ν  3397, 3056, 2955, 
2871, 1955, 1728, 1452, 1260, 1204, 857, 742 cm-1.  MS m/z (%) 311 (11), 310 (44), 267 (63), 
239 (76), 207 (74), 180 (67); EI-HRMS calcd for C19H22N2O2 m/z [M+] 310.1681; found 
310.1684. 
Tetracyclic Indolyl Pyrrolines 4-26 
AgNO3, acetone
dark, rt, 18 h
N
H
NH
•
OO
4-24
R
N
H
N
OO
4-26
R
 
General Procedure J: Preparation of 4-26b 
N
H
N
OO
4-26b
F
 
Methyl 5-(4-Fluorophenyl)-5,6,11,11a-tetrahydro-3H-indolizino[6,7-b]indole-11a- 
carboxylate 4-26b.  To a solution of allenic tetrahydro-β-carboline 4-24b (51 mg, 0.141 mmol, 
as a 2 : 1 mixture of diastereomers) in acetone (2.8 mL) in a septum-sealed 10 mL reaction vial 
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wrapped in aluminum foil, was added silver nitrate (4.8 mg, 0.028 mmol, 20 mol%, weighed and 
transferred under low light).  The reaction mixture was kept in a dark hood and stirred for 18 h 
until no starting material was evident by TLC (Rf = 0.51, 30% ethyl acetate/hexanes).  The 
reaction mixture was diluted with CH2Cl2 and washed with sat’d NaHCO3 (2x).  The combined 
aqueous layers were extracted with CH2Cl2 (2x) and the combined organic layers dried over 
MgSO4, filtered, and concentrated under vacuum.  The residue was chromatographed on silica 
gel (15% ethyl acetate/hexanes) to afford 4-26b (37 mg, 72%) as a 2 : 1 mixture of diastereomers 
as an amorphous yellow solid.  An 83% yield of 4-26b was obtained when using 40 mol% silver 
nitrate under similar conditions.  The diastereomers were separated via silica gel column 
chromatography (column diameter: 1.5 cm; silica gel height: 14.5 cm; 100% toluene; column 
progress followed by UV and KMnO4 staining of the TLC plates).  Major diastereomer 
(amorphous yellow solid, contains ~ 6% minor diastereomer by 1H NMR): 1H NMR (CDCl3, 300 
MHz) δ 7.61 (dd, JHF = 5.4 Hz, J = 8.4 Hz, 2H), 7.57 – 7.53 (m, 1H), 7.40 – 7.35 (m, 1H), 7.25 – 
7.20 (m, 1H), 7.17 – 7.09 (m, 4H), 6.02 (dt, J = 6.3, 1.8 Hz, 1H), 5.97 (dt, J = 6.3, 1.8 Hz, 1H), 
5.04 (d, J = 1.5 Hz, 1H), 4.12 (A of an ABq, t, J = 13.8, 1.8 Hz, 1H), 3.84 (A of an ABq, J = 
14.7 Hz, 1H), 3.80 (B of an ABq, t, J = 13.8, 1.8 Hz, 1H), 3.47 (s, 3H), 2.79 (B of an ABq, d, J = 
14.7, 1.8 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 175.1, 162.5 (d, JCF = 245.0 Hz), 136.8 (d, JCF 
= 2.5 Hz), 136.0, 134.3, 131.1, 130.1 (d, JCF = 7.5 Hz), 128.4, 126.9, 121.6, 119.6, 118.2, 115.6 
(d, JCF = 21.3 Hz), 111.0, 107.7, 74.9, 61.3, 59.9, 52.1, 29.3.  Minor diastereomer (amorphous 
white solid, spectroscopically pure by 1H NMR): 1H NMR (CDCl3, 700 MHz) δ 7.56 (ddd, J = 
7.7, 1.4, 0.7 Hz, 1H), 7.37 (bs, 1H), 7.37 (dd, JHF = 5.6 Hz, J = 8.4 Hz, 2H), 7.20 (ddd, J = 7.7, 
1.4, 0.7 Hz, 1H), 7.14 – 7.10 (m, 2H), 7.03 (dd, JHF = 9.1 Hz, J = 8.4 Hz, 2H), 6.11 (ddd, J = 6.3, 
2.1, 1.4 Hz, 1H), 6.01 (ddd, J = 6.3, 2.1, 1.4 Hz, 1H), 5.51 (s, 1H), 3.73 – 3.71 (m, 1H), 3.70 (A 
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of an ABq, d, J = 14.0, 1.4 Hz, 1H), 3.57 (s, 3H), 3.38 (B of an ABq, t, J = 13.3, 1.4 Hz, 1H), 
2.99 (B of an ABq, d, J = 14.0, 2.8 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 174.6, 162.6 (d, JCF 
= 245 Hz), 136.8, 136.6, 136.1, 132.1, 131.5, 130.3 (d, JCF = 8.8 Hz), 127.1, 121.7, 119.4, 118.4, 
115.6 (d, JCF = 21.3 Hz), 110.8, 108.0, 74.0, 58.6, 54.3, 51.7, 29.5. (IR, MS, and HRMS analyses 
performed on the original 2 : 1 diastereomeric mixture.)  IR (thin film) ν 3386, 3059, 2950, 2845, 
2800, 1724, 1603, 1506, 1463, 1221, 1054, 840, 742 cm-1; MS m/z (%) 362 (20), 331 (19), 303 
(100), 236 (80); EI-HRMS calcd for C22H19FN2O2 m/z [M+] 362.1431; found 362.1416. 
N
H
N
OO
4-26a  
Methyl 5,6,11,11a-tetrahydro-3H-indolizino[6,7-b]indole-11a-carboxylate 4-26a.  According 
to General Procedure J, 4-24a (33.7 mg, 0.126 mmol) in acetone (2.5 mL), was reacted with 
silver nitrate (4.3 mg, 0.025 mmol) for 18 h.  The crude residue was chromatographed on silica 
gel (25% ethyl acetate/hexanes) to afford 4-26a (18.9 mg, 56%) as an amorphous, white solid. 
(Rf = 0.46, 60% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 7.79 (bs, 1), 7.51 (d, J = 
7.5 Hz, 1H), 7.32 – 7.29 (m, 1H), 7.18 – 7.07 (m, 2H), 6.17 (dt, J = 6.0, 1.8 Hz, 1H), 6.02 (dt, J 
= 6.0, 1.8 Hz, 1H), 4.49 (A of an ABq, J = 14.4, 1.8 Hz, 1H), 4.10 (B of an ABq, J = 14.4 Hz, 
1H), 3.99 (A of an ABq, t, J = 12.9, 1.8 Hz, 1H), 3.88 (B of an ABq, t, J = 12.9, 1.8 Hz, 1H), 
3.61 (A of an ABq, d, J = 14.7, 2.1 Hz, 1H), 3.55 (s, 3H), 2.82 (B of an ABq, t, J = 14.7, 2.1 Hz, 
1H), minor inseparable impurities: 5.40 (A of an ABq, J = 11.4 Hz, 0.15H), 5.35 (B of an ABq, J 
= 11.4 Hz, 0.15H), 3.21 (s, 0.18H); 13C NMR (75 MHz, CDCl3) δ 174.3, 136.4, 132.5, 132.0, 
131.4, 127.4, 121.4, 119.2, 118.0, 110.7, 107.5, 72.7, 56.9, 51.7, 43.7, 29.3; IR (thin film) ν  
3392, 3144, 3060, 2947, 2878, 2845, 1726, 1448, 1170, 1027, 741 cm-1; MS m/z (%) 268 (17), 
  
 141 
253 (25), 209 (69), 143 (66), 117 (100); EI-HRMS calcd for C16H16N2O2 m/z [M+] 268.1212; 
found 268.1210. 
4-26b
N
H
N
OO
F
2 : 1 dr
N
H
N
OO
F
1 : 4 dr
TFA, CDCl3, 2.5 h
4-26b
 
Thermodynamic Isomerization of 4-26b.  To a solution of 4-26b (5.0 mg, 0.014 mmol, 2 : 1 
mixture of diastereomers) in CDCl3 (0.5 mL) in an NMR tube was added trifluoroacetic acid     
(3 µL, 0.034 mmol).  The reaction was followed by 1H NMR (peaks are broadened in the 
mixture due to TFA-amine salts).  Analysis after 2.5 h indicated a reversal in the diastereomer 
ratio from 2 : 1 to 1 : 4 in favor of the major product isomer (cis) shown above.  Analysis after 
24 h showed the same ratio.  The reaction mixture was diluted with ether and washed with sat’d 
NaHCO3 (2x).  The combined aqueous layers were extracted into ether (2x) and the combined 
organic layers were dried over MgSO4, filtered, and concentrated under vacuum to afford crude 
4-26b (5.0 mg, 100%) as a 1 : 4 mixture of diastereomers.  Subsequent reaction of the crude 
product with 6 µL trifluoroacetic acid in the same manner for an additional 24 h did not change 
the diastereomeric ratio.  Spectral data for each isomer is provided above.  The isomers shown 
are supported by modeling studies (see text). 
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N
H
NH
•
OO
4-26a
HO
O
isobutyl chloroformate, 
N-methylmorpholine, THF
N
H
N
•
OO
O
4-29a  
Methyl 2-(but-2-ynoyl)-2,3,4,9-tetrahydro-3-(propa-1,2-dienyl)-1H-pyrido[3,4-b]indole- 
3-carboxylate 4-29a.  To a solution of 2-butynoic acid (16 mg, 0.18 mmol) and N-
methylmorpholine (51 µL, 0.46 mmol) in THF (1.8 mL) at 0 °C was added isobutyl 
chloroformate (24 µL, 0.18 mmol).  The resultant white suspension was warmed to room 
temperature and stirred for 25 min.  A solution of 4-24a (41 mg, 0.15 mmol) in THF (1.5 mL) 
was added via cannula and the mixture stirred for 20 h until no starting material was evident by 
TLC.  The reaction mixture was quenched with sat’d NaHCO3 and diluted with ethyl acetate.  
The layers were separated and the aqueous layer extracted into ethyl acetate (3x) and the 
combined organic layers were dried over MgSO4, filtered, and concentrated under vacuum.  The 
residue was chromatographed on silica gel (30% ethyl acetate/hexanes) to afford 4-29a (37 mg, 
72%) as an amorphous white solid. (Rf = 0.49, 60% ethyl acetate/hexanes); 1H NMR (CDCl3, 
300 MHz) δ 8.34 (bs, 1), 7.48 (d, J = 7.8 Hz, 1H), 7.34 (d, J = 7.8 Hz, 1H), 7.17 (t, J = 7.2 Hz, 
1H), 7.10 (d, J = 7.2 Hz, 1H), 5.46 (t, J = 6.6 Hz, 1H), 5.35 (A of an ABq, J = 16.2 Hz, 1H), 4.76 
(dd, J = 11.7, 6.6 Hz, 1H), 4.72 (B of an ABq, J = 16.2 Hz, 1H), 4.52 (dd, J = 11.4, 6.6 Hz, 1H), 
3.81 (s, 1H), 3.46 (A of an ABq, J = 15.9 Hz, 1H), 3.21 (B of an ABq, J = 15.9 Hz, 1H), 1.99 (s, 
3H), minor inseparable impurities: 7.58 (dd, J = 7.5 Hz, 0.15H), 7.02 (s, 0.07H), 6.57 (s, 0.08H), 
5.63 (t, 0.12H), 5.41 (s, 0.17H), 5.03 (m, 0.31H), 3.74 (s, 0.28H), 3.61 (s, 0.05H), 3.58 – 3.53 
(m, 0.07H), 3.21 (m, 0.20H), 1.90 (s, 0.23H); 13C NMR (75 MHz, CDCl3) δ 208.2, 171.3, 155.9, 
136.4, 128.8, 126.9, 121.9, 119.6, 118.0, 110.9, 107.6, 90.8, 90.7, 79.3, 73.4, 62.6, 52.6, 44.2, 
26.9, 4.0; IR (thin film) ν  3057, 2949, 2855, 2236, 1958, 1739, 1628, 1395, 1257, 1044, 741 cm-
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1; MS m/z (%) 335 (11), 334 (41), 275 (44), 192 (34), 174 (81), 143 (100); EI-HRMS calcd for 
C20H18N2O3 m/z [M+] 334.1317; found 334.1323. 
N
H
N
•
OO
O
4-29a
MWI, DMF, 
225 °C, 7 min N
H
N
OO
4-30a
O
 
Fused Pentacyclic Indolyl bicyclo[4.2.0]octa-1,6-diene 4-30a.  A solution of 4-29a (10.0 mg, 
0.03 mmol) in freshly distilled DMF (0.3 mL) was heated under microwave irradiation in a 
Biotage Initiator microwave reactor at 225 °C for 7 min (Absorption level: very high; vial type: 
0.2 – 0.5 mL; pre-stirring: 0; initial power: 0; dynamic deflector optimization: on; stir rate: 600; 
approximate ramp time: 4 min).  An absence of starting material was observed by TLC after the 
described reaction time (Rf = 0.49 for both starting material and product, 60% ethyl 
acetate/hexanes; staining with PAA followed by a secondary water dip gives the product a green 
color and the starting material a brown/yellow color).  The mixture was partitioned between 
ether and water and the layers were separated.  The aqueous layer was extracted with ether (3x) 
and the combined organic layers were washed with water (3x) and brine (1x), dried over MgSO4, 
filtered, and concentrated under vacuum.  The residue was chromatographed on silica gel (30% 
ethyl acetate/hexanes) to afford 4-30a (3.9 mg, 39%) as a white powder. (Rf = 0.49, 60% ethyl 
acetate/hexanes); 1H NMR (CDCl3, 500 MHz) δ 8.22 (bs, 1H), 7.50 (d, J = 7.5 Hz, 1H), 7.34 (d, 
J = 8.0 Hz, 1H), 7.17 (t, J = 7.5 Hz, 1H), 7.12 (t, J = 7.5 Hz, 1H), 5.55 (A of an ABq, J = 17.5 
Hz, 1H), 5.30 (s, 1H), 4.47 (B of an ABq, J = 17.5 Hz, 1H), 3.79 (A of an ABq, J = 15.3 Hz, 
1H), 3.59 (s, 3H), 3.22 (A of an ABq, J = 16.5 Hz, 1H), 3.17 (B of an ABq, J = 16.5 Hz, 1H), 
3.03 (B of an ABq, t, J = 15.3, 2.0 Hz, 1H), 2.27 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 171.2, 
158.6, 153.3, 137.3, 136.6, 131.6, 129.5, 126.5, 121.9, 119.5, 118.1, 110.9, 106.4, 106.0, 70.7, 
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53.1, 40.4, 39.3, 32.9, 16.6; IR (thin film) ν 3310, 2951, 2913, 2858, 1732, 1663, 1623, 1432, 
1333, 1199, 1043, 743 cm-1; MS m/z (%) 357 (93, M + 23Na), 335 (40). 
N NHBz
•
OO
N BzN
•
OO
Boc Boc
Br
NaH, DMF, 0 °C 
to rt  2 h
4-22b 4-35  
Tert-butyl 3-(2-(methoxycarbonyl)-2-(N-(but-2-ynyl)benzamido)penta-3,4-dienyl)-1H- 
indole-1-carboxylate) 4-35.  To a mixture of sodium hydride (108 mg of a 60% dispersion in 
mineral oil, 2.70 mmol) in DMF (6.8 mL), was added a solution of 4-22b (623 mg, 1.35 mmol) 
in DMF (4.5 mL) via cannula and the mixture stirred for 5 min.  1-Bromo-2-butyne (0.24 mL, 
2.70 mmol) was added via syringe.  After 2.5 h, sodium hydride (54 mg of a 60% dispersion in 
mineral oil, 1.35 mmol) was added to the mixture, in one portion, followed by 1-bromo-2-butyne 
(0.12 mL, 1.35 mmol) via syringe.  The reaction mixture was stirred for another 30 min, until no 
starting material was evident by TLC.  The reaction mixture was poured into water and diluted 
with ethyl acetate.  The layers were separated and the aqueous layer extracted into ethyl acetate 
(4x).  The combined organic layers were washed with water (1x) and brine (1x), dried over 
MgSO4, filtered, and concentrated under vacuum.  The residue was chromatographed on silica 
gel (10% to 30% ethyl acetate/hexanes) to afford 4-35 (500 mg, 72%) as an amorphous, light 
brown solid. (Rf = 0.67, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 8.14 (d, J = 
7.2 Hz, 1H), 7.64 – 7.58 (m, 3H), 7.50 (s, 1H), 7.45 – 7.35 (m, 3H), 7.32 – 7.19 (m, 2H), 5.97 (t, 
J = 6.6 Hz, 1H), 5.11 – 4.98 (m, 2H), 4.14 (A of an ABq, J = 14.4 Hz, 1H), 3.78 – 3.76 (m, 5H), 
3.51 (B of an ABq, J = 14.4 Hz, 1H), 1.66 (s, 9H), 1.51 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
207.6, 172.3, 171.3, 149.6, 135.8, 135.2, 131.7, 130.3, 128.2, 127.4, 125.8, 124.2, 122.6, 119.8, 
115.1, 115.0, 91.2, 83.5, 80.4, 79.1, 75.8, 69.1, 52.3, 39.7, 29.1, 28.2, 3.1; IR (thin film) ν 3058, 
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2980, 2949, 2228, 1958, 1735, 1640, 1453, 1369, 1259, 1157, 1085, 856, 742 cm-1; MS m/z (%) 
513 (11), 512 (36), 412 (49), 411 (25), 283 (67), 174 (78), 105 (100); EI-HRMS calcd for 
C31H32N2O5 m/z [M]+ 512.2311; found 512.2307. 
N BzN
•
OO
Boc
MWI, DMF, 
225 °C, 7 min
N
H
BzN
OO
4-35 4-36  
Heterocyclic bicyclo[4.2.0]octa-1,6-diene 4-36.  A solution of 4-35 (503 mg, 0.98 mmol) in 
freshly distilled DMF (9.8 mL) was heated under microwave irradiation in a Biotage Initiator 
microwave reactor at 225 °C for 7 min (Absorption level: very high; vial type: 10 – 20 mL; pre-
stirring: 0; initial power: 0; dynamic deflector optimization: on; stir rate: 600; approximate ramp 
time: 4 min).  No starting material was evident by TLC after the described reaction time.  The 
mixture was partitioned between ether and water and the layers were separated.  The aqueous 
layer was extracted with ether (3x) and the combined organic layers were washed with water 
(3x) and brine (1x), dried over MgSO4, filtered, and concentrated under vacuum.  The residue 
was chromatographed on silica gel (30% ethyl acetate/hexanes) to afford 4-36 (203 mg, 50%) as 
an amorphous brown solid (please note that the indolyl Boc group is also removed during this 
reaction). (Rf = 0.13, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 8.46 (bs, 1H), 
7.72 (d, J = 7.5 Hz, 1H), 7.34 – 7.26 (m, 4H), 7.20 – 7.07 (m, 4H), 7.01 (d, J = 1.2 Hz, 1H), 5.10 
(s, 1H), 4.41 (A of an ABq, J = 14.7 Hz, 1H), 3.82 (s, 3H), 3.80 – 3.74 (m, 4H), 3.40 (B of an 
ABq, J = 14.7 Hz, 1H), 2.99 (m, 2H), 2.65 – 2.59 (m, 1H), 1.59 (s, 3H); 13C NMR (75 MHz, 
CDCl3) δ 173.7, 172.1, 138.9, 137.0, 136.4, 135.8, 134.4, 129.0, 128.6, 128.3, 126.2, 123.5, 
121.7, 119.7, 119.3, 110.9, 110.5, 105.9, 66.1, 52.5, 43.7, 39.1, 30.0, 15.1; IR (thin film) ν 3351, 
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3056, 2947, 2853, 1735, 1626, 1405, 1243, 1057, 740 cm-1; MS m/z (%) 412 (32), 282 (42), 130 
(74), 105 (100) ; EI-HRMS calcd for C26H24N2O3 m/z [M+] 412.1787; found 412.1780. 
N BzN
OO
Boc
O
DMSO, 
180 °C, 10 min
4-37b 4-37a
N
H
BzN
OO
O
 
Heterocyclic bicyclo[4.3.0]nona-2,7-dien-1-one 4-37a. A solution of 4-37b (239 mg, 0.44 mol) 
in DMSO (4.4 mL) in a 10 mL round bottomed flask was placed into a silicone oil bath 
preheated to 180 °C for 15 min until no starting material was evident by TLC.  The reaction 
mixture was cooled to room temperature and partitioned between water and ether.  The layers 
were separated and the aqueous layer extracted with ether (2x).  The combined organic layers 
were washed with water (3x) and brine (1x), dried over MgSO4, filtered, and concentrated under 
vacuum.  The residue was chromatographed on silica gel (50% to 60% ethyl acetate/hexanes) to 
afford 4-37a (152 mg, 78%) as an amorphous, brown solid. (Rf = 0.38, 60% ethyl 
acetate/hexanes); 1H NMR (CDCl3, 300 MHz) δ 8.21 (s, 1H), 7.67 (d, J = 7.8 Hz, 1H), 7.41 – 
7.32 (m, 4H), 7.23 – 7.15 (m, 3H), 7.10 (dt, J = 6.9, 1.2 Hz, 1H), 6.95 (d, J = 2.4 Hz, 1H), 5.83 
(s, 1H), 4.42 (A of an ABq, J = 14.7 Hz, 1H), 4.30 (A of an ABq, J = 17.7 Hz, 1H), 3.81 (s, 3H), 
3.49 (B of an ABq, J = 14.7 Hz, 1H), 3.04 (A of and ABq, J = 21.6 Hz, 1H), 2.95 (B of an ABq, 
J = 17.7 Hz, 1H), 2.95 (B of an ABq, J = 21.6 Hz, 1H), 1.38 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ 203.3, 171.9, 171.7, 155.2, 135.9, 135.8, 135.6, 134.1, 129.9, 128.6, 128.0, 126.5, 123.6, 122.0, 
121.5, 119.6, 119.2, 111.2, 109.8, 66.4, 52.8, 44.5, 37.4, 29.6, 7.7; IR (thin film) ν 3351, 3056, 
2947, 2853, 1735, 1626, 1405, 1243, 1057, 740 cm-1; MS m/z (%) 412 (32), 282 (42), 130 (74), 
105 (100) ; EI-HRMS calcd for C26H24N2O3 m/z [M+] 412.1787; found 412.1780. 
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N BzN
OO
Boc
O1 atm CO, DCE, 
50 °C, 1 h
4-35 4-37b
[Rh(CO)2Cl]2
5 mol%
 
Heterocyclic Bicyclo[4.3.0]nona-2,7-dien-1-one 4-37b.  Allene-yne 4-35 (204 mg, 0.398 
mmol) and rhodium biscarbonyl chloride dimer (7.8 mg, 0.02 mmol, 5 mol%) were dissolved in 
DCE (4 mL) in a septum-sealed 10 mL round bottomed flask.  The headspace was evacuated 
under vacuum and filled with CO gas three times then the reaction mixture was placed into an oil 
bath preheated to 50 °C.  The reaction mixture was stirred for 1 h until no starting material was 
evident by TLC.  The mixture was concentrated to approximately 1 – 2 mL under vacuum and 
directly chromatographed on silica gel (40% ethyl acetate/hexanes) to afford 4-37b (189 mg, 
88%) as an amorphous, brown solid.  (Rf = 0.09, 30% ethyl acetate/hexanes); 1H NMR (CDCl3, 
300 MHz) δ 8.12 (d, J = 8.1 Hz, 1H), 7.58 (d, J = 7.5 Hz, 1H), 7.42 – 7.27 (m, 5H), 7.24 – 7.19 
(m, 3H), 5.81 (s, 1H), 4.35 (A of an ABq, J = 14.7 Hz, 1H), 4.33 (A of an ABq, J = 18.0 Hz, 
1H), 3.82 (s, 3H), 3.43 (B of an ABq, J = 14.7 Hz, 1H), 3.21 (B of an ABq, J = 18.0 Hz, 1H), 
3.02 (A of an ABq, J = 20.1 Hz, 1H), 2.91 (B of an ABq, J = 20.7 Hz, 1H), 1.62 (s, 9H), 1.42 (s, 
3H); 13C NMR (75 MHz, CDCl3) δ 202.8, 171.9, 171.5, 154.7, 149.3, 136.2, 135.6, 135.1, 134.4, 
130.8, 130.0, 128.6, 126.4, 124.8, 124.6, 122.7, 121.0, 119.6, 115.1, 115.1, 83.8, 65.8, 53.0, 44.7, 
37.3, 29.4, 28.1, 7.9; IR (thin film) ν 3056, 2980, 2950, 1736, 1707, 1645, 1453, 1372, 1258, 
1157, 1073, 736 cm-1; MS m/z (%) 540 (69), 525 (30), 510 (19), 311 (46), 230 (35); EI-HRMS 
calcd for C32H32N2O6 m/z [M+] 540.2260; found 540.2258. 
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Most spectra for compounds from Chapter 3 have been uploaded with the supporting information 
for our δ- and ε-lactam publication in Organic Letters.40  Those compounds not reported in that 
publication have spectra depicted below. 
Compound Cross-Reference 
Current Compound Number Compound Number in Organic Letters 
E3-1 6b 
3-26a 9a 
3-26f 9b 
3-26g 9c 
3-26h 9d 
3-26i 9e 
3-26j 11 
3-23a 8a 
3-23b 8f 
3-23f 8b 
3-23g 8c 
3-23h 8d 
3-23i 8e 
3-23j 10 
3-19 6c 
3-24f 7b 
3-24i 7e 
3-25 13 
3-35 15 
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